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Executive Summary 
Introduction 
The trend towards rising numbers of (older) people diagnosed with long-term conditions, 
such as Parkinson’s in the United Kingdom (UK) continues. To address the needs of the 
currently estimated 127,000 people with Parkinson’s the Government has to be responsive to 
the direct financial expenditure for commissioning health and social care services, and to 
understand how the condition will affect society as a whole.  
This report details the main findings of research conducted through a survey of people 
affected by Parkinson’s looking at health and social care costs incurred during the past 12 
month period. The data is enriched by five in-depth interviews with people with Parkinson’s 
and their caregivers who responded to the survey, providing a longitudinal view of their lived 
experience of the condition from the time around diagnosis up till the time of interview. 
The survey questioned key accountable and non-accountable costs relating to the quality of 
life and wellbeing of the respondents, economic and financial costs, plus their utilisation of 
health services. Although many of the survey respondents lived alone, the majority were 
older and married, so ‘the household’ in the context of this study refers to a mean average 
size of 2 people.  
The findings from the interviews allows for a view of the less tangible costs, such as the 
psychological impact, in addition to specifics of social and financial strain to the individuals, 
their family and to society as their Parkinson’s has progressed.  
The research implications are summarised into recommendations for implementation by those 
who write policy from a national health and social care perspective, and to those in the 
voluntary sector considering the support needs of people with Parkinson’s. 
The research and main findings 
The study was undertaken largely utilising Parkinson's UK resources to seek responses. The 
profile of respondents mirrors the membership of the charity; largely white, married (with 
mainly female spouses in the role of caregiver), and with qualifications beyond GCSE. Whilst 
most people are over 65 years and retired, the age group of respondents from this study is 
younger than those involved in most studies, with people in the earlier stages of Parkinson’s 
than in the literature reviewed. The responses were received mainly from England (80.3%), 
then Scotland (11.2%), Wales (5.5%), and Northern Ireland (1.2%), with only 5% people 
from ethnic minorities.  
Not all sections of the 853 returns were filled. As each survey requested information about 
people with Parkinson’s as well as their carers, analysis has been conducted on available data 
from up to 776 people with Parkinson’s and their 546 carers. Where appropriate, a further 
breakdown into the four Home Countries has been performed in the main report. In some 
cases however, the low number of responses received from individual countries make further 
breakdown of figures unrepresentative of the population. In these cases, the figures are 
presented at aggregate level. 
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The research findings of the survey have been organised into four categories, with 
information from the five in-depth interviews adding salient comments to help understand 
aspects of living with Parkinson’s that illustrate the figures, or that are harder to account for. 
The interviews utilised a conceptual social framework developed by a group of people 
affected by Parkinson’s for a different study providing a perspective that counters the 
negative, linear medical model to consider strategies utilised by people as the condition 
progresses. Other qualitative information received from individual questionnaires has been 
considered as additional material in the Appendices, and will be analysed more fully as a 
separate account.  Direct and indirect health service costs 
A high proportion of people with Parkinson’s continually used NHS services to consult 
professionals during the past 12 months (e.g. GP, neurologist and specialist nurse; in total 22 
consultations), to undergo investigations e.g. blood tests or scans, obtain medication or 
acquire large pieces of equipment/health care packages. Other NHS costs included emergency 
and unplanned hospital admissions for people with Parkinson’s, especially in the later stages, 
spending longer in hospital once admitted than the non-Parkinson’s person.   
Private payment was used for items not easily or regularly accessible through the NHS, e.g. 
sessions with podiatrist/chiropodists, chiropractors, optometrists or physiotherapists, small 
equipment such as mobility aids or pill timers, and also for out-of-pocket expenses such as 
travel and parking to health venues. For example, one of the interviewees, MA, pays for 
private chiropodist visits as podiatry in the local hospital was only available every four to six 
weeks, and he requires management at least monthly, stating: ‘… and even in between then 
I’m suffering’. 
Things like physiotherapy and exercise might be through private means e.g. specialist clinic, 
leisure centre or subsidised through Parkinson’s UK. 
There was a £1,285,354 cost to the NHS and £161,920 for out-of-pocket expenses over the 
past 12-month period for those who completed the survey. This averaged out to £2,388 direct 
healthcare costs per person with Parkinson’s. Taking into account out-of-pocket expenses 
towards travel and equipment purchased, the total annual healthcare cost per person with 
Parkinson’s elevated to £4,347.  Social care costs 
Households with people affected by Parkinson’s paid towards alterations in accommodation 
to adapt to changes in mobility conditions, or even moved from their previous home, most of 
which were self-financed capital expenditure. The changes were not easy, with some people 
feeling forced into the situation as can be seen in MA’s statement about his move: 
‘I’m now in a bungalow because I couldn’t manage the stairs where I was before. So I’ve moved 
into a sheltered housing… At first I wasn’t going to accept this property because I thought oh it’s 
going to be too small, too cramped, but I felt well yes I can’t carry on where I am now…there 
was a risk of me having a fall [steep stairs]… So I had to really bite the bullet and say well my 
health is not, is obviously not going to get any better, it’s only going to get worse. So I need to 
not only think now but look ahead to the future. …but it was a case of I had no choice. It’s 
something I had to do because I couldn’t have continued where I was’. 
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Other costs included payments for daily living assistance such as personal care, transport to 
appointments or shopping, house cleaning and gardening. Additional utility (mainly energy) 
costs and use of takeaway or ready meals added to their expenses.  
Some of the social care costs were accessed through the local authority, but much came from 
family or out-of-pocket expenses of the people affected by Parkinson’s. The total annual 
mean out-of-pocket expense was estimated at £3,622 per household that included a person 
with Parkinson’s. 
 Societal costs  
Societal costs were noted mainly in terms of productivity loss arising from altered working 
patterns, with nearly one quarter of households reporting reduced monthly income. 
Parkinson’s directly impacted on employment and working conditions, with half those 
diagnosed, and one-third of family members decreasing their working hours, seeking more 
manageable or adaptable positions, or giving up work completely.  
The interviews permitted an insight into the psychological costs of oncoming symptoms, even 
prior to diagnosis. For example, MA, self-employed to install and service hands-free kits in 
cars for mobile phones, or radio systems stated: 
‘I noticed when I was doing installations that I was having problems sort of feeding cables 
through small gaps whereas previously I would’ve done it say in a matter of a few seconds. It 
would take me several minutes to do the same thing. Because I didn’t seem to be able to, I didn’t 
have the dexterity in my hands. Using tools was becoming more difficult…I would have to give 
myself longer on the job which isn’t always a good thing…You’ve got a limited amount of time to 
do it so it increased the pressure on me as well’. 
‘As a result the business was starting to suffer. I ended up having to sell my house because I 
couldn’t afford the mortgage…I eventually had to give up self-employment and I then when to 
work for my local authority’. 
For CC, it was his loss of concentration and inability to word-find on tours he was guiding at 
the museum he worked at that affected his work prior to diagnosis. 
Survey data calculated on an average a working person with Parkinson's lost 62.1 workdays 
per annum as a consequence of having Parkinson’s, with caregivers losing  on an average 
18.9 workdays annually. Working persons with Parkinson's also reduced weekly hours by 
12.4 and this reduction for caregivers was 10.7 working hours per week. This worked out to 
an average annual loss of £1,981 per household for those who continued to work. One in 
three people with Parkinson's were forced to take early retirement, or unable to work due to 
illness/incapacity or looking for a job adaptable to the needs of their Parkinson's. This 
accounted for annual earnings loss of £6,013 per household. Several informal caregivers were 
not enrolled with the Department for Work and Pensions for carer allowance, thus they were 
providing unpaid care to people with Parkinson's. This resulted in an annual earning loss of 
£1,235 per household. A considerable number of PwP and carers experienced discontinuance 
of their state benefits and pensions resulting in an additional loss of annual income of £1502 
per household. Thus, direct and indirect annual employment earnings/income loss totalled 
£10,731 per household.  
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Utilising early retirement figures of people with Parkinson's and their carers, it has been 
calculated that the working lifetime earnings loss to a person affected by Parkinson’s who 
takes premature retirement at any age averages £43,170 per household.  
 Quality of life and wellbeing issues 
The majority of respondents with Parkinson’s noted a decline in their health status over the 
year, compared with about half of the carers (adding to their task of managing basic 
household needs), and only a third of people with Parkinson’s reported their health status as 
good or very good, with up to two-thirds reporting a need for help with activities within and 
outside the house. Compared to the general population of their age, this was observed in 
lower quality-adjusted life years (QALY) and mean wellbeing scores (life-satisfaction, life 
worthwhile, happiness and anxiousness) in carers, but more so in people with Parkinson’s, 
worsening in those who had been diagnosed for longer.  
One of the in-depth interviewees, LA, noted her fatigue issues in an interview, affecting her 
enjoyment of her occupation as a Greenspace officer (project-work spread her working hours 
differently each day). 
‘…Because I kept irregular hours, I’ve always eaten my dinner late. If I was working in the 
evening I would have a snack late afternoon/teatime before I went back out to work and then I’d 
come back in after work and have my main meal then. I’ve noticed a big difference being off 
since October because I’m now eating at more what would be described as regular times’. 
There was also some fear expressed of facing a potential future that affected participation in 
activities with the local support group for Parkinson’s. LA’s account is a common issue in 
people with progressive conditions:  
‘And the reason for that [non-attendance at meetings, although a member of Parkinson’s UK] is 
I have a fear of meeting people who are at a much more advanced stage of Parkinson’s, which I 
could potentially be as well. I mean they’re all different, as you’re probably aware, everybody 
with Parkinson’s is different and quite unique, so there’s no saying how it will go, but it’s just the 
fear factor of seeing somebody’. 
The social framework highlighted the positives that kept people well, and socially or 
politically engaged; for example, those involved in the local Parkinson’s UK branch network 
gain from their contributions. Hence in an interview with AL and his wife, who have become 
the organisers of events for their local Parkinson’s group, AL notes: 
‘…I think a lot of the phone calls I get, people contact me because I’m the name in the... I’m the 
one that organises, and we go to the odd forum, and Parkinson’s has become my life really’. 
AL’s wife adds: ‘Actually if we want to talk about expenses, financial yes, but the actual benefit 
from belonging to the Parkinson’s group and being the coordinator I think outweigh all of that. I 
think they’ve been extremely important’. 
There is pride in contributions individuals make to the charity impacting on their wellness, 
e.g. in his interview CC proudly recounted raising £1,200 in a sponsored walk for the charity. 
Where markers of independence are lost, e.g. AL noted:  
‘...Last week DVLA took the licence away on medical grounds…so where we’ll be taking buses 
and taxis and the like, so there will be expenditures on that’, people approach it with pragmatism 
or humour: ‘…But then again we won’t have to insure the car! 
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The interviews were able to add a perspective of the impact of priority changing behaviour. 
Some lessening life quality e.g. alterations to holiday destination to ones closer to home (a 
financial saving on travel, but increased insurance prices), transport or hotels that cannot 
always accommodate needs (psychological cost from stress of planning), creating fewer 
opportunities for people to go out with friends and associates (social costs), but for others 
creating gains from new social sets. 
Conclusion 
From the completed surveys by people affected by Parkinson’s, this study was able to 
calculate an annual health and social care cost of Parkinson's to society by adding direct 
(mainly NHS) and indirect (mainly out-of-pocket) healthcare costs, non-healthcare expenses 
(paid for by the households), employment earnings losses (including unpaid caregiver earning 
loss), and cuts to benefits or pensions since registering with the Department for Work and 
Pensions as an elderly, disabled person or carer. The total societal cost was £20,123 per 
household, and excluding the NHS costs and exchequer loss, the annual direct financial 
burden on a household affected by Parkinson's averages £16,582. As the majority of 
households receiving gross annual income under £30,000, the direct financial impact of 
Parkinson’s on their household budget was enormous. Monetary impact in terms of reduced 
income and savings and increased borrowings including mortgage equity release was the 
most felt; this was followed by the changed priorities for spending, reduced social activities 
and holidays and reduced spending on festive gifts. 
The survey questions yielded over 750 variables for analysis. There is a strong message that 
as the condition progressed, and as people aged, whether diagnosed with Parkinson’s or 
caring for someone with the condition, life quality and finances undergo a reduction. 
The results have yielded recommendations for policy making based on improved 
understanding of the economic and social consequences of Parkinson's, the main ones being:  That policy makers resolve inconsistencies in the provision of services, and funding 
accessible to people with Parkinson’s across the UK. This includes consideration of 
identified work-related and benefit-related issues, impacting on households due to the 
Department for Work and Pensions, and Local Authorities regulations.   The development of a positive, empowering model to achieve the social policy drive 
whereby people with long term conditions share management, including acknowledged 
support available from non-health resources such as voluntary organisations.    Finding  means that enable people living with, or affected by Parkinson’s to remain 
independent and well for as long as possible through consistent provision of health and 
care services from diagnosis across the health, social care and independent sectors  To commission investigation into longer term societal and human capital costs, studying 
the needs of people newly diagnosed, right through to those in the advanced stages of the 
condition, and their support networks.  
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1. Introduction 
1.1 Background 
The 21st Century has seen epidemiological and demographic changes that have resulted in an 
unprecedented shift towards an ageing population, particularly in the developed world (Lutz 
et al. 2008). The global population of those aged 60 years and over is projected to more than 
double in size from its current level, to nearly 2.1 billion by 2050; and the number of people 
aged 80 years or over, the “oldest-old” persons will grow much faster to reach 434 million by 
2050 (United Nations 2015).  
The population in the United Kingdom (UK) is estimated to increase from 14.9 million in 
2015 to 23.2 million in 2050 (United Nations, 2015) with one in seven people projected to 
live over the age of 75 (Government Office for Science, 2016). Whilst life expectancy has 
doubled and people are living longer than before, these statistics come with a rise in the 
diagnosis of people with long-term and multiple health conditions in the UK (Government 
Office for Science 2016; Department of Health 2012).  
Parkinson's2 (also known as Parkinson’s disease or PD) is one of these long-term conditions 
(LTC) largely affecting the older population. It is a neurodegenerative condition, currently 
diagnosed when the part of the brain that controls movement is affected by a deficiency of a 
neurotransmitter dopamine resulting in specific motor symptoms; but it is also evident from 
the presence of non-motor symptoms such as depression, fatigue and pain that manifest 
before the motor features (Schrag et al. 2014). There is no cure for Parkinson’s, but early 
diagnosis can help in enabling the person to self-manage their condition through support from 
health professionals, carers and families (Baker and Graham 2004). The progressive, and 
variable nature of Parkinson’s from both the motor- and non-motor symptoms experienced 
over the course of the condition substantially impact on quality of life, requiring diverse 
strategies of intervention and support. 
There are an estimated 127,000 people diagnosed with Parkinson’s in the UK and this 
population is projected to rise to 161,000 by 2020 (Parkinson’s UK 2009), and even the 
projected figure is considered an underestimate. The estimated cost for management is large, 
in terms of financial, social and psychological costs.  
Over a decade ago, the UK government committed itself to improving community health, but 
to do this requires an understanding of the direct financial outlay for commissioning services 
(Department of Health 2006). The delivery of both health and social care provision to address 
the management of Parkinson’s, especially in an ageing population, has the potential to incur 
a sizeable economic and financial cost to individuals, families, the Government, and society. 
                                                          
 
2
 Parkinson’s UK consider it good practice to use the word Parkinson’s in preference to the term Parkinson’s 
disease or PD when undertaking to describe the condition, or to refer to individuals with the condition as person 
with Parkinson’s (PwP). Throughout this report we will refer to people as individuals with Parkinson’s, or PwP, 
unless in a specific context e.g. patients. 
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There is a lack of research in estimating this total financial burden on society in the UK. As, a 
parallel, the cost of dementia in the UK sees an annual economic burden of £26.7 billion, 
with an average cost of £32,350 per case (Alzheimer’s Society 2014); and about 50% of the 
cost was associated with unpaid informal care (health care costs £4.3 billion, social care 
£10.3 billion and informal care £11.6 billion). The extent of the financial burden may be 
similar to the Parkinson’s-related expenditure borne by individuals with the condition and 
their families. 
Much of Parkinson’s care is informal, meaning that this impact on quality of life is not 
restricted to the individual with Parkinson’s, but extends to carers, family, and friends 
(Williamson et al. 2008). Information sought, especially at diagnosis, or when there is a 
change in circumstances, is often un-costed as it is resourced via the Internet, and through the 
voluntary activities of Parkinson’s-related charities.  
Given the large, and increasing numbers of people with Parkinson’s (PwP) in the UK, it 
would be of benefit to understand the various dimensions of the cost of care, management and 
effective treatment available in the UK to the individual with Parkinson’s and to society. The 
National Institute for Health and Care Excellence (NICE) guideline on Parkinson's Disease 
was issued almost a decade ago (NICE 2006) without much description of the economic 
impact of the condition on UK finances. Therefore, there is a need to carry out a detailed cost 
of illness study to assess both the economic and social burden of disease on the people 
immediately affected by Parkinson’s as well as in the wider society. This proposal will use a 
household approach, enhanced through in-depth case study interviews, to focus on both the 
direct and indirect impact on income, living conditions, and wellbeing of the households, as 
well as on the individuals with Parkinson’s and their carers.  
1.2 Aims and Objectives 
The main aim of the study was to provide estimates of economic, social and financial cost of 
Parkinson's on people with condition and their families. The key study objectives were:  To assess the economic cost of Parkinson’s in the UK.  To utilise the improved understanding of the economic and social consequences of 
Parkinson's on the individuals and their families, as well as on the ageing society to 
provide evidence to inform Government and policy makers where to improve care.  To investigate various dimensions which include treatment cost borne by the government, 
direct and indirect healthcare costs to PwP, social care costs borne by the local 
government and paid/unpaid carer costs to the PwP households and societal costs in terms 
of productivity loss arising due to inability of PwP and family carers to attend to work.  To examine the impact of Parkinson's on quality of life and personal wellbeing of PwP 
and their caregivers.   To explore and estimate through in-depth case studies both accountable and non-
accountable medical, non-medical, and indirect costs to the patients and their families 
over the year as well as over the individual's lifespan as a result of the progression of the 
condition.  To assess the financial impact of treatment and care on PwP households.  To ensure the findings and key messages reach the target audience in an accessible and 
effective manner by delivering a number of communication outputs. 
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1.3 Conceptual Framework  
To make an assessment of direct, indirect and intangible costs of Parkinson’s on people 
affected by3 the condition, one needs to look beyond the bio-medical model. This study 
utilises a conceptual social framework to identify the costs to the individuals and their 
immediate families.  
Cost-of-illness studies can be undertaken using one of two methods: (1) the prevalence 
approach to estimate a condition’s total cost in a given year, or (2) the incident approach, to 
estimate a lifetime cost. Although more difficult to determine, this second approach is of 
greater use when considering the expense of a condition such as Parkinson’s, as the full costs 
(financial and social) can only be experienced over a period of several years (Drummond 
1992). Also, if the progression of Parkinson’s (based on the subtype of presentation and age 
at diagnosis) results in the development of different symptoms over time (van Rooden et al. 
2010; Selikhova et al. 2009), this will create variations in how a person manages as an 
individual.  
Cost-of-illness studies that only use survey data, or that measure lost production using a 
human capital model (by multiplying the total period of absence by the wage rate of the 
absent worker), cannot tell us where resources should be devoted for a condition to be treated 
adequately (World Health Organization [WHO] 2009; Drummond 1992), and the focus 
towards disease burden estimated through measurements of morbidity and mortality do not 
depict how illness influences the welfare of an individual (WHO 2009). Living with 
Parkinson’s can impact on people’s mood, communication, and confidence in addition to the 
physical symptoms they seek support for, and much of health and social care costs are spent 
on these impacts.  
A journey with Parkinson’s as conceptualised by people affected by the condition 
Since 2008, work has been ongoing in Sheffield, UK to utilise the experience of people 
affected by Parkinson’s to consider factors that support management of the condition 
(Ramaswamy 2010). A social framework has since been developed by co-researchers affected 
by Parkinson’s for an ongoing project looking at supporting wellness throughout the course 
of the condition. The co-researchers mapped their journey with Parkinson’s from a period 
prior to diagnosis (a stage missed by surveys, and often ignored by clinicians) towards what 
they considered as their future years (see Appendices 2 and 3 for modified version of the 
framework).  
The socially constructed framework counters the negative language and linear focus of the 
medical models currently utilised by health professions to describe and understand 
Parkinson’s. In medical models, Parkinson’s is either categorised on a one to five (1 - 5) scale 
along a pathway from diagnosis to decline (Hoehn and Yahr [H&Y] 1967); follows a 
                                                          
 
3
 The term ‘affected by’ is inclusive of people with the diagnosis of Parkinson’s, their friends, family 
and carers, plus professionals who deliver services to improve the quality of life of people with the 
condition. 
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stepwise worsening in the person’s symptomatic presentation of the condition as certain 
milestones are reached e.g. Levodopa-induced dyskinesia, H&Y stage 3 (a point at which 
falls occur), a movement disturbance known as freezing, and cognitive decline, each also 
affected by other factors e.g. age, co-morbidity (Evans et al. 2011); or provides a clinical 
scale of categories that place individuals according to the increasing therapies and support 
needs to be required (McMahon and Thomas 1998). 
The social model provides a novel and more adaptable perspective. It considers the positive 
strategies of management utilised by people affected by Parkinson’s over its time-course as 
the condition progresses.  
Although widely accepted that the progression of an individual will vary, health professionals 
anecdotally quantify the timeline of progression of Parkinson’s in five-year periods i.e. the 
earlier stage described from diagnosis to the first five years; the mid-stage being between five 
and 10 years, and from 10 years onward, or a point where a person has developed dementia or 
severe disability, when they are considered to be in the later stages of Parkinson’s (Hawkes et 
al. 2010; Jancovic and Kapadia 2001).  
To a health professional, such classification helps in the planning of interventions and support 
a person with Parkinson’s might need as the years pass, especially with regard to direct costs 
of services available to them, yet it lacks insight into specific ways people will personally 
adjust to accommodate to their changing lives, with no understanding of some of the 
intangible costs of ill health (Rice 1967). The purpose of conducting telephone interviews 
with one person from each of the home countries of the UK - England, Scotland, Wales, and 
Northern Ireland, in addition to an online survey was to gather in-depth information about 
such incidental costs and provide some idea of variations in how people manage their 
Parkinson’s outside the traditionally offered services. 
 
1.4 Data and Methods 
Study Design 
 
A mixed-method approach was employed to assess the economic impact of Parkinson's on 
individuals, their carers, and families. This included (a) UK wide mailed/online survey and (b) 
in-depth interviews with PwP and carers from varied socioeconomic environments. Such case 
studies probed further in order to reconstruct the scenarios for lifetime costs and burden on 
PwP at various stages of the progressive condition. These in-depth interviews provided an 
understanding as to how the progression of Parkinson’s affects wellbeing, including daily 
living, managing the economic condition and finances, health care and social life.  
 
The quantitative survey spread across all four countries of the UK has provided an estimate 
on the key cost drivers of health care, social care, and informal care components. The key 
cost and economic burden indicators included health and social service utilisation during the 
last 12 months. The survey questionnaire and in-depth interview schedule, as well as topic 
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guide, were designed after consulting experts and advisors to the project; the questionnaire 
was later piloted at a focus group meeting with PwP in Sheffield.  
In addition to recording the country a person lived in, certain question were asked for the 
following reasons: 
1. Age at onset, a factor linked with a difference in how Parkinson’s progress over time (van 
Rooden et al. 2010; Selikhova et al. 2009). People diagnosed below the age of 40, or over 
the age of 75 are considered to have either slower progression, or a more rapid 
progression of Parkinson’s respectively. In order to pick up any impact in the cost of 
Parkinson’s financially and socially for people according to their age, this was asked in 
the online survey.  
2. The subtype of a person at diagnosis i.e. whether they present first with tremor, or with 
slowness and stiffness, is believed to have links with the cognitive ability, mood of the 
individual with Parkinson’s (van Rooden et al. 2011), as is the length someone has been 
diagnosed (Selikhova et al. 2009). This was asked of the people who participated in the 
in-depth interviews to consider any difference in services they chose to access to help 
support any such issues. 
3. The type of area of residence of our interviewees was ascertained to see if there was a 
difference in the services they could access to meet their needs. 
Finally, in order to make a fair assessment of the economic impact of Parkinson’s on people 
and society, the findings from the primary data were supplemented and collated with the 
findings from a literature review. 
Recruitment Strategy  
 
The research team utilised Parkinson's UK services to collect the data. Parkinson's UK has a 
large membership of PwP, their carers, and professionals. This network has facilitated the 
recruitment of a large number of participants in a short span of time. The study was granted 
an approval from the Sheffield Hallam University, Research Ethics Committee. At an early 
stage, the research established a project advisory group to develop and guide the various 
stages of the study. The advisory group suggested developing and piloting a sample 
questionnaire with PwP and their carers. A focus group meeting was arranged through one of 
the team members (Bhanu Ramaswamy) who works with PwP; the feedback from focus 
group was essential to ensure that questionnaire and information were fully understood by 
PwP and carers.  Particular attention was paid to the structure of the questions, ensuring that 
as far as possible the questions were simple to answer, pre-coded with choices and offered in 
both electronic and paper format.  
 
The time needed to complete the questionnaire was also factored in, so as not to overly 
burden the PwP and their carers. The sample questionnaire went through several iterations 
before the final version was approved by the advisory group. After approval, the sample of 
the questionnaire was piloted with PwP and carers. All the comments and changes were 
reflected in the final version. The advisory group received regular updates through monthly 
teleconference calls and quarterly meetings during the project lifespan.  
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To promote the research study and the online survey to PwP and their carers, an information 
sheet describing the aims and objectives of the study was developed and designed with input 
from health professionals including Parkinson’s Nurses, as well as the PwP and carers. The 
study leaflet was developed as an A5 two-page flyer/tear-off postcard which was mailed out 
in the July 2015 edition of "The Parkinson" magazine. This was an important and timely 
strategy to access to the Parkinson's UK membership and obtain their interest and willingness 
to participate in the study. Those who showed interest were asked to fill in a short self-
completion survey online or through a postcard.  The tear-off postcard was returned to the 
Centre for Health and Social Care Research at Sheffield Hallam University, where a database 
was generated.  In addition, the leaflets were also administered through the "Network News" 
publication sent to local groups. A copy of the information sheet and leaflet are provided in 
Appendix 4. 
 
A link to the online survey which was hosted via the software, Survey Monkey, was emailed 
to potential participants with the Parkinson's monthly electronic newsletter.  Forum members 
were also targeted as it was anticipated that as the forum is separate from the membership 
system there could potentially be additional unique users whose profile may be different. For 
those who requested a paper copy of the questionnaire, a copy with a prepaid envelope was 
mailed to their home address.  In order to recruit potential participants who may not currently 
be known to Parkinson's UK, online forums such as 
http://www.mumsnet.com/Talk/nonmember_requests were approached. To further ensure 
participation from the black and minority ethnic (BME) community, contacts were sought via 
the Minority Ethnic Health Forum; Race Equality Foundation; REACH Community Health; 
and national charities working directly with the BME community e.g., 
http://www.mecopp.org.uk/home.php?section_id=1 
 
Recruitment of PwP from BME and Nursing/Care Homes (Booster Sample)  
 
Recruitment of ethnic minorities into research is a challenge, particularly with people in the 
older age groups who have several barriers to participation including language and 
communication, lack of cultural relevancy, mistrust of the health care system, and relatively 
low levels of education and socioeconomic status (Ismail et al. 2014).  
 
Drawing on prior experiences of researching with people from ethnic minorities, the decision 
was made to partner with locally established community organisations that were able to 
identify potential participants from BME communities in Sheffield and Manchester.  In the 
initial stage, the research team sought to make contact with Parkinson’s healthcare 
professionals for help in recruiting PwP and carers from the local BME community. However, 
the response from healthcare professionals was poor due to Data Protection policies.  One of 
the challenges of this task was that Parkinson’s was either not acknowledged or discussed 
within the community (as is the case with other neurological and also mental health 
conditions). To help address this challenge, a member of the research team who specialises in 
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BME community engagement used various methods to recruit participants. The methods 
included: emails, telephone calls, and conversations with community leaders of BME groups, 
attending local community events and visiting places of worship to help publicise information 
and raise awareness about the Parkinson’s research study. In Manchester, the research team 
contacted and visited a number of BME organisations in Longsight and Moss Side (BHA- 
Black Health Agency, SASCA – Somali Community group, Pakistani Resource Centre, 
MRSN, NEESA Group, Awaaz and Afro-Caribbean Carer Group).  Similar types of 
organisations in Sheffield were also contacted (South Sheffield Community Empowerment 
Project, Pakistani Muslim Centre, Somali community Centre, Pakistani advice Centre, 
Yemeni community association and Afro-Caribbean centre SADDACA). Most of the 
participants from this group were recruited by word of mouth, and individual carers who were 
interviewed were asked to introduce other PwP and carers. Participants whose proficiency in 
the English language was limited were offered help from members of the research team who 
spoke their language and helped in filling the survey questionnaire.   
 
Elderly nursing/care home residents have different health needs compared to those who are 
living in their own homes. Their mental and physical frailty makes it difficult for them to 
make choices as in the main their families make the decisions on their behalf. However, 
family carers are constrained by a lack of time and other family commitments, which in turn 
make them less likely to engage in other activities, particularly when visiting the PwP at their 
nursing home.   
 
To identify nursing home residents with Parkinson’s, the research team searched online 
databases for Registered Nursing Homes who provide care for PwP.  The contact details of 
those nursing homes were extracted by a member of the research team who then made the 
initial contact with the nursing/care home staff to enquire as to whether there were any 
residents with Parkinson’s. Nursing homes which confirmed the presence of PWP were 
invited to support the study.  The identified nursing homes with PwP, were sent an 
information leaflet about the research study, participant information sheet, and copies of the 
research questionnaire consummate with the number of residents with Parkinson’s in the 
nursing home.  The research team were not allowed to speak directly to family members of 
residents with Parkinson’s, so relied on the nursing home managers to identify potential 
participants. A member of the research team visited each of the nursing/care homes and 
discussed with the respective managers the details of the study and potential recruitment 
strategies. This helped to establish a relationship and to gain their confidence in the research 
team and to ascertain that the research topic was relevant to PwP and family carers. However, 
the research team had limited success partly due to the culture of nursing/care homes and 
inadequate time to establish the relationship. A study by McMurdo et al. (2011) reported that 
managers of nursing/care homes are often concerned about the level of disruption that 
research can cause in relation to other daily nursing/care home planned activities. Other 
factors which may have caused concern for nursing/care home managers include issues 
related to patient privacy, cognitive or communications difficulties, patients having complex 
health needs and the length of the questionnaire.   
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Response Size 
In response to call made in the Parkinson's Newsletter, over 1000 people had expressed 
interest in participating in the study (including 220 who requested a printed copy of the 
questionnaire in post) during July-Sept 2015. Between October 2015 and February 2016 
people were invited to fill online and/or postal questionnaires. In all together 853 people 
provided the information (485 filled the live online questionnaire and 368 who received an 
email invitation or hardcopy of questionnaires to complete the survey). The response was 
very low from PwP living in nursing/care homes and from BME community. In all, the 
research team was able to recruit 27 PwP and carers (10 from Sheffield and 17 from 
Manchester) from the BME community, a smaller sample than was originally planned. Other 
factors include the lack of any local statistics about the number of people from minority 
ethnic origin who have Parkinson’s and the lack of response from Parkinson's health care 
professionals. Given the short time schedule of data collection, there was no response from 
local nursing homes in Manchester; however, eight people were recruited from nursing 
homes in Sheffield. All the PwP in Sheffield were recruited through community contact with 
nursing/home care staff who promoted the research with their family members and carers of 
PwP. 
Methods of recruitment for the in-depth case studies 
The online survey asked if respondents were willing to be contacted for further questioning if 
necessary. Of those who provided both an email and a telephone contact, four people were 
selected randomly according to the home country they lived in, to get a basic understanding 
whether a difference existed in access to services across the UK.  
This method, however, resulted in a selection of four retired males, three diagnosed with 
Parkinson’s, and one carer, so a female who was still in employment (the fifth interviewee), 
was chosen through purposive sampling methods from the survey respondents. Attempts were 
made to also investigate any differences in a person from a younger onset category; however, 
none of the people contacted responded as able to be interviewed further.  
The five interviewees were contacted the week prior to their interview to obtain their 
permission, and to ascertain a time and date best for the telephone conversation. They were 
then emailed or posted the conceptual framework of the social model for Parkinson’s to be 
used as a guide to the interview (Appendix 2). The conceptual framework had been trialled by 
a group of people with Parkinson’s earlier in the project to help agree on the content of the 
survey questions.  
The initial contact and in depth telephone interviews took place during the week of 22nd 
February 2016. Verbal consent was obtained to record the conversation on a voice recorder 
(for anonymised transcription purposes) (Appendix 3), and permission sought that should 
further clarification be required, the person was happy to be emailed a question, or to have a 
second, short [unrecorded] phone conversation. 
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1.5  Limitations of Current Study 
Some of the limitations of this study are mentioned below. 
The study sought responses from community-dwelling adults, excluding those currently at 
rehabilitation centres or hospitals for extended period.  
Whilst the methods utilised to acquire responses covered people both living in their own 
homes, as well as specifically seeking information about people in institutional care facilities, 
there was a negligible response from those in nursing/care homes. This may have been due in 
part to the use of a household approach in order to understand the cost and impact of 
Parkinson's on household budgets and finances. These were less of an issue for people living 
in institutional places. 
Of the eight people living in nursing homes in Sheffield who were specifically sought for the 
study, no information of cost of care was provided. Ironically, the family or care staff 
assisting with the form filling reported that the frequency of health service use during the last 
12 months of the eight people was very high, but they did not have time to check nursing 
home records for usage of health services, especially hospitals.  
As the request was extensively distributed through Parkinson’s UK channels for online users, 
the profile of respondents' matches that of people previously described in research to engage 
or ascertain the opinions of people with Parkinson’s i.e. highly educated, confident, and 
informed people (Deane et al. 2014). To reduce such bias, a postal survey method was 
offered with a limited response. The results of this study therefore apply most directly to 
people who are representative of the membership of Parkinson’s UK.  
There were greater numbers of respondents in the earlier, and mid stages of the condition 
(mean duration was around 9 years since diagnosis) as well as the younger age group, as 
opposed to the later stages (possibly due to difficulty accessing online information, or 
responding to a long survey) and older age group. Whilst the study has provided insight into 
costs hitherto unknown for this group of people, it allows little comparison to the normative 
data collected in UK literature, usually based on people in the later stage of Parkinson's from 
clinical or hospital data. 
The main results from the study have been analysed from cross-sectional data providing a 
snapshot of a 12-month period of costs incurred by people with Parkinson’s. Whilst the case 
study interviews provided a longitudinal view of this condition, it would have been valuable 
to capture changes in the health and wellbeing of more respondents over a longer period of 
time given the progressive nature and altering needs and impact on the wider support 
networks of people affected by Parkinson’s. 
Finally, the utilisation and cost of healthcare services information were limited to PwP and 
thus not collected for carers (spouses or other family members) who might have reported 
increased use of health services as a result of caring workload and resultant deterioration in 
their general health and quality of life (mainly due to depression and fatigue). 
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1.6  Structure of the Report 
 
The report is divided into nine chapters.  The study background, aims and objectives, 
conceptual framework for the cost of illness study, mixed methods approach for data 
collection (quantitative and qualitative) from PwP and carers are illustrated in Chapter 1.  
Chapter 2 synthesises the UK evidence from the published peer-reviewed journals and grey 
literature on prevalence, management and care of Parkinson’s; impact on QoL and wellbeing 
of PwP, carers and family members; the cost of healthcare use; and societal (economic and 
financial) cost of Parkinson’s. Chapter 3 describes items of information included in the 
questionnaire for the quantitative survey, response rate by parameters, socio-demographic 
profile of PwP and carers, their economic activities including employment, living 
environment of PwP and duration of Parkinson’s. Chapter 4 presents current health status, 
quality of life and wellbeing of PwP and carers as well as the impact of Parkinson’s on their 
quality of life. Chapter 5 describes the utilisation of primary care, hospital outpatient and 
inpatient, and emergency services by PwP for their Parkinson’s care over the last 12 months 
as well as associated out-of-pocket (OOP) payments by them to use these services. The 
estimates of direct and indirect healthcare costs are also provided in this chapter. Chapter 6 
gives the economic and financial costs of Parkinson’s on PwP and their families, the changes 
in their financial situations and the estimates of societal costs of Parkinson’s. Chapter 7 
presents the extent of the financial impact of Parkinson’s on PwP households. Chapter 8 
illustrates financial costs to PwP and their families during the course of their journey with 
Parkinson's through in-depth case studies. Chapter 9 provides summary and conclusion and 
offers recommendations based on findings set out in earlier chapters. 
 
References 
Alzheimer’s Society (2014). Dementia UK: Update. London: Alzheimer’s Society, November 2014. 
Baker MG, Graham L (2004). The journey: Parkinson’s disease. BMJ, 329:611–4. 
Department of Health (2006). Our Health, Our Care, Our Say. London. 
Department of Health (2012). Long-term Conditions: Compendium of Information: 3rd ed., London. 
Deane KHO, Flaherty H, Daley DJ et al. (2014). Priority setting partnership to identify the top 10 
research priorities for the management of Parkinson’s disease. BMJ Open, 4, e006434. 
Drummond, M. (1992). Cost-of-illness studies. A major headache? PharmacoEconomics; 2(1), 1-4. 
Evans J, Mason S, Williams-Gray C, et al. (2011). The natural history of treated Parkinson’s disease 
in an incident, community based cohort. Journal of Neurology, Neurosurgery & Psychiatry, 82, 1112-
1118.  
Government Office for Science (2016). Future of an Ageing Population. London, Government Office 
for Science. 
Hawkes C, Del Tredici K, Braak H (2010). A timeline for Parkinson's disease. Parkinsonism & 
Related Disorders, 16 (2), 79-84. 
Hoehn M, Yahr M (1967). Parkinsonism: onset, progression and mortality. Neurology, 17(5), 427-42.  
 Page 16 
 
Jancovic J, Kapadia A (2001). Functional Decline in Parkinson Disease. Archives of Neurology, 58, 
1611-1615. 
Ismail MM, Gerrish K, Naisby A, Salway S, Chowbey P (2014). Engaging minorities in researching 
sensitive health topics by using a participatory approach. Nurse Researcher , 22(2), 44-48. 
Lutz W, Sanderson W, and Scherbov S (2008). The Coming Acceleration of Global Population 
Ageing. Nature, 451, 716–19. 
MacMahon D, Thomas S (1998). Practical approach to quality of life in Parkinson’s disease: the 
nurse’s role. Journal of Neurology, 245, Supplement 1, 19-22. 
McMurdo MET, Roberts H, Parker S. et al. (2011). Improving recruitment of older people to research 
through good practice. Age & Ageing, 0, 1-7, doi:10.1093/ageing/afr115. 
Parkinson’s UK (2009). Parkinson’s prevalence in the United Kingdom (2009). Accessed at: 
http://www.parkinsons.org.uk/sites/default/files/parkinsonsprevalenceuk_0.pdf. 
NICE (2006). Parkinson's disease in over 20s: diagnosis and management. National Institute of 
Health and Care Excellence guidelines CG65, June 2006. Accessed at: 
https://www.nice.org.uk/guidance/cg35. 
Ramaswamy B (2010). Working with people with Parkinson’s to determine their current coping 
mechanisms and to identify appropriate self-management strategies. Innovation Grant K-0810 report. 
Submitted to Parkinson’s UK, March 2010. 
Rice DP (1967). Estimating the costs of illness. American Journal of Public Health, 57, 424-440.  
Schrag A, Horsfall L, Walters K et al. (2014). Prediagnostic presentations of Parkinson’s disease in 
primary care: a case-control study. Lancet Neurology, 14 (1), 57-64. 
 
Selikhova M, Williams DR, Kempster PA et al. (2009). A clinico-pathological study of subtypes in 
Parkinson’s disease. Brain, 132, 2947-2957. 
van Rooden S, Cola F, Matinez-Martin P et al. (2011). Clinical subtypes of Parkinson’s Disease. 
Movement Disorders, 26 (1), 51-58. 
van Rooden S, Heiser W, Kok J et al. (2010). The Identification of Parkinson’s Disease Subtypes 
Using Cluster Analysis: A Systematic Review. Movement Disorders, 25 (8), 969-978. 
United Nations (2015). World Population Ageing 2015, New York. 
World Health Organization (WHO) (2009). WHO guide to identifying the economic consequences of 
disease and injury. Accessed at: 
http://www.who.int/choice/publications/d_economic_impact_guide.pdf.  
Williamson C, Simpson J, Murray C (2008). Caregivers’ experiences of caring for a husband with 
Parkinson’s disease and psychotic symptoms. Social Science & Medicine, 67, 583-589. 
  
 Page 17 
 
2. Literature Review 
2.1 Methods  
The literature review aimed to gather evidence on the impact of Parkinson’s on the socio-
economic life of individuals with the condition, their families and society based on prior 
research undertaken in the UK. The review also sought to enable a better understanding of the 
key medical and non-medical cost components directly associated with Parkinson's 
management and care, with an understanding of where public resources are currently directed. 
The literature has been synthesised using a comprehensive and transparent literature review 
process. 
Inclusion criteria: The review searched for published, peer-reviewed papers and grey 
literature from the UK, which underpins and quantify the direct and indirect impact of 
Parkinson's on society. Articles published in the English language between January 1991 and 
August 2015 were eligible for inclusion. All quantitative and/or qualitative study types were 
included.  
Search strategy: The literature search strategy was developed in consultation with the 
research team and comprised three facets: (1) terms for Parkinson's, (2) terms to describe the 
costs associated with the condition, such as financial, employment, pension, housing, 
healthcare costs, quality of life (QoL), and (3) terms to limit to studies situated in the UK.  
All terms included in facet one and facet two were searched for in the title and abstract fields 
and controlled vocabulary terms used where available. All terms included in facet three were 
searched for in the author address field and controlled vocabulary terms were used where 
available. The Boolean operators AND and OR were used, alongside truncation, phrase 
searching and proximity operators. The following databases were searched: ASSIA 
(ProQuest), CINAHL (EBSCO), Cochrane Library (Wiley), EMBASE (via NICE Evidence 
Search), MEDLINE (EBSCO) and Web of Science (Thomson Reuters). All search results 
were exported to RefWorks, a bibliographic management tool. A copy of the search strategy 
is provided in Appendix 5.  
Quality appraisal and study selection: After removal of most duplicate records, the database 
searches retrieved 2143 papers. In the first instance, the titles of all retrieved papers were 
screened for relevancy, with abstracts read where necessary. This resulted in a shortlist of 79 
papers. A second, thorough screening of the abstracts and full text of all shortlisted papers 
resulted in 50 papers deemed relevant to this review. The 29 papers excluded at this stage 
were eliminated for the following reasons: six were duplicates, two were descriptive in nature, 
seven were conference abstracts, nine were non-UK based studies, two were 
letter/advocacy/media papers, and three focused on validating scales/questionnaires. The 
scrutinising and selection of papers for inclusion were carried out by two members of the 
research team. The literature search screening process is summarised in the flow chart 
(adapted from Moher et al., The PRISMA Group, 2009) in Figure 2.1.  
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Figure 2.1: Flow chart of papers selection process from the database searches 
Flow chart  
 
 
 
 
 
 
 
 
 
 
 
 
 
Data extraction and synthesis: Papers meeting the inclusion criteria were read and data 
extracted using a standardised extraction form encompassing: author ⁄ date, the focus of the 
study, research design and sample size. The evidence was grouped into six themes: (a) 
Parkinson's incidence differentials by socio-economic status, (b) Parkinson's management and 
care, (c) impact on QoL and wellbeing of PwP, (d) impact on quality of life and wellbeing of 
carers and family members, (e) cost of healthcare use, and (f) societal (economic, social and 
financial) cost of Parkinson’s. 
2.2 Studies Included for Review 
Final inclusion of papers: A majority of the papers included in the literature review studied 
the impact on quality of life of PwP, carers and their family members (27 papers). Out of 
these, 10 papers examined the impact on the health and wellbeing of the caregivers (in the 
majority of cases, the papers focused on spouses) and other family members. A small number 
of studies (12) focused on estimating the healthcare costs of Parkinson’s, costs to the families 
of PwP as well as on society. A brief summary of the topics covered by these studies as well 
as their detailed references is presented in Tables 2.3.1 to 2.3.4. 
Grey Literature Search: In addition to the database searches, grey literature searches were 
undertaken on NICE Evidence Search and Google. Grey literature was considered essential to 
Papers screened by title (and abstract were 
necessary) 
(n = 2143) 
Papers identified through database searching  
(n = 3046) 
Papers after duplicates removed  
(n = 2143) 
Abstract and full-text papers screened for 
eligibility 
(n = 79) 
Papers included in this review  
(n = 50) 
Papers excluded  
(n = 29) 
Papers excluded due to following 
reasons: 
six duplicates, two descriptive in 
nature, seven conference abstracts, 
nine non-UK based studies, two 
letter/advocacy/media papers, three 
focused on validating 
scales/questionnaires  
Papers excluded  
(n = 2064) 
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this research and its inclusion is aligned to the comprehensive review methodology, as 
previously outlined. The inclusion of grey literature also helped minimise publication bias 
(Booth, Papaioannou and Sutton 2012, p.77). The grey literature searches used an abridged 
set of search terms; this was due to NICE Evidence Search and Google allowing a limited 
number of characters. The most salient search terms were identified through a scan of the 
literature yielded from the database searches. Most of the grey literature which was deemed 
to be relevant was also found to have been published elsewhere and thus duplicated with the 
previous searches. After screening for direct relevancy to costs of Parkinson's, the grey 
literature searches yielded eight additional resources which merited attention.  The key 
findings from these resources are summarised below (Table 2.1). 
Table 2.2: Summary of key messages from grey literature studies 
1. To detect and serve: DaTSCAN SPECT used to diagnose in cases of uncertainty. 
Although this approach is costly, it can differentiate a dopaminergic deficit in non-
Parkinsonian condition. The new procedures were beneficial to the unnecessary 
treatment particularly anti-Parkinsonian drugs in people with no dopaminergic 
deficiency states and peoples 'quality of life. 
2. Protect Parkinson’s nurses in England and save the (NHS) money: Parkinson’s nurses 
have played a significant role in the care and help of PwP. Their timely visits and 
interventions have helped to reduce: unnecessary consultant appointments, unplanned 
admissions, re-admissions, and lengths of stay in the hospital, thereby saving an 
additional NHS expenditure of £35.1 million per year. However, there was currently the 
budget constraint, as a result, Parkinson’s nurse service may receive a cut in the 
investment. It meant that PwP were likely to omit delivering of vital care from 
Parkinson’s nurses affecting on Parkinson’s themselves and their carers. 
3. Royal College of Nursing (RCN) Factsheet: Specialist nursing in the UK: Specialist 
nurses were significant for patients. They provided tailored care for the individual. The 
Parkinson’s nurse can potentially save unnecessary costs in the healthcare system of 
almost £148,000 per year in bed days, £44,000 for avoiding consultant appointments, 
and £80,000 for unplanned admission. 
4. Medical experts call for hospitals to ensure Parkinson’s patients get the right treatment 
after report reveals they are twice as likely to die compared to other people following 
A&E admission: PwP were more likely to be admitted as an emergency admission than 
for planned medical procedures (72% v. 28% respectively). The cost of emergency 
admissions for PwP to the NHS was annually £200m (£3,338 per PwP as compared to 
£1,417 for a planned nonemergency hospital stay). The main causes for emergency 
admissions were pneumonia, physical deterioration, urinary tract infection and hip 
fractures, and PwP were up to twice as likely to be admitted for these conditions 
compared to the average patient. Further, PwP were almost twice as likely to stay in the 
hospital for more than 3 months and almost 2.5 times more likely to die in the hospital 
after an A&E admission. There is an urgency to ensure that PwP receives the correct, 
cost-effective interventions to reduce the burden of unplanned hospital admissions. 
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5. England hospital Episode Statistics Project: The results from a cross-sectional analysis 
of England Hospital Episodes database for 2009-2013 showed 324,055 hospital 
admissions by 182,859 PwP with the larger figure for non-elective than elective 
admissions. The share of emergency admission was 72% (costing £777 million). The 
main unplanned admissions were for pneumonia, motor deterioration, urinary tract 
infection, and hip fractures.  PwP were more likely to stay longer (up to 7 days) at the 
hospital than their controls; there was also a two-fold share of PwP compared to 
controls for admission having a length of hospital stay exceeding more than 3 months. 
Therefore, people affected by Parkinson’s should receive an accurate diagnosis of their 
condition to get timely treatment. 
6. Parkinson’s Fact Sheet: The number of PwP was approximately 120,000 in the UK in 
2011.  The manifestation of Parkinson’s shows in three main symptoms, including 
bradykinesia, tremor and rigidity; a diagnosis of Parkinson’s is based on having 
bradykinesia and one or two of the other three symptoms. An autopsy is an absolute 
approach for the diagnosis of Parkinson’s. However, there are tools to help differential 
states namely PET scan, DaTSCAN, and CT and MRI. Parkinson’s has a significant 
impact on quality of life of both PwP and their carers. This disorder directly affects 
ability to work thus forcing many PwP to withdraw from their jobs and occupation. 
There is also a tendency to a reduction in working hours for carers. PwPs are also likely 
to become isolated. The effect of Parkinson’s on the socio-economic burden, therefore, 
affects both the PwP and carers. 
7. Life with Parkinson’s Non-motor symptoms: Parkinson’s has an economic impact on 
both direct and indirect costs. The direct costs are presented in terms of medicine and 
medical care; the indirect costs are associated with loss of employment in person with 
the disease and also some carers. The major problem occurring in PwP is non-motor 
symptoms that these are not related to the movement difficulty in Parkinson’s. 
8. Parkinson’s Change Attitudes: The PwP needed assistance for their daily living for 
instance support from someone (42.8% of PwP), transport (42.8%), motability (40.9%), 
health treatment (25.9%), and mobility aid (22.0%) and thus resulted in extra money 
spent per month.  
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2.3 Main Findings from Studies 
2.3.1 Incidence of Parkinson’s by Socioeconomic Status and Geography 
Using Primary Care practices data in North East Scotland, Caslake et al. (2013) estimated the 
crude annual incidence of Parkinson’s at 28.7 per 100,000 persons with a higher incidence in 
men (21.1) as compared to women (14.7). The incidence of Parkinson’s has risen 
exponentially with age particularly post 60 years in both men and women (incidence 
increased from 11.9 in 50-59 years to 149.3 in 80-89 age group). The overall age-adjusted 
male- female ratio for Parkinson’s incidence was 2.18. However, the incidence didn't 
significantly vary by level of deprivation in Scotland. Caslake et al. (2013) also undertook a 
meta-analysis of 12 similar international studies (of which three were UK based). In other UK 
studies, the estimated Parkinson’s incidence which varied between 13.3 and 18.3 was lower 
than estimated by Caslake et al. for North East Scotland. Dick et al. (2007) epidemiological 
study (conducted in four European countries: northern Scotland, south-eastern Sweden, 
northern Italy and eastern Romania) examined the association between occupational exposure 
and incidence of Parkinson’s. Scottish data showed a non-significant increased risk for 
agriculture but significantly reduced the risk for ‘transport and communication’ for 
developing Parkinson’s incidence. However, overall there was no significant relationship 
between lifetime toxic occupations exposure and incidence of developing Parkinson’s. 
 
Table 2.3.1: UK Studies on Parkinson’s incidence differentials by socio-economic status 
 
 Theme and Focus Design / Sample Size Reference 
1. Socio-economic status (SES) 
and deprivation (Scotland) 
Epidemiological: 377 PwP, meta-
analysis 
Caslake et al. 
(2013) 
2. SES and occupational 
exposure 
Epidemiological: 649 exposed and 
1587 controls 
Dick et al. (2007) 
3. SES and deprivation  
Longitudinal: aged 50+ from 469 GP 
sites (6,813 men and 5,929 women) 
Horsfall et al. 
(2013) 
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Horsfall et al. (2013) examined time trends and the influence of socio-demographic and 
geographic factors on the incidence of Parkinson’s diagnosis using the UK Primary Care 
database for patients aged over 50 years. The incidence of Parkinson’s varied by age, gender, 
time period, social deprivation score and urban/rural status. The overall incidence of 
Parkinson’s for people over 50 years was 84 per 100,000 person years. After accounting for 
socio-demographic factors, the adjusted incidence rates were 46 % higher in men than in 
women, 12% higher in urban than rural areas and marginally lower in less socially deprived 
areas. Over time, there was a downward trend in Parkinson’s diagnosis with the adjusted 
incidence rate declining by around 6% every calendar year between 1999 and 2009 which 
may largely represent changes in diagnosis and/or coding rather than a true decline in 
incidence. The study concluded that the Parkinson’s diagnosis rates in the primary care 
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setting were higher in men and greater in urban areas but not different between socio-
economic groups.  
2.3.2  Parkinson’s Management and Care 
Deane et al. (2014) undertook a study with stakeholders (PwP, caregivers, family and friends 
of PwP, healthcare and social care professionals) to identify and prioritise the top 10 
evidential uncertainties that impact on everyday clinical practice for the management of 
Parkinson’s in the UK. After surveying 1000 participants and in-depth discussions, 
stakeholders agreed on the following top 10 research priorities for Parkinson’s management: 
the need to address motor symptoms (balance and falls, and fine motor control), non-motor 
symptoms (sleep and urinary dysfunction), mental health issues (stress and anxiety, dementia 
and mild cognitive impairments), side effects of medications (dyskinesia) and the need to 
develop interventions specific to the phenotypes of Parkinson’s and better monitoring 
methods.  Deane et al.'s study thus identified crucial gaps in the existing evidence to address 
everyday practicalities in the management of the complexities of Parkinson’s. 
Skelly et al. (2015) studied views of consultant geriatricians and neurologists and PDNS on 
the quality of in-hospital care provided to PwP. The study found wide variations in the 
standard of care and one-fifth of hospital professionals rated the overall standard of care as 
poor and three-fifths felt that medications were not given on time. The study suggested 
piloting out various interventions to improve the care of PwP in hospitals. 
Walker et al. (2011) study aimed to assess the PwP health and social care living in North 
Northumberland (a mostly rural area), UK.  About 13.3% of PwP were living in institutional 
care, and remaining 86.7% living in their own homes. Of those living in their own homes 
27.7% had domestic home care services provided and 26.2% used personal home care, 
services. Five PwP had significant care input from a carer or a family member (7.7%) and 11 
from a care worker (17%). Two patients were regularly visited by a district nurse, one by a 
social worker, and four by an occupational therapist and two patients regularly attended a 
local day care centre. The study concluded that living in a rural area appeared to be no 
hindrance to accessing care services when required. 
Armitage et al. (2009) undertook in-depth interviews of PwP and their close relatives in care 
homes to explore the effectiveness of care specifically on the role of family members in 
implementing care pathways. Five primary themes included were:  lack of information about 
PwP, functional variation, nature of relatives’ involvement, care home environment and 
culture, and care provision. The study found an apparent shortfall in the knowledge and 
understanding of PwP among care home staff and there was a lack of involvement of PwP 
family in better management of care. 
McLaughlin et al. (2011) explored the caring experience of relatives providing palliative care 
for PwP. All 26 caregivers were spouses, the majority female (n = 17) and all were 
responsible for providing physical, social and emotional care in the home. The majority 
(81%) were aged over 55 years of age and the length of their caring activities ranged between 
two and 20 plus years. Four themes emerged from the in-depth analysis: medical support for 
PwP, burden related to caregiving, information needs and economic implications. Although 
the relatives of PwP viewed caregiving as their role and duty, the results highlighted the 
widespread burden of providing care on the emotional and physical health of the caregivers. 
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The financial implications for providing care were outlined, with many reporting difficulties 
in accessing benefits. From the point of diagnosis, which had a huge emotional impact on 
relatives and caregivers, many felt that health professionals hadn’t consulted them for the care 
pathway plan. Since diagnosis, caregivers commented on the lack of continued and 
coordinated care plans for relatives, resulting in symptoms being mismanaged and care 
opportunities for family and relatives being missed. Stereotypes of the meaning and timing of 
palliative care were common with many viewing it as being synonymous with cancer and not 
applicable to a PwP. As the wellbeing of the informal caregiver directly influences the care of 
the PwP, support interventions are required to relieve their burden, maximise outcomes and 
ensure targeting of services. 
Waldron et al. (2013) examined the social worker's role in the delivery of palliative care to 
PwP. Differing perceptions of palliative care emerged: from a holistic approach to specialist 
care near the end of life. Negative associations of palliative care were identified. Other 
barriers also exist such as a lack of knowledge and experience of Parkinson’s and a lack of 
resources that hinder the delivery of palliative care to clients with chronic conditions. 
Different interpretations of palliative care affect its delivery to clients with LTC. Very few 
PwP were referred to specialist palliative care specifically for management of their 
symptoms, which must prevent holistic care. Social workers have an important, yet 
underdeveloped, role in identifying and addressing palliative care needs. Participants stressed 
that palliative care provision should be extended to support family carers. They felt that the 
demanding role of a carer often goes unrecognised. Carers, who may have their own health 
problems, may have to adapt to their loss of independence, increased social isolation, physical 
exhaustion and psychological stress. They favoured a separate assessment of carers’ needs 
and respite provision for carers that would depend on factors such as a client's level of 
mobility. Practical help, information, emotional support, referral to appropriate agencies that 
might be of benefit and respite opportunities were highlighted as carers’ needs. Policies and 
procedures should be clarified regarding prioritisation and access for clients with chronic 
LTC to appropriate palliative care.  
Higginson et al. (2012) examined changes in palliative care needs with Parkinson’s in late 
stage, shown by H&Y stage 3-5. Over two-thirds of patients had a severe disability, of which 
over one-third were wheelchair-bound/bedridden. Over the year, half of the patients showed 
either an upward (worsening, 24/60) or fluctuant (8/60) trajectory on palliative care outcome 
scale and symptoms. The strongest predictors of higher levels of symptoms at the end of 
follow-up were initial scores on the palliative care outcome scale and being male, both were 
more predictive than initial H&Y scores. The quality of life of PwP in late stage (measured 
through EuroQuol-5 dimension [EQ5D] and Parkinson’s Disease Quality of Life 
Questionnaire [PDQ]-8 tools) had deteriorated considerably over one year with one-third of 
PwP having died. The findings point to a profound and complex mix of non-motor and motor 
symptoms in PwP in late stage. Symptoms are not resolved and half of the patients 
deteriorate. Palliative problems are predictive of future symptoms, suggesting that an early 
palliative assessment might help screen for those in need of earlier intervention. 
The results have been summarised below (Table 2.3.2). 
  
 Page 24 
 
Table 2.3.2: UK Studies on Parkinson’s management and care 
 Theme and Focus Design / Sample Size Reference 
1. Priority settings by clinicians, 
health professionals and families 
Cross-sectional: 1000 people Deane et al. (2014) 
2. In-hospitalisation care: clinicians 
and health professionals view 
Cross-sectional: 93 staff Skelly et al. (2015) 
3. Care services for rural PwP Cross-sectional: 75 PwP Walker, Sweeney 
and Gray (2011) 
4. Effectiveness of care in nursing 
home 
Qualitative: carer's experience- 
51 relatives and 24 PwP 
Armitage et al. 
(2009) 
5. Palliative care needs, QoL in 
Late stage 
Longitudinal: 82 PwP Higginson et al. 
(2012) 
6. Palliative care needs, QoL of 
carers 
Qualitative:  26 carer's 
experience 
McLaughlin et al. 
(2011) 
7. Social workers' role Qualitative: 13 in-depth 
interviews of social workers 
Waldron et al. 
(2013) 
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2.3.3 Quality of Life 
(A) Impact on quality of life and wellbeing of PwP 
Parkinson’s is a progressive condition and thus has a significant impact on QoL and 
wellbeing of PwP over time. A number of studies have documented the impact of the 
progression of Parkinson’s into the gradual loss of both motor and non-motor functions, 
consequently impacting on QoL of PwP. To recognise and factorise specific aspects of impact 
on QoL and wellbeing on PwP, the eighteen studies identified could be classified into two 
broad groups: First, Parkinson’s symptoms severity and diversity; second, self-help groups 
and social support and their interface with health and wellbeing. 
1. Differential effects of symptoms with Parkinson’s stage  
Varied symptoms that emerge from the point of onset of Parkinson’s will worsen, particularly 
in people who have been diagnosed for more than 6 years (Politis et al. 2010). Both the 
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experience of the motor (movement) and non-motor symptoms directly affects the QoL of 
PwP and worries/anxieties/depression associated with further deterioration in QoL in PwP 
with condition progression. The Parkinson’s Disease Quality of Life Questionnaire (PDQ-39) 
which covers eight domains and comprises 39 items, is widely used as a disease-specific 
measure of health-related quality of life (HRQoL) in PwP. The eight domains are: mobility, 
activities of daily living (ADLs), emotional wellbeing, stigma, social support, cognition, 
communication, and bodily discomfort.  
Motor symptoms: Bradykinesia, rigidity and tremor are the ‘cardinal motor symptoms’ 
affecting the everyday activities and life of PwP. Problematic mobility problems include: 
shuffling gait, start hesitation, freezing, festination, propulsion, and difficulty in turning. The 
most important consequence of the motor symptoms is falling, influencing costs related to 
injury, increased the length of hospital stay, and restricting participation in social activities. 
Motor symptoms were also shown to significantly impact on QoL scores and thus resulted in 
poorer HRQoL in PwP (Rahman et al. 2008). In comparing the QoL of PwP attending 
movement disorders clinic vs. general medical clinic in Scotland, it was found that the QoL 
of PwP attending the movement disorders clinic was significantly higher (Blackwell, Brown 
and Rochow 2005). 
Non-motor symptoms: Non-motor symptoms manifest in a diverse range of symptoms 
comprising: mood, cognition, sensory disturbance, autonomic disturbance, and pain. The 
level and degree of non-motor symptoms are correlated to advancement in age and the 
severity of the disease. The evidence suggests that these symptoms have a significantly 
greater influence on HRQoL of PwP from early through to the advanced stages of 
Parkinson’s. Depression, anxiety, impaired concentration, memory retrieval, sleep 
disturbance, and autonomic disturbance had shown significantly negative impacts on QoL 
(Findley et al. 2002; Politis et al. 2010; Rahman et al. 2008; Leroi et al. 2011; Duncan et al. 
2014; Simpson, Lekwuwa and Crawford 2014). Depression develops in approximately 50% 
of PwP as the condition progresses, and although the most troublesome of the non-motor 
symptoms, it remains under-recognised and lacks effective treatment (Politis et al. 2010).  
Shearer et al. (2012) evaluated health state utility value affecting motor and non-motor 
symptoms of patients with idiopathic Parkinson's using the EQ-5D. Findings indicated pain, 
depression, motor impairment and insomnia as the main declining factors in utility value of 
PwP. Depression had the greatest impact during the early stage of the condition. Thus an 
improvement of the main factors influencing utility value could contribute to an increase in 
QoL among PwP. 
In a survey of PwP, the most troublesome symptoms, the pain (in particular musculoskeletal 
and visceral pain) was ranked the highest amongst non-motor symptoms  in an early stage 
Parkinson’s group, thus affecting directly their QoL (Politis et al. 2010). These symptoms 
resulted in a direct increase in medical and other health care costs, and should therefore be 
recognised as a key factor of this disorder, and taken into account for developing better 
management of the condition. 
2.   Self-help groups and social support in PwP 
The literature highlighted that as Parkinson’s progresses, PwP experience three main 
alterations in their perception and adaptation of living with the condition: (1) change, (2) 
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addressing changes, and (3) reflections on living with Parkinson’s (Benharoch and Wiseman 
2004).  
First, the most common symptom changes in PwP included tremors, changes in movement 
quality, dribbling, difficulties in swallowing and speech, tiredness, problems with digestion, 
and deterioration of memory. Other changes included a decline in mobility, loss of 
employment, but gains in new skills due to being diagnosed with Parkinson’s. Second, the 
need to address changes identified medications management over time, reactions to other 
people’s involvement, occupations undertaken to maintain wellbeing, and finding new ways 
of doing things. Third, reflections on living with Parkinson have included thoughts on 
problems encountered, acceptance of the disease, self-consciousness, the importance of a 
positive attitude and maintaining normality. PwP who were participating in self-help groups 
were more likely to accept their condition and also adapt their usual lifestyle. However, they 
also expected that self-help groups should be more supportive. Conversely, PwP who were 
not supported socially reported higher scores/levels of distress, anxiety, stress, and less 
satisfaction (Simpson et al. 2006). Further, those PwP who had stronger social support in 
terms of the number of close relationships, reported better psychological outcomes (Simpson 
et al. 2006). Therefore, further research should explore the social support and services that 
might mitigate deterioration in QoL of PwP.   
Barrow and Charlton (2002) explored how progression of the condition had affected the lives 
of eight PwP and whether self-help group membership was related to coping methods (four of 
the participants were members of the Parkinson's UK Society and four were not). It was 
found that all participants had experienced losses of physical and mental functioning and 
independence, self-identity and future quality of life and were afraid of further losses as the 
Parkinson’s progressed. Although all participants used a range of coping methods, it was 
found that there were differences between members and non-members in the prominence of 
certain methods and overall coping style. For non-members, coping centred upon maintaining 
a normal life and denying they had the condition; for group members, the condition and its 
likely consequences were accepted and incorporated into everyday life. The discourse of non-
members contained many references to a self-help group as a source of distress, while 
discourse of members identified it as a supportive resource. This exploratory study enhances 
our understanding of differences between people in their willingness to use a self-help group, 
and in turn, raises questions about the provision of psychological services in a chronic 
progressive disorder. 
To sum up, the QoL of PwP is mainly affected by non-motor and motor symptoms. Non-
motor symptoms include psychological wellbeing, particularly depression and anxiety. 
Depression is a significant problem affecting PwP, it is not well treated and leads to direct 
medical and healthcare costs. On the other hand, common motor symptoms derived from 
bradykinesia, rigidity, and tremors are associated with the physical wellbeing of PwP. These 
symptoms can provoke a fall associated with injury, treatment in hospital, and additional 
social care needs. These factors accelerate a reduction in QoL in PwP.  
Some studies focused on the impact of Parkinson's on wellbeing. Two studies found poorer 
QoL and emotional wellbeing in early onset groups than late-onset of PwP (Knipe et al. 2011; 
Lawson et al. 2014). Another study showed that the subjective wellbeing scores of PwP 
living in a care home were lower than in people living alone in their own home (Cubi-Molla 
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and Devlin 2014). Moreover, people with advanced Parkinson's experienced a decline in their 
ability to perform their occupation well due to lower physical, psychological, social and 
spiritual wellbeing, leading to the difficulties with their employment. These caused distress 
and disappointment of PwP, as well as impacting on their QoL and wellbeing (Murdock, 
Cousins and Kernohan 2014). 
 
(B)  Impact on quality of life and wellbeing of carers and family members 
Parkinson's not only impacted on people who are living with the condition, but it also affects 
the QoL of caregivers, as assessed using PDQ-carer, questionnaire and Short form (SF)-12 
questionnaire and self-reported wellbeing questions. Studies have found a number of factors 
influencing QoL in carers, including: age, gender, health status, duration of caregiving role, 
the level of mobility in PwP, and impaired cognitive function in PwP. Most caregivers were 
female and were the spouse or partner of the PwP. The caregivers were younger, with mean 
age lower than those of PwP. An increase in morbidity, particularly psychiatric symptoms, 
was found almost five-times higher in caregivers compared to the general population of 
similar age group.  In addition, the QoL of caregivers over the long-term duration of 
caregiving was inferior as compared to the general population particularly in the four 
dimensions of social, anxiety and depression, stress, and self-care. It has been reported that 
Parkinson’s has a widespread impact on caregivers’ social, psychosocial, and physical 
wellbeing (Davey et al. 2004; O’Reilly et al. 1996; Kudlicka, Clare and Hindle 2014; Peters 
et al. 2011; Peters et al. 2013; Morley et al. 2012; Drutyte et al. 2014). Morley et al. (2012) 
indicated that a carer's age, gender, health status, caregiving duration, mobility and cognitive 
impairment were significant factors influencing QoL of caregivers.  
Schrag et al. (2004) explored the impact of Parkinson’s on the offspring of PwP. The 
activities of daily living help and the loss of social life were main burdens where the children 
were still in adolescence. In some of the adult children, the aspect of caring for their own 
family was a significant influence. Morley et al. (2011) examined the QoL and wellbeing 
affecting younger children and older children of parents with Parkinson’s and multiple 
sclerosis (MS). A comparison found that there was no difference in QoL and wellbeing in 
either group. The clinical guideline was important for offspring who were looking after their 
parents with PD and MS. The NICE guidelines for Parkinson’s disease published in 2006 
made no reference to the children of PWP; many children who were providing informal care 
to PwP expressed that they did not have enough information about their parent’s Parkinson's 
(Schrag et al. 2004; Morley et al. 2011).  Future guidelines should include information for 
adult children to help ensure better communications and interactions with health 
professionals. 
Falls in PwP were identified as the most important factor that significantly impacted on 
informal care, with carers experiencing anxiety, worry, fear, anger, frustration, and shock due 
to falls in PwP. Increased occurrence of falling in PwP lessened the chances for carers to go 
out for their normal activities, decreased contact with their friends and neighbours. 
Furthermore, falling also increased health care costs of PwP and caregivers (Davey et al. 
2004). Education courses and support for informal caregivers was limited and there is a need 
for them to be supported by health professionals, particularly Parkinson’s Disease Specialist 
Nurses (PDNS).  
The results have been summarised below (Table 2.3.3). 
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Table 2.3.3: UK Studies on Parkinson’s impact on quality of life  
 
 Theme and Focus Design / Sample Size Reference 
(A)  Impact on QoL - PwP only 
1. Physical and mental functioning, 
independence and self-identity 
Qualitative: 8 in-depth 
interviews of PwP 
Barrow and 
Charlton (2002) 
2. Positive impact by participation in 
different daily activities 
Qualitative: 7 in-depth 
interviews of PwP 
Benharoch and 
Wiseman (2004) 
3. QoL differentials: attending general 
vs. movement disorder clinic 
Cross-sectional: 42 PwP Blackwell, Brown, 
Rochow (2005) 
4. QoL and Wellbeing differentials Cross-sectional: 199 PwP Cubi-Molla and 
Devlin (2014) 
5. Condition progression (Advanced 
stage) and treatment 
RCT:280 PwP, Sumanirole 
vs. placebo 
Duchane and 
Jenkinson (2003) 
6. Non-Motor symptoms at Early stage Epidemiological: 58 PwP and 
99 healthy controls 
Duncan et al. 
(2014) 
7. QoL differential factors after 
controlling for disease severity and 
medication 
Cross-sectional (UK, Italy, 
Spain, USA, Canada, Japan): 
 203 clinicians,  1020 PwP, 
687 carers 
Findley et al. 
(2002) 
8. Differentials by young vs older Cross-sectional: 426 PwP Knipe et al. (2011) 
9. Early stage cognitive impairment Epidemiological: 219 PwP 
and 99 healthy controls 
Lawson et al. 
(2014) 
10. Differentials by Parkinson’s stages Cross-sectional: 123 PwP Lee et al. (2006) 
11. Differentials and predictors Cross-sectional: 81 PwP Lekuwa and 
Crawford (2014) 
12. Early stage - apathy and impulse 
controls 
Cross-sectional: 99 PwP Leroi et al. (2011) 
13. Parkinson’s progression Qualitative: 10 in-depth 
interviews of PwP 
Murdock,Cousins 
and Kernohan 
(2014) 
14. Daily activity and most severe 
health complaints by Parkinson’s 
progression 
Cross-sectional: 130 PwP Politis et al. (2010) 
15. Daily activity and management of 
symptoms/complaints by Parkinson’s 
progression 
Cross-sectional: 265 PwP Rahman et al. 
(2008) 
16. Motor and Non-Motor symptoms 
by Parkinson’s progression 
Cross-sectional: 162 PwP Shearer et al. 
(2012) 
17. Wellbeing and social support Cross-sectional: 34 PwP Simpson et al. 
(2006) 
(B)  Impact on QoL - Carers and Family members 
1. Fall management by carers Qualitative: 14 in-depth 
interviews of carers  
Davey et al. (2004) 
2. Stress and financial impact on carers Cross-sectional: 1881 carers Drutyte et al. 
(2014) 
3. Stress on carers Cross-sectional: 123 carers Schrag et al. (2006) 
4. PwP and Carers by Parkinson’s 
severity 
Cross-sectional: 65 PwP, 50 
carers 
Kudlicka, Clare 
and Hindle (2014) 
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5. PwP and Carers by Parkinson’s 
severity 
Cross-sectional: 238 PwP-
carers 
Morley et al. 
(2012) 
6. Health and wellbeing differentials 
Carer spouse vs. non-carer spouse 
Epidemiological: 154 carer 
spouses, 124 non-carer 
spouses as control 
O'Rielly et al. 
(1996) 
7. Health and wellbeing differentials 
of PwP and Carers 
Cross-sectional: 901 PwP, 
734 carers 
Peters et al. (2011) 
8. QoL and health and social services 
experience of Carers of Parkinson's vs. 
Other neurological conditions 
Cross-sectional: 1910 carers 
(434-motor neuron disease, 
721-multiple sclerosis and 
755-Parkinson’s disease) 
Peters et al. (2013) 
9. QoL of Offspring Cross-sectional: 143 
offspring 
Morley et al. 
(2011) 
10. QoL of Offspring Cross-sectional: 89 offspring Schrag et al. (2004) 
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2.3.4 Cost of Healthcare Use  
The greatest impact of Parkinson’s is on the deterioration of QoL of both PwPs and 
caregivers. There is also a tremendous economic and financial burden on society in terms of 
social care and health care delivery costs. The overall economic burden of Parkinson’s could 
be assessed by measuring the direct medical and non-medical costs as well as indirect costs.  
The annual total costs of a Parkinson’s case varied markedly between £13,800 (McCrone, 
Allcock and Burn 2007) and £29,000 (Findley et al. 2011). The direct medical costs were 
estimated to be £1,881 per patient per annum which comprised hospitalisation (£1,378), 
professional visits (£385), and tests (£117).  Direct non-medical costs (professional care 
costs) were £13,364 per person per annum, and indirect costs (informal care costs by families, 
productivity losses, and sick-leave) ranged between £11,000 and £12,500 per person per 
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annum (McCrone, Allcock and Burn 2007; Findley et al. 2011). The proportion of direct 
medical costs, direct non-medical costs, and indirect costs were 7%, 50% and 43% 
respectively (Findley, et al. 2011). As seen in the previous figure, the overwhelming costs of 
Parkinson’s were attributed to direct non-medical costs and indirect costs. In addition, 
McCrone, Allcock and Burn (2007) demonstrated that the burden of informal care cost was 
the greatest, contributing to 80.3% of the total cost of £13804, whilst direct social cost was 
just 5%. Further, the data from the studies which focused on the impact on caregivers’ QoL 
showed that most carers were retired, female and also the spouse or partner of the PwP. 
McCrone et al. further argued that as most PwP were male, there was an underestimation of 
the costs of time put in by female caregivers.  
Total costs of care varied by QoL of PwP in relation to medication cycles and the severity of 
the condition. The severe health states resulted in an increase in the time spent in OFF state 
(when medication to improve the dopaminergic system and movement was not at its optimal, 
and people experienced tremor, stiffness, slowness of movement, and/or mobility problems), 
with increasing H&Y scores, and thus resulted in rising costs. Also the longer duration of 
Parkinson’s, depression, gait disturbance, and community/neighbourhood related problems 
resulted in a further increase in costs (Findley et al. 2011). Findley (2007) estimated that the 
total cost of PD was between £450 million and £3 billion per year; the underlying variation 
was mainly due to the indirect costs and prevalence rate for Parkinson's used in the model. 
Hospitalisations cost the NHS more, as compared to ambulatory care. According to hospital 
admissions data for PwP, 28% were a consequence of elective admission and 72% non-
elective admission as compared to age and sex-matched individuals admitted to hospital for 
who the respective proportions were 60% and 40% (Low et al. 2015). Almost double the rate 
of non-elective admission was found in PwP, with the highest rate (45.3%) recorded in those 
in the age range between 75-84 years (Low et al. 2015).  The cost of excess bed days (EBD) 
accounted for 12% of the total costs (Low et al. 2015). Pneumonia, Parkinson’s itself, urinary 
tract infections, cardiac-related and hip fractures were the most causes of non-elective 
admissions. The proportion of falls and fractures, particularly hip fractures contributed much 
more in the total costs (comparison frequencies and costs) (Low et al. 2015). These were 
consistent with motor symptoms in which falls were the significant troublesome complaint 
affecting QoL and informal care costs. Furthermore, PwP who had co-morbidities associated 
with urinary tract infections, pneumonia and hip fractures were likely to stay longer in the 
hospital, and in those over 85 years, the likelihood of mortality was higher as compared to the  
younger age cohorts (Low et al. 2015). Similarly, Xin et al. (2014) found that pneumonia, 
urinary tract infections, falls and fractures, cardiovascular and circulatory disorders, central 
nervous system disorders and disorders of sense organs, gastrointestinal disorders, and mental 
disorders were the main causes for emergency admissions and hospitalisations in PwP with 
disease progression. 
The PDNS can reduce number of doctors and specialist consultations about Parkinson’s care. 
According to Hobson, Roberts and Meara's (2003) study, the PDNS assessed 321 patients and 
made 881 interventions during one year. The estimated cost saving by employing a PDNS 
was £54,992. Community visits by PDNS potentially saved £8,296 on outpatient and £1203 
on inpatient visits. Jerman et al. (2002) and Hurwitz et al. (2005) examined PDNS 
intervention and found the nurse specialists had little impact on the clinical conditions of PwP 
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but that they were able to improve the overall wellbeing of the PwP without adding 
healthcare costs.  
A cost-effectiveness and QoL review of Parkinson's undertaken by Dowding, Shenton and 
Salek (2006) found that the carers' burden was the major source of economic costs which so 
far had not been factored into cost-effectiveness analysis studies. They further stated that 
Parkinson's cost of social care as well as healthcare could significantly be decreased by 
improving HRQoL of carers.  
The summary results from reviewed papers are shown below (Table 2.3.4). 
Table 2.3.4: UK Studies on healthcare and societal costs related to Parkinson’s 
 Theme and Focus Design / Sample Size Reference 
1.Cost- effectiveness/ QoL 
reviews 
Literature review: 
International 
Dowding, Shenton and 
Salek (2006) 
2. Medication costs differentials 
by Parkinson’s progression 
Cross-sectional: 409 PwP, 
movement disorder clinic 
Dodel et al. (1998) 
3. Economic and healthcare 
impact 
Cross-sectional: 432 PwP Findley et al. (2007) 
4. Healthcare costs: home vs. 
residential care 
Cross-sectional: 302 PwP 
by severity 
Findley et al. (2011) 
5. Healthcare costs by Parkinson’s 
progression 
Cross-sectional: 444 PwP Findley et al. (2003) 
6. Specialist Nurse service cost Cross-sectional: 321 PwP Hobson,  Roberts & Meara 
(2003) 
7. Specialist Nurse Intervention on 
health care costs and QoL 
RCT: 1859 PwP Jarman et al. (2002); 
Hurwitz et al. (2005) 
8. Hospitalisation costs and 
incidence  
Routine Hospital Episode 
Statistics data for 4 years 
 Low et al. (2015) 
9. Hospitalisation costs, incidence  
by Parkinson’s progression 
RCT: 2074 PwP, followed 
over 10 years 
Xin et al. (2014) 
10. Healthcare and societal costs 
by severity 
Longitudinal: 174 PwP McCrone,  Allcock and 
Burn (2007) 
11. Societal costs - loss of 
employment 
Quantitative: two datasets: 
151 and 308 PwP 
Schrag and Banks (2006) 
12. Employment loss and financial 
burden  
Cross-sectional: 72 PwP Clarke,  Zobkiw and 
Gullaksen (1995) 
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2.3.5 Societal (Economic, Social and Financial) Cost of Parkinson’s 
Only a few studies revealed the societal costs of Parkinson's. In terms of (loss of) 
employment for PwP, the duration since diagnosis of the condition had a direct impact on 
full-time and part-time work status. The more advanced the condition, the less employment 
was noted in those populations. Schrag and Banks (2006) found that in PwP with Parkinson’s 
duration of more than 5 years, only 6-10% of them were working full-time and 7% held part-
time jobs. 46 % of PwP were unable to work after having Parkinson's for more than 5 years 
and this figure increased to 82% for those having Parkinson's for more than 10 years. 
Additionally, the average time loss of employment due to Parkinson’s was 4.9 years. Gender, 
type of work, and living circumstances had the least influence on average years of 
employment lost (Schrag and Banks 2006). McLaughlin et al. (2011) through in-depth 
interviews with caregivers outlined the financial implications for providing care to PwP by 
family members and underlined the difficulties in accessing benefits and the loss of income.  
Clarke, Zobkiw and Gullaksen (1995) studied the QoL and care of PwP attending movement 
disorders clinics in England and found that the main problems were related to their housing/ 
accommodation, travel, holidays and pursuing hobbies.  They also found financial difficulties 
arose amongst PwP due to involuntary early retirement and delays in receiving welfare 
benefits. PwP were satisfied with their hospital care, specialised clinic and PDNS input. It has 
been suggested that there is a need to strengthen the roles of physiotherapists, speech 
therapists, specialist nurses and social workers in the management of Parkinson's, as well as 
place more value on the support needs of carers, which includes providing respite care. 
Drutyte et al. (2014) found an important stressor amongst carers was a reduced household 
income which was due to caring for the PwP; 25% of carers were found to have reduced their 
employment and 30% also experienced a reduction in their financial conditions. 
There was a significant correlation between the H&Y score for Parkinson’s and the direct 
economic costs of health and social care with the more advanced stage of the condition 
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leading to increased direct costs, particularly that of social care. These costs by stages varied 
as follows: stage 0 and I, II, III, IV, and V (£2,971, £3,065, £6,183, £10,134, and 18,358 
respectively) (Findley et al. 2003). Those PwP who were in later stages of Parkinson’s were 
likely to become non-responsive to medication (or develop drug resistance) and thus 
aggravate the condition, leading to increased expenditure on health and social care. 
Furthermore, the difference in the type of accommodation was a significant variant of the cost 
of care. People who were living in their own home (compared to those in a nursing home) had 
the lowest total of annual direct costs (£4,189). Costs for PwP living full-time in institutional 
care were almost fivefold higher than PwP living in their own home (Findley et al. 2003). 
2.4 Conclusion 
Parkinson’s is an incurable, long-term, neuro-degenerative condition with movement, 
cognitive, psychological and physiological symptoms that have a substantial impact on QoL, 
especially as the condition progresses and particularly as an individual becomes less able to 
look after him or herself. In many cases, Parkinson’s care is informal, as family members and 
friends take on a carer role assisting the PwP. Indeed, the vast majority of the cost of 
managing Parkinson’s has been attributed to informal care and social care, rather than direct 
medical costs. The literature clearly highlights that not only does the QoL of PwP deteriorate 
over time, but the QoL of their family members and carers are also severely affected – both in 
economic and social contexts. Family members gave up their time, employment and 
resources, plus watched the deterioration of the QoL of people they cared for; thus 
accentuating the total societal costs. Grey and published literature has also highlighted the 
critical role played by Parkinson's nurses in the management and care of Parkinson's, and 
reiterates that additional funding by the NHS should be allocated for strengthening and 
extending outreach services of Parkinson's nurse specialists (and possibly other health and 
social care specialists) to PwP and their families.  
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3  Survey Response Profile 
3.1 Items Included in the Questionnaire 
Resource use and items for financial costings 
The collection of ‘resource use’ information is crucial for any cost of illness study. However, 
this would have involved filling out a lot of quantitative numbers and values for type, 
frequency and specific reference/recall period. Therefore, information on key cost drivers 
collected through online survey questionnaire were simplified and pre-coded for the ease of 
participants. The following table (Table 3.1) presents key items/indicators considered for this 
study. 
Table 3.1: Key items and indicators included in the questionnaire 
1. Socio-demographic 
profile (PwP and 
Carer) 
Gender, age, marital status, education, economic activity,  current/recent 
occupation, ethnicity, country of residence, postcode, duration of stay at current 
address, housing status, living with whom, household size and composition  
Changes in work status, employment conditions and working hours due to 
Parkinson’s; annual workdays off related to Parkinson’s  
2. Parkinson’s / Long-
term condition Year of diagnosis of Parkinson’s, any other LTC and its treatment.  
3. Health and 
Wellbeing (PwP and 
Carer) 
General health status, change in general health over 12 months, health-related 
quality of life (mobility, self-care, usual activities, pain/discomfort, 
anxiety/depression), health state scale, life satisfaction, life worthwhile, 
happiness, anxiousness 
4. Use of Healthcare 
Services (last 12 
months) 
  
  
  
  
Outpatient Care:  Number of contacts to GP, Practice Nurse, Hospital Nurse, 
Hospital Doctor, Neurologist, Psychiatrist, Geriatrician/Care of the Elderly 
Consultant, Parkinson’s Nurse, Speech and Language Therapist, 
Physiotherapist, Occupational Therapist, Mental Health Professional, 
Psychologist/Counsellor, Optometrist, Dietician, Chiropodist, Podiatrist, 
Chiropractor, Pharmacist; Funding source (NHS, Self-funded, Private health 
scheme, Reimbursement health scheme, Combination of funding, Other); Cost 
to you 
Diagnostic tests: Number of Blood test, MRI scan, EEG, CT scan, DAT scan, 
PET scan, X-ray, Other  tests; Funding source (NHS, Self-funded, Private 
health scheme, Reimbursement health scheme, Combination of funding, Other); 
Cost to you 
Inpatient Care: Incidence, Total hospitalisation days; Planned inpatient stays, 
Unplanned inpatient stays under 3 days/more than 3 days; Funding source 
(NHS, Self-funded, Private health scheme, Reimbursement health scheme, 
Combination of funding, Other); Cost to you 
A&E Visits: number of times called 999 or 111; used ambulance service, 
visited A&E; funding source (NHS, self-funded, private health scheme, 
reimbursement health scheme, combination of funding, other); Cost to you 
Medication: Number of medications/prescriptions; Funding source (Free 
prescription, Privately funded, 3 month pre-payment certificate, 12 month pre-
payment certificate, MedEx, HC2 certificate, HC3 certificate, Exempt from 
charges, MatEx); Cost to you; Number of non-prescription medicines and Cost 
to you; Side effects of Parkinson’s medications and Cost to you 
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5. Access and Mode 
of Travel to 
Healthcare Services 
Problems in accessing GP, Practice Nurse, Hospital Nurse, Hospital Doctor, 
Neurologist, Psychiatrist, Geriatrician/Care of the Elderly Consultant, 
Parkinson’s Nurse, Speech and Language Therapist, Physiotherapist, 
Occupational Therapist, Mental Health Professional, Psychologist/ Counsellor, 
Optometrist, Dietician, Chiropodist, Podiatrist, Chiropractor, Pharmacist; Main 
transport use to access; Who accompanied you; Funding source (NHS, Self-
funded, Private health scheme, Reimbursement health scheme, Combination of 
funding, Other); Cost to you 
6. Equipment 
Purchased 
Number and type of equipment purchased; Funding source (NHS, Self-funded, 
Local council grant, Charity support, Other); Cost to you  
7. Alterations to 
Accommodation 
Number, type, and date of alterations; Funding source (NHS, Self-funded, 
Local council grant, Charity support, Private health scheme, Reimbursement 
health scheme, Combination of funding, Other); Cost to you 
8. Access and 
Alterations to Vehicle 
Type of driving license, Access to any vehicle, mobility vehicle, Alterations to 
vehicle; Funding source (NHS, Self-funded, Local council grant, Charity 
support, Private health scheme, Reimbursement health scheme, Combination of 
funding, Other); Cost to you 
9. Utility and other 
expenses 
Problem in home indoor temperature (Central heating, Electric blanket, Fan 
heater, Air conditioning, Cooling fan, Other); Additional monthly cost to you; 
purchasing takeaway and convenience food and additional monthly cost to you 
10. Access to Daily 
Living Support 
Whether needed assistance for Cleaning, Shopping, Personal care, Bathing, 
Cooking, Gardening, Ironing, Decorating, Transport, Attending medical 
appointments, Exercise/physiotherapy classes; How often; Who helps; Cost to 
you 
11. Receipt of 
Income/Benefits by 
Household Members 
Receipt and Changes in finances related to Regular income from employment, 
Working Tax Credit, Income Support, Jobseekers Allowance, State Pension, 
Occupational Pension, Pension Credit, NHS Continuing Care, Attendance 
Allowance £55.10 a week/£82.30 a week, Mobility Allowance, Carers 
Allowance, Employment and Support Allowance work-related activity group 
(£102.15/ week), Employment and Support Allowance support group 
(£109.30/week), Disability Living Allowance lower rate care component 
(£21.80/week), DLA middle rate care component (£55.10/week), DLA higher 
rate care component (£82.30/week), DLA lower rate mobility component 
(£21.80/week), DLA higher rate mobility component (£57.45/week), Personal 
Independent Payment lower rate daily living component (£55.10/week), PIP 
higher rate daily living component (£82.30/week), Personal Independent 
Payment lower rate mobility living component (£21.80/week), PIP higher rate 
mobility living component (£57.45/week), Child Benefit, Child Tax Credit, 
Housing Benefit, Council Tax Benefit, Other benefit, Other income 
12. Household Income 
Gross annual income (Under £10,000, £10,000 - £19,999, £20,000 - £29,999, 
£30,000 - £39,999, £40,000 - 49,999, £50,000 or more, Don't know); Reduction 
in monthly income, how much and why;  
 13. Impact of 
Parkinson’s on 
Household Finances 
Not affected; Affected (Savings have been reduced, Borrowing has increased to 
meet basic needs, Re-mortgage to release equity, Reduced holidays, Changed 
priorities for spending, Reduced social activities e.g. eating out, Level of 
income to use on gifts for birthdays/Christmas has reduced, Other) 
 
Health economic evaluation framework 
A basic framework of health economics evaluation has been used, with both NHS and 
societal perspectives in mind.  The cost of illness (here with Parkinson's) study included 
individual’s (PwP) level costs and their reported outcomes. The costs covered direct medical 
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and non-medical costs, indirect costs, and tangible costs associated with physical and 
psychological experiences as well as other costs associated with the management and care of 
PwP. As listed in Table 3.1, the use of health care services (resource use) by PwP included 
primary and outpatient care, diagnostic tests, ambulance and A&E services, inpatient care and 
medications. Any out-of-pocket (OOP) payments made by PwP and their family to use health 
care services were also recorded. Non-medical costs included OOP towards travel to attend 
medical appointments and equipment purchased in order to improve mobility both within and 
outside of the home as well as for better management of conditions (e.g. medication dispenser 
with timer). Non-healthcare costs included alterations to accommodation, mobility or other 
vehicle, living environment in terms of regulation of hot or cold temperature, regular 
purchasing of takeaway and convenience food, and payments towards daily living assistance 
such as  personal care, bathing, cooking, gardening, ironing, cleaning, decorating, shopping, 
transport, attending medical appointments, and exercise/physiotherapy classes. The 
individuals' level outcomes/consequences/effects as a result of Parkinson’s were stated in both 
monetary and non-monetary indicators. These included health-related quality of life using the 
EQ5D-5L instrument to convert into quality-adjusted life years (QALYs), wellbeing and loss 
of income/wages as a result of PD. Further, if using a longer timeframe (usually more than 
two years), then appropriate discounting to both costs and effects needed to be applied. 
All physical resource use items including time-related to health and social care services were 
monetised using the published unit costs (reference costs) from the Department of Health and 
reports from the PSSRU http://www.pssru.ac.uk/project-pages/unit-costs/. The societal cost, 
in terms of productivity loss (workdays off due to sickness, reduction in weekly hours, and 
early retirement), as well as other non-monetised costs including state benefits were 
computed and monetised using the published sources. However, in the total societal cost, the 
research team did not account for premature mortality due to Parkinson’s during the working 
life. The total annual financial burden on the PwP household was computed by adding all 
OOP expenses and loss of income of both PwP and caregivers incurred during the last 12 
months. 
 3.2 Survey Response Rate 
Filling in of the questionnaire, either online or through the post, was a challenge for the PwP 
and their caregivers. The survey sought varied quantitative and qualitative information 
through 112 detailed questions spread over 30 A4 size pages. Due to the volume and quality 
of the information needed from relatively older people, it was reported by some to be a 
daunting task. To achieve an acceptable response rate, various forms of reminders and 
appeals were made by the Parkinson's UK charity. Table 3.2.1 shows the number of people 
who responded to the survey between October 2015 and the end of February 2016. 
  
 Page 38 
 
Table 3.2.1: Responses by invitation type and respondent type, Nov 2015-Feb 2016 
 
  
Date of 
Count 
Invitation type Who Filled The Questionnaire First 
Email Invitation/ 
Leaflet response 
Parkinson's 
2015 LIVE Total PwP Carer Other Missing 
03/11/2015 274 315 589 379 169 31 10 
18/11/2015 321 353 674 438 185 39 12 
10/12/2015 323 425 748 475 201 51 21 
14/01/2016 361 442 803 510 219 54 20 
04/02/2016 367 448 815 517 223 53 22 
23/02/2016 367 459 826 521 230 53 22 
02/03/2016 368 (43%) 
485 
(57%) 
853 
(100%) 
533 
(62.5%) 
245 
(28.7%) 
53 
(6.2%) 
22 
(2.6%) 
 
After scrutiny of the returned questionnaires section by section, it became clear that of the 
responses received, many were only partially completed, resulting in missing information and 
data gaps. People who clicked on the online survey hyperlink, 51 people, read just one-page, 
the Patient Information Sheet and didn't continue further to fill-in the detailed questionnaire. 
Further, in 26 cases no information was provided about the PwP; these were excluded from 
the database. Out of the remaining 776, there was also missing information for the key cost of 
illness variables. 126 respondents managed to fill in demographic information, with another 6 
not providing the date (month/year) of diagnosis of Parkinson's. The detailed data analysis to 
examine the extent of economic and financial costs to PwP and their families is therefore 
based on 644 cases (Table 3.2.2). However, within these 644 individual records, there was 
missing information for some variables. For instance, various sections of healthcare use 
information (listed as item 4 in Table 3.1) was provided by 610 respondents only (644-
34=610), thus, the estimates of direct medical costs of Parkinson’s are based on these 610 
PwP.  Similarly, the impact on household financial condition was based on the 580 (644-
64=580) responses received, although the caregiver's information was missing in 42 cases. 
 
Table 3.2.2: Main missing information by type of respondent 
 
  
Response Type 
Respondent Type 
Total 0 PwP Carers Other 
Total 16 560 234 43 853 
  
1. No Response (to be deleted) 16 17 10 8 51 
  
2. No PwP Information  0 0 13 13 26 
  
Remaining cases after deletion 1 and 2 0 543 211 22 776 
  
Demographics Only 0 56 59 11 126 
  
No Parkinson's Diagnosed date 0 6 0 0 6 
Net Cases 0 481 152 11 644 
  
No Healthcare Use 0 30 3 1 34 
  
No HH Impact 0 53 10 1 64 
  
No Carer information 0 42 0 0 42 
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3.3 Socio-demographic Profile of Respondents (PwP and Carers) 
This section is based on analysis of 776 respondents. Epidemiological studies show that 
Parkinson’s is higher among men; in our study also, the percentage of men amongst PwP was 
61%, as compared to 39% for women. A majority of PwP (65%) were aged 65 years and over 
with a mean age 67.1 years. Most of the PwP had some education and more than two-thirds 
had further or higher education qualifications (beyond GCSE level). Only 11% of PwP (n=85) 
had no qualification.  The majority of PwP 78.6% (n=610) were married, 7.6% were widowed 
(n=59) and 7.1% were divorced or separated.  
In contrast to PwP demographics, the majority of the carers were female, 67% (n=364), with 
a mean age of 62.6 years (significantly lower than those of PwP). As the majority of 
caregivers were spouses of the PwP (of which a majority were men), this was reflected in the 
carers’ demographics (i.e. a dominance women and over-representation in younger age 
groups of under 55 years than men). Only 11.2% (n=61) of carers had no qualification and the 
majority 63% had similar higher and further education qualification as compared to PwP. The 
majority of the carers were married or living as married 85% (n=465), and only 2.6% were 
widowed. The demographic profile reveals that the majority of PwP were men and of an older 
age, as compared to their caregivers who were their spouses and younger in age. 
In terms of ethnicity, a large majority of people who participated in the survey belonged to 
the white ethnic group. As mentioned earlier about the participants' recruitment in Section 1.4, 
a booster sample of ethnic minorities (BME) was added from Manchester and Sheffield. As a 
result 41 (5.3%) PwP and 37 (4.7%) carers belonged to non-White ethnic groups. 
The results have been summarised below (Table 3.3). 
Table 3.3: Demographic and social attributes of PwP and Carers 
 
Profile 
  
PwP Carers 
N % N % 
Total 776 100 546 100 
Gender 
Male 472 60.8 174 31.9 
Female  298 38.4 364 66.7 
Other   2 0.4 
prefer not to say 1 0.1 6 1.1 
NR 5 0.6   
Age Group 
 Up to 44 10 1.3 40 7.3 
45-54 57 7.3 72 13.2 
55-64 198 25.5 121 22.2 
65-74 325 41.9 223 40.8 
75-84 149 19.2 76 13.9 
85 & above 28 3.6 5 0.9 
NR 9 1.2 9 1.6 
Mean Age (years) 67.1 62.6 
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Education  
No formal education 14 1.8 11 2.0 
Went to school but did not finish 17 2.2 6 1.1 
Completed school no qualifications 85 11.0 61 11.2 
Completed school with qualifications  138 17.8 108 19.8 
Further education qualification 163 21.0 107 19.6 
Higher education qualification 345 44.5 237 43.4 
Other 3 0.4 3 0.5 
NR 11 1.4 13 2.4 
Marital Status  
Single 39 5.0 31 5.7 
Married or living as married/civil partnership 610 78.6 465 85.2 
Widowed 59 7.6 14 2.6 
Divorced or separated 55 7.1 23 4.2 
Other 3 0 .4 4 0.7 
NR 10 1.3 9 1.6 
Ethnic group 
 White  714 92.0 504 92.3 
 Mixed/Multiple ethnic groups  1 0.1 1 0.1 
 Asian/Asian British  30 3.9 29 3.7 
 Black/African/Caribbean/Black British  6 0.8 6 0.8 
 Other ethnic group  4 0.5 1 0.1 
 NR 21 2.7 5 0.9 
 
3.4 Economic Activity (Employment) Status of PwP and Carers 
The majority of the PwP were retired/pensioners (74.1%, n=568), of which 182 PwP (23.7%) 
took early retirement due to ill health. Further, 87 (11.3%) PwP were not able to work due to 
illness or incapacity. Therefore, Parkinson’s had a direct impact on the employment of 269 
(35%) PwP as it meant they forcefully withdrew themselves from the workforce. Only 95 
(12.4%) PwP were currently working of which 34 (4.4%) PwP were still in full-time 
employment, 29 (3.8%) in part-time employment and 32 (4.2%) were self-employed. About 
1.3% (n=10) PwPs were looking for work (i.e. unemployed). 
Among carers, more than a half of them (56%) had retired (pensioners) and 6% were caring 
for children/relatives and/or homemakers. Compared to PwP, a higher proportion of carers 
were working (31.2%, n=169), of which 62 (11.4%) carers were in paid full-time 
employment, 54 (10%) in part-time paid employment and 53 (9.8%) were self-employed. A 
notable number of carers either took early retirement to shoulder caring responsibilities or 
were unable to work due to illness were few (11.8%, n=64); another 16 (3%) carers were full-
time caring for their relatives.  It appears that caregivers held the responsibility for not only 
looking after the PwP, but also the responsibility for having to work in order to lessen the 
financial difficulties which arose because of having Parkinson’s in the family.  
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The results as follows are summarised in Table 3.4. Further breakdown of main economic 
activity by home countries is presented in Appendix 6: Table A2. 
Table 3.4: Economic activity of PwPs and Carers 
Main Economic Activity  
PwP Carers 
N % N % 
Employment Status 
Paid employment - full time 34 4.43 62 11.46 
Paid employment - part time 29 3.78 54 9.98 
Self-employed with employees 5 0.65 14 2.59 
Self-employed (working alone without employees) 27 3.52 39 7.21 
Sub-total of Workers 95 12.39 169 31.24 
Unemployed (looking for work) 10 1.30 9 1.66 
Not working due to illness or incapacity 87 11.34 8 1.48 
Caring for relatives 3 0.39 16 2.96 
Early retired due to ill health/caring responsibilities 182 23.73 56 10.35 
Retired/pensioner 386 50.33 249 46.03 
Sub-total of Retired/pensioners + Early retired 568 74.05 305 56.38 
Homemaker 1 0.13 17 3.14 
Volunteer 0 0.00 2 0.37 
In education or training 0 0.00 1 0.18 
Others 3 0.39 14 2.59 
Total 767 100.00 541 100.00 
NR 9 5 
 
3.5  Living Environment of PwP 
Of all PwPs who participated in the survey, most of them (over 80.3%) were living in 
England, 11.2 % in Scotland, 5.5% in Wales and 1.2% in Northern Ireland (Table 3.5). The 
lower representation from Northern Ireland was due to a lack of response from PwP and their 
carers. 14 (1.8%) PwP did not report which country they lived in.  
Regarding their housing status, the majority of PwP were owner occupiers with no mortgage 
60.6% (n=470), owner occupied - with a mortgage were 11.3% (n=88), 3.6% rented privately 
(n=28) and a small percentage (5.3%) reported living in sheltered and non-sheltered social 
housing. The proportion of PwP living with parents, family members and friends was 11.4%.         
For current living arrangements most PwP were living with their spouse or partner, nearly 63% 
(n=488), 13.4 % (n=104) were living alone, 12.6% (n=98) were living with children and 
grandchildren and 4.8% lived in shared accommodation or care home. There were very few 
individuals who lived with other family members, friends/carers, and 11 PwP did not report 
where they were living.  
The majority of the PwP (78%, n=602) were living with just their partner or spouse, thus their 
household size was 2. 14% (n=106) lived alone, therefore their household size was 1. The 
proportion of PwP who were living in households of 3 people or more was 5% (n=53), and 
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there were 15 PwP who did not report their household size. The overall mean household size 
was 1.99. 
The results have been summarised below (Table 3.5). 
Table 3.5: Geographical and social profile of PwP 
 
Country of Residence    N %  
England 623 80.3 
Northern Ireland  9 1.2 
Scotland 87 11.2 
Wales 43 5.5 
Not Reported 14 1.8 
Housing Status 
Owner occupied - no mortgage  470 60.6 
Owner occupied - with mortgage  88 11.3 
Shared ownership 11 1.4 
Housing Association Non-Sheltered tenant 16 2.1 
Housing Association Sheltered tenant  11 1.4 
Local Authority Non-Sheltered tenant  7 0.9 
Local Authority Sheltered tenant 7 0.9 
Rent privately 28 3.6 
Living with parents/partner/children/friends 11 1.4 
Resident in a residential /nursing home 17 2.2 
Of no fixed abode 1 0.1 
Other 4 0.5 
NR 105 13.5 
Current living arrangement 
Alone 104 13.4 
Spouse/partner  488 62.9 
Children/grandchildren  98 12.6 
Parents/grandparents  10 1.3 
Other family members  13 1.7 
Friends/Carers 15 1.9 
Shared accommodation/care home 37 4.8 
NR 11 1.4 
Household size 
1 106 13.7 
2 602 77.6 
3 29 3.7 
4+ 24 3.1 
NR 15 1.9 
Mean Adults 1.88 
Mean Children 0.11 
Mean All 1.99 
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3.6 Duration of Parkinson’s 
Out of 776 PwP, 52 (6.7%) did not provide information about the date of diagnosis of their 
Parkinson's. Amongst one-thirds of PwPs, Parkinson's was diagnosed less than 5 years ago, 
for another one-third it was between 5 and 10 years ago, and for the remainder, it was more 
than 15 years ago. The mean duration since diagnosis of Parkinson's was 8.37 years and this 
figure was significantly higher for men (8.77 years) as compared to women (7.76 years).  
The results have been summarised below (Table 3.6.1). 
Table 3.6.1: Distribution of PwP by duration since diagnosis of Parkinson’s 
 
Duration of Parkinson's N % % of 724 
Up to 2 years 84 10.82 11.60 
2.1-5 155 19.97 21.41 
5.1-10 253 32.60 34.94 
10.1-15 130 16.75 17.96 
15.1-20 65 8.38 8.98 
20+ 37 4.77 5.11 
Total 724 93.30 100.00 
Not Recorded 52 6.70   
All 776 100.00   
Mean duration 8.37  
 
Out of 581 PwP who provided information about medication, 9 (1.5%) were not on any 
medication and 38% were on one or two prescribed medications. At the other extreme, 4% 
were taking more than 10 prescribed medications to manage the condition and the side effects 
of the anti-Parkinsonian medications. Further, 253 (42%) PwP had no other LTC beside 
Parkinson's, and of the remainder, 307 PwP were also currently being treated for other 
conditions including diabetes, angina, blood pressure, and other cardiovascular diseases 
(Table 3.6.2). The number of medications taken for the Parkinson's as well as for other LTC 
with a possible detrimental effect on daily routine activities, physical mobility and quality of 
life are discussed in the next section. 
Table 3.6.2: PwP receiving treatment for LTC in addition to Parkinson's 
 
 Long-term Condition N % % of 608 
Yes - not on medication 48 6.19 7.89 
Yes – treated with medication 307 39.56 50.49 
No other LTC 253 32.60 41.61 
Total 608 78.35 100.00 
Not Recorded 168 21.65   
All 776 100.00   
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4. Quality of Life and Wellbeing 
4.1 Health Status of PwP and Carers 
With respect to general health status, 253 (38.5%) PwP reported that their health was fair, 194 
(29.5%) reported it was good and 39 (5.9%) that it was very good. Overall, 26% of PwP 
reported their general health status to be poor or very poor. The majority of PwP (72%) 
reported a worsening of their health status over the last 12 months, 24% stated that it stayed 
the same and the remaining 4% felt that their health had got better (Table 4.1).  
Among carers, 13.3% reported their health status as very good, 42.4% as good and 29.8% as 
fair. Relatively fewer carers (14.6%) reported their health status to be poor or very poor. 
More than 46% of carers reported that their health status has worsened over the last 12 month 
period (Table 4.1). From this, it is possible to state that the increased burden of care over time 
has coincided with deterioration in the health of many of the caregivers.  
Table 4.1: General health status and its change over 12 months for PwP and Carers 
Health Status 
 
PwP Carers 
N % N % 
In general your health status 
 Very Good 39 5.9 41 13.3 
 Good  194 29.5 131 42.4 
 Fair  253 38.5 92 29.8 
 Poor 129 19.6 34 11.0 
 Very Poor 42 6.4 11 3.6 
 Total Reported 657 100.0 309 100.0 
Change in health status over 12 month  
 Got better 29 4.5 10 3.4 
 Stayed the same 153 23.8 149 50.3 
 Got worse 460 71.7 137 46.3 
   Total Reported 642 100.0 296 100.0 
4.2 Daily Living Assistance of PwP 
Health status and QoL dimensions may be better understood by examining the dependence of 
PwP on other people to undertake daily routine activities. Out of 776 PwP, 529 provided 
information about a need for help with daily or routine activities within and outside the house. 
Between 32% and 60% of PwP needed help in one or more of their usual daily activities. 
More than one-third of PwP needed help with personal care and bathing, and about a half 
needed assistance to cook a meal. 62% of PwP needed help with cleaning their house and 
between 41% and 49% of PwP needed help with ironing, decorating and gardening.   
Similarly, outside of the house, 52% of PwP needed help with daily/weekly shopping. About 
half of the PwP also needed help with transport to attend medical appointments as and when 
they were scheduled. The PwP needing help with their routine daily activities varied by 
gender, age and living arrangement. For instance, except cleaning and shopping, higher 
percentages of men compared to women with Parkinson’s needed help with their daily living. 
Similarly, a majority of PwP who were aged 75 years and over were dependent on others for 
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their daily activities; in contrast, those who were living alone were able to manage better on 
their own (Table 4.2). 
Table 4.2: PwP needed help in daily living/routine activities  
DLA Yes No NR 
Yes as % 
of 529 
If Man If Aged 
75+ 
If Living 
Alone 
In Home 
Cleaning  316 210 3 59.7 59.5 75.4 56.9 
Personal care  199 316 14 37.6 39.5 57.6 15.3 
Bathing  167 345 17 31.6 33.7 51.3 15.3 
Cooking  243 268 18 45.9 47.2 58.1 23.6 
Gardening  252 177 100 47.6 55.0 73.9 60.0 
Ironing  211 217 101 39.9 52.2 64.8 22.8 
Decorating  242 167 120 45.8 57.2 67.8 52.7 
Outside Home 
Shopping  260 258 11 49.2 49.8 59.5 33.3 
Transport  232 192 105 43.9 53.8 73.4 47.5 
Medical appointments  257 186 86 48.6 56.2 78.8 42.4 
Exercise/physiotherapy  171 217 141 32.3 45.8 62.2 34.5 
4.3  Quality of Life of PwP and Carers 
PwP and carers were asked to complete the health-related quality of life (EQ-5D-5L) 
questionnaire; these were filled by 650 PwP and 301 carers. Table 4.3 provides the 
distribution of responses of the five health-related dimensions by the level of problems. In the 
majority of PwP, QoL was at sub-optimal level as only about 11.9% reported having no 
problem with mobility, 28% no problem with self-care, 10.5% no problem with usual 
activities, 9.6% no problem with pain/discomfort and 26.2% no problem with 
anxiety/depression. A very high percentage of PwP reported between moderate and extreme 
problems for mobility (63%), usual activities (58%), and pain/discomfort (59%); thus 
reflecting their low quality of life. The responses for the five dimensions were combined by 
using weight suggested by Devlin et al. (2016) to arrive at individual level Quality Adjusted 
Life Year (QALY).  The average QALY score for PwP was 0.576; a health person could 
expect to achieve a QALY score of 1. The Mean Visual Analogue Scale (VAS) score which 
varies between 0 (worst health state) and 100 (worst health state) was 57.9 for PwP. 
 
Amongst carers, HRQoL was relatively better than PwP. However, between 70% 
(anxiety/depression) and 30% (self-care) of carers reported a sub-optimal level of QoL. 
About 1 in 4 carers reported moderate to extreme problems with mobility, usual activities, 
pain/discomfort, as well as anxiety/depression. This could be a reflection of their fatigue and 
the burden of day to day caring for their PwP. The mean QALY score was 0.764 and the VAS 
score was 70.1 (much lower than the general adult population). The QoL of PwP and carers 
varied by their demographics as well as by the duration since diagnosis of Parkinson’s. 
Interestingly, the mean QALY score of PwP didn't differ between men (0.5758) and women 
(0.5757); however it was significantly lower for PwP aged 75 and over (0.5289 vs. 0.5876 
those aged under 65, and higher for those living alone (0.6127). Figure 4.1 shows the QALY 
score was lowest for PwP aged over 85 (almost half compared with those aged less than 45).  
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Table 4.3: Quality of life among PwP and Carers 
 
 Health Related Quality of Life 
  
PwP Carers 
N % N % 
Mobility 
   I have no problems in walking about 77 11.9 169 56.1 
   I have slight problems in walking about 163 25.2 65 21.6 
   I have moderate problems in walking about 228 35.2 33 11.0 
   I have severe problems in walking about 143 22.1 27 9.0 
   I am unable to walk about 36 5.6 7 2.3 
  647 100.0 301 100.0 
Self-care 
   I have no problems washing or dressing myself 182 28.0 239 79.7 
   I have slight problems washing or dressing myself 210 32.4 30 10.0 
   I have moderate problems washing or dressing myself 167 25.7 12 4.0 
   I have severe problems washing or dressing myself 45 6.9 8 2.7 
   I am unable to wash or dress myself 45 6.9 11 3.7 
  649 100.0 300 100.0 
Usual activities 
   I have no problems doing my usual activities 68 10.5 160 53.3 
   I have slight problems doing my usual activities 202 31.2 76 25.3 
   I have moderate problems doing my usual activities 208 32.1 28 9.3 
   I have severe problems doing my usual activities 105 16.2 20 6.7 
   I am unable to do my usual activities 64 9.9 16 5.3 
  647 100.0 300 100.0 
Pain/Discomfort 
   I have no pain or discomfort 62 9.6 108 36.2 
   I have slight pain or discomfort 205 31.7 109 36.6 
   I have moderate pain or discomfort 261 40.3 56 18.8 
   I have severe pain or discomfort  91 14.1 21 7.0 
   I have extreme pain or discomfort 28 4.3 4 1.3 
  647 100.0 298 100.0 
Anxiety/Depression 
   I am not anxious or depressed 170 26.2 91 30.4 
   I am slightly anxious or depressed 243 37.4 116 38.8 
   I am moderately anxious or depressed 174 26.8 68 22.7 
   I am severely anxious or depressed  40 6.2 16 5.4 
   I am extremely anxious or depressed 23 3.5 8 2.7 
  650 100.0 299 100.0 
 Mean QALY*  0.576 0.764 
Mean VAS Score 57.9 70.1 
*To compute QALYs, level specific weights in each domain are taken from Devlin et al. (2016): Table 2. 
 
Further, the QALY score was much lower for PwP belonging to BME group compared to 
those of white ethnicity. Figure 4.2 shows that the QoL of PwP fell steeply with the duration 
since diagnosis of Parkinson's but stabilised in later years. Thus, QoL of PwP deteriorated 
significantly with age and progression of Parkinson’s. Amongst carers, the mean QALY score 
was significantly lower for women carers (0.7465) than men carers (0.7902); the score was 
significantly lower for carers aged 75 and over (0.7163 vs. 0.7722 for aged under 65). 
Interestingly the QALY score was much higher for carers from BME group when compared 
to white ethnic group (Figure 4.1). The QoL of carers also fell sharply with the duration since 
diagnosis of Parkinson's, thus reflecting on the longer they were caring for the PwP lower 
were their QoL (Figure 4.2).  
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Figure 4.1: QALY scores for PwP and Carers by age and ethnicity 
 
 
 
 
Figure 4.2: QALY scores for PwP and Carers by duration of Parkinson's 
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4.4 Wellbeing of PwP and Carers 
In the survey, people were asked to rate their wellbeing on a scale of 0 to 10. The four questions 
regarding life satisfaction, life worthwhile, happiness and anxiousness were adapted from the Office 
for National Statistics (ONS) framework for measuring personal wellbeing (ONS 2012). The 
wellbeing information was completed by 638 PwP and 294 carers (Table 4.4). The mean wellbeing 
score for PwP was 5.3 for satisfaction with life, 5.8 for feelings about doing things in life that are 
worthwhile, 5.5 for how happy they felt yesterday and 3.9 for feeling anxious yesterday. The majority 
of PwP reported low scores of wellbeing for all four questions. The ONS categorised 0-4 scores as 
"very low" and 5-6 as "low" wellbeing for life satisfaction, worthwhile and happiness questions. 
Similarly, high scores on anxiousness reflect low wellbeing as well (6-10 scores categorised as "very 
high" and 4-5 as "high" on anxiousness). Compared to the general population aged 65 years and over, 
the wellbeing scores for PwP were much lower (Gumber and Owen 2014). 
 
Amongst carers, the mean wellbeing scores were 5.7 for satisfaction with life, 6.6 for doing things in 
life that are worthwhile, 5.8 for how happy they felt yesterday and 4.3 for how anxious they felt 
yesterday. These scores were marginally better than those of PwP. However, a large percentage of 
carers had reported low scores on their wellbeing too, which ranged from 39.4% for worthwhile to 59% 
for anxiousness. 
 
Table 4.4: PwP and Carers reporting low scores on wellbeing  
 Wellbeing (Mean score / % ) 
PwP Carers 
Mean 
score 
% having low 
wellbeing* 
Mean 
score 
% having low 
wellbeing* 
How satisfied are you with your life nowadays? 5.3  61.9 5.7  55.8 
To what extent do you feel the things you do in 
your life are worthwhile? 5.8  53.1 6.6  39.4 
How happy did you feel yesterday? 5.5  60.1 5.8  57.9 
How anxious did you feel yesterday? 3.9  52.9 4.3  59.0 
* Low wellbeing refers to people reporting scores between 0 and 6 for life satisfaction, worthwhile and 
happiness and between 4 and 10 for anxiousness (ONS 2012). 
 
Figure 4.3: Wellbeing scores for PwP by duration since diagnosis of Parkinson's 
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Figure 4.4: Wellbeing scores for Carers by duration since diagnosis of Parkinson's 
 
 
Figures 4.3 and 4.4 show the variations in mean wellbeing scores of PwP and carers by the 
duration since diagnosis of Parkinson's. The mean wellbeing scores of PwP for life 
satisfaction, worthwhile, and happiness declined with the duration since diagnosis of 
Parkinson's (and reached the lowest levels in those diagnosed with Parkinson's for more than 
20 years). The score on anxiousness for PwP had also gone down with the duration since 
diagnosis of Parkinson's; this suggests that they stopped worrying too much about their 
current situation vis-à-vis that in the past.  Mean wellbeing scores of carers didn't decline 
sharply (as was the case for PwP) with the duration since diagnosis of Parkinson's. Their 
anxiety level among them also subsided with the passage of time. 
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5. Healthcare Use and Cost 
5.1 Primary Care and Outpatient Services 
5.1.1  Utilisation 
Out of 776 PwP, 610 had provided information about the use of primary care (GP or Clinic) 
and hospital outpatient services. The use of services is presented in Table 5.1.1 by type of 
healthcare professionals. About three-fourths (73.4%) of PwP consulted a GP for their 
Parkinson’s treatment; the next to follow were a neurologist (67.5%) and a hospital doctor 
(27.4%). Other specialists consulted were the Psychiatrist (8.4%) and Geriatrician/Elderly 
Care Consultant (12.3%). Amongst nurses, a Parkinson’s nurse was most consulted (75.9%), 
followed by Practice nurse (31%) and hospital nurse (16.4%). The other key health 
professionals contacted were: Physiotherapist (43.3%), Speech and Language Therapist 
(26.9%), Occupational Therapist (24.8%), Optometrist (25.4%), Chiropodist/Podiatrist 
(33.4%) and Pharmacist (32.3%). The average annual number of consultations was highest 
for the GP (3.7) followed by Physiotherapist (2.9), Pharmacist (2.8), Parkinson’s nurse (2.2), 
Chiropodist/Podiatrist (1.6) and Neurologist (1.4). On average PwP made 21.8 consultations 
with various health professionals in a year; this reflected a very high usage of healthcare 
services (which turned out to be nearly having consultation every two to three weeks). 
However, some PwP reported the problem in accessing healthcare services. The accessing 
problem was higher for the three most sought healthcare professionals by PwP for their 
Parkinson's (i.e. GP, neurologist and Parkinson's nurse); varied between 17.4% and 12.8% of 
PwP reported the problem.  
 
Table 5.1.1: Consultations with healthcare professionals during last 12 month  
Healthcare Consultations % 
Contacted 
Total 
consultations 
Mean 
consultations 
% Reported 
access problem  
GP 73.44 2241 3.67 12.79 
Practice Nurse 30.98 881 1.44 3.11 
Hospital Nurse 16.39 528 0.87 2.62 
Hospital Doctor 27.38 661 1.08 4.10 
Neurologist 67.54 830 1.36 12.95 
Psychiatrist 8.36 104 0.17 2.46 
Geriatrician/Elderly Care Consultant 12.30 194 0.32 1.31 
Parkinson’s Nurse 75.90 1333 2.19 17.38 
Speech and Language Therapist 26.89 619 1.01 4.10 
Physiotherapist 43.28 1793 2.94 9.02 
Occupational Therapist 24.75 488 0.80 3.77 
Mental Health Professional 7.05 157 0.26 2.30 
Psychologist/ Counsellor 5.90 241 0.40 2.13 
Optometrist 25.41 251 0.41 1.97 
Dietician 7.70 106 0.17 1.64 
Chiropodist, Podiatrist 33.44 958 1.57 3.44 
Chiropractor 5.57 206 0.34 0.82 
Pharmacist 32.30 1696 2.78 1.97 
Total Consultations  13287 21.78 
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5.1.2  Consultations Cost 
Although most of the healthcare services were provided by the NHS free at the point of 
contact, a significant number of PwP have consulted further utilising private services with 
OOP payments. In more than 50% Chiropodist, Podiatrist and Chiropractor consultations, 
PwP incurred OOP expenses; 29% saw an Optometrist privately, and 19.3% consulted a 
Physiotherapist privately. On average, PwP incurred £180.90 OOP expenditure annually on 
healthcare consultations (Table 5.1.2). After applying a unit cost per contact time of NHS 
healthcare professionals, an average of £443.04 per PwP per annum turned out to be the cost 
to the NHS. Both together, the total annual healthcare consultations cost worked out to be 
£623.94 per PwP for the treatment of Parkinson’s utilising conventional professionally 
provided health services. 
 
Table 5.1.2: Mean consultations costs and OOP expenditure during last 12 month  
Healthcare 
Consultations 
OOP Expenses 
(£) 
Funding source 
(% distribution) 
Cost to NHS (£) Total 
Cost 
(NHS+ 
OOP) 
Total Mean NHS SF Other Unit 
cost  
Total Mean  
GP 2175 3.57 96.43 2.90 0.67 44 94688 155.23 158.80 
Practice Nurse 575 0.94 97.44 1.54 1.03 12 10188 16.70 17.64 
Hospital Nurse 875 1.43 89.91 6.42 3.67 12 6132 10.05 11.48 
Hospital Doctor 7725 12.66 91.76 3.30 4.95 14 8596 14.09 26.75 
Neurologist 11450 18.77 88.84 6.65 4.51 58 41702 68.36 87.13 
Psychiatrist 1175 1.93 90.14 2.82 7.04 59 5428 8.90 10.83 
Geriatrician/Elderly 
Care Consultant 1025 1.68 
96.67 3.33 0.00 58 10846 
 
17.78 
19.46 
Parkinson’s Nurse 1850 3.03 96.36 2.14 1.50 22 28512 46.74 49.77 
Speech & Language 
Therapist 500 0.82 
96.09 1.12 2.79 17 10030 
 
16.44 
17.26 
Physiotherapist 29975 49.14 72.63 19.34 8.03 17 15079 24.72 73.86 
Occupational Therapist 6825 11.19 90.91 2.42 6.67 17 7548 12.37 23.56 
Mental Health 
Professional 425 0.70 
95.31 1.56 3.13 19 2907 
 
4.77 
5.47 
Psychologist/ 
Counsellor 1125 1.84 
87.27 5.45 7.27 32 5216 
 
8.55 
10.39 
Optometrist 15375 25.20 57.41 29.01 13.58 31 4185 6.86 32.06 
Dietician 1275 2.09 87.30 7.94 4.76 17 1479 2.42 4.51 
Chiropodist, Podiatrist 16875 27.66 39.15 53.77 7.08 17 4556 7.47 35.13 
Chiropractor 7475 12.25 41.67 50.00 8.33 31 434 0.71 12.96 
Pharmacist 3650 5.98 86.27 7.84 5.88 9 12726 20.86 26.84 
Total Consultations 110350 180.90         270252 443.04 623.94 
* Unit cost per contact time was derived from Curtis and Burns (2015). SF- Self-financed 
5.1.3  Diagnostic Cost 
Various consultations in the primary care and outpatient care also involved diagnostic/clinical 
tests during the course of management of the condition. These included a blood test, MRI 
scan, EEG, CT scan, DAT scan, PET scan, X-ray and other test/procedure. Several PwP 
reported having blood test(s) (43.3%), an MRI scan (18.2%), X-ray (15.9%) and CT scan 
(13.3%) during the last 12 months (Table 5.1.3). On an average 2.65 diagnostic tests were 
carried out annually, most of which were undertaken via NHS provision. After applying a 
unit cost per diagnostic procedure, on average £165.11 per PwP per annum was turned out to 
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be the cost to the NHS. Including OOP expenses, the total annual diagnostic tests cost worked 
out to £183.47 per PwP.  
5.2 Emergency (A&E) Services 
Two out of thirteen PwP used emergency healthcare services during the last 12 months (Table 
5.2). About 16% of PwP called 999 or 111 for medical help, 15% visited A&E and 13% used 
ambulance services. The mean usage of emergency services during the last 12 months was a 
little over 0.3 contacts.  After applying a unit cost for emergency service episode, on an 
average £95.37 per PwP per annum was the cost to the NHS. Including OOP expenses, the 
total annual cost of emergency service use worked out to be £96.56 per PwP.  
5.3 Inpatient Services 
Over the past 12 months, 121 PwP (19.8%) were admitted to the hospital because of their 
Parkinson's and related complications. Considering all multiple episodes together, on an 
average, they reported 12.56 days of hospital stay in a year. Table 5.3 breaks down hospital 
admissions into 'day case', 'planned', 'unplanned short stay (up to 3 days)', and ‘unplanned 
longer stay (>3 days)'. This distinction was important to capture cost differentials due to 
variability in the unit cost by type of hospital admission. About 9% of PwP were admitted to 
a hospital as a day case and 6.2% had a planned inpatient admission. However, unplanned 
admissions (13.2%) were higher than planned ones (4.8% and 8.4% of PwP reported 
unplanned admission for up to 3 days and more than 3 days respectively). The mean inpatient 
admission during last 12 months was a little over 0.6 episodes, with most admissions were 
into the NHS hospitals. After applying a unit cost by types of hospital admissions, on average 
£1241.49 per PwP per annum was the cost to the NHS. Including OOP expenses, the total 
annual cost for inpatient admission worked out to be £1250.96 per PwP.  
5.4 Mode of Travel and Travel Cost 
A majority of PwP didn’t travel alone to attend for various healthcare appointments. The 
percentage of PwPs who travelled alone varied between as low as 21.2% when consulting a 
specialist such as Neurologist/ Geriatrician/ Elderly Care Consultant or 28.8% for a 
Parkinson’s nurse to as high as 48.1% in the case of a Pharmacist.  Significant contribution 
and support were provided by family members to attend these appointments. A relatively 
small number of PwP walked to attend medical appointments, the proportion of which was 
relatively higher when using community-based services such as GP services and Pharmacy. 
The most frequent mode of travel to medical appointments was by car (either self-driving or 
as a passenger). Use of public transport and the taxi was minimal unless the visit was to the 
Mental Health Professional (including a psychologist, psychiatrist, and counsellor) when a 
higher number of PwP (11.5%) used a taxi (Table 5.4.1). The mode of travel (public vs. 
private transport) reflects on the extent of OOP expenses on travel. The percentage of PwP 
reporting travel expenses varied between 2.5% for visiting a Dietician to 62.6% for visiting 
their GP. Those who incurred OOP expenses, on an average a visit to their GP or Practice 
nurse cost them £8.82 or £5.95 whereas for the Optometrist £39.81 and the Mental Health 
Professional £35.24. 
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Table 5.1.3: Mean diagnostic tests and out-of-pocket expenditure during last 12 month 
Diagnostic Test/ 
Procedure 
% 
Screened 
Number of Episodes OOP Expenses (£) Funding source (% distribution)  Cost to NHS (£) Total Cost 
(NHS+OOP)  Total Mean Total Mean NHS SF Other Unit cost  Total Mean  
Blood test 43.28 870 1.43 700 1.15 95.94 1.11 2.95 6 4782 7.84 8.99 
MRI scan 18.2 167 0.27 4625 7.58 87.2 4 8.8 395 56485 92.6 100.18 
EEG 8.52 92 0.15 225 0.37 92.42 4.55 3.03 116 9860 16.16 16.53 
CT scan 13.28 101 0.17 1225 2.01 92.39 1.09 6.52 151 13892 22.77 24.78 
DAT scan 5.25 35 0.06 1425 2.34 86.05 0 13.95 151 4077 6.68 9.02 
PET scan 1.31 12 0.02 0 0.00 88.89 0 11.11 151 1057 1.73 1.73 
X-ray 15.9 269 0.44 1350 2.21 93.64 0.91 5.45 14 3458 5.67 7.88 
Other  test 4.26 71 0.12 1650 2.70 84.62 5.13 10.26 145* 7105 11.65 14.35 
Total Test   1617 2.65 11200 18.36         100716 165.11 183.47 
* Weighted mean costs of the non-blood test procedures. Unit cost derived from Curtis and Burns (2015). 
Table 5.2: Mean ambulance and A&E services and OOP expenditure during last 12 month 
A&E services % 
Used 
Number of Episodes  OOP expenses (£) Funding source (% distribution)  Cost to NHS (£) Total Cost 
(NHS+OOP)  Total Mean Total Mean NHS SF Other Unit cost  Total Mean  
Called 999 or 111  15.9 201 0.33 100 0.16 94.5 4.59 0.92 12 2160 3.54 3.7 
Used an ambulance 13.11 191 0.31 50 0.08 98.88 0 1.12 99 18909 31 31.08 
Visited A & E  15.41 190 0.31 575 0.94 94.95 4.04 1.01 205 37105 60.83 61.77 
Total       725 1.19         58174 95.37 96.56 
* Unit cost per contact derived from Curtis and Burns (2015). 
Table 5.3: Mean inpatient admissions and OOP expenditure during last 12 month 
Inpatient services % 
Admitted 
Number of Episodes OOP  expenses (£) Funding source (% distribution)  Cost to NHS (£) Total Cost 
(NHS+OOP) Total Mean Total Mean NHS SF Other Unit cost  Total Mean  
Day case 9.02 89 0.15 2300 3.77 97.73 1.14 1.14 704 59840 98.10 101.87 
Planned inpatient stay  6.23 64 0.1 950 1.56 94 2 4 3405 207705 340.50 342.06 
Unplanned-stay up to 3 
days  
4.75 47 0.08 
650 1.07 
94.29 0 5.71 608 
26752 43.86 44.92 
Unplanned-stay 3+ 
days  
8.36 160 0.26 
675 1.11 
98.36 0 1.64 2863 
458080 750.95 752.06 
Other  0.82 11 0.02 1200 1.97 80 10 10 1233* 4932 8.09 10.05 
Total   371 0.61 5775 9.47         757309 1241.49 1250.96 
* Weighted mean of all planned and unplanned hospitalisation cost.  Unit cost derived from Curtis and Burns (2015). 
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In a very small number of cases, the NHS provided transport, but in the majority of cases 
travel was self-funded OOP. The total travel expenses incurred by 610 PwP amounted to 
£21875. The travel cost here was underestimated for those who drove their own car and 
forgot to mention petrol expenses under travel cost; however several of PwP had reported 
paid for parking charges at the hospital if using their own/family car (Table 5.4.2). 
Table 5.4.1: Mode of travel and travelled with whom by healthcare services 
Mode of Travel 
to Healthcare 
Services 
Mode of transport Travelled with 
Walk Car 
driver 
Car 
passe
nger 
Bus/ 
train 
Taxi Cycle/ 
Motor 
cycle 
Alone Family 
member 
Carer Friend 
/Other 
GP  18.2 37.0 35.3 3.5 4.6 1.5 42.3 38.3 18.1 1.4 
Practice nurse  17.0 33.9 42.2 2.2 4.8 0.0 37.4 44.1 18.0 0.5 
Neurologist/ 
Geriatrician, 
Elderly Care 
Consultant  
2.0 36.7 47.2 10.1 4.0 0.0 21.2 55.4 19.0 4.4 
Parkinson’s 
Nurse  
4.2 41.5 44.2 6.9 3.0 0.3 28.8 50.7 18.0 2.6 
Speech/Language 
Therapist  
4.3 34.5 42.2 12.1 6.0 0.9 42.2 42.2 13.7 2.0 
Physiotherapist  1.8 49.1 38.7 4.9 4.9 0.6 46.3 34.7 14.3 4.8 
Occupational 
Therapist  
9.1 34.5 47.3 7.3 1.8 0.0 40.4 46.8 8.5 4.3 
Mental Health 
Professional* 
6.6 37.7 41.0 1.6 11.5 1.6 42.9 39.3 14.3 3.6 
Optometrist  9.8 28.7 45.1 10.7 4.9 0.8 33.0 48.2 16.1 2.7 
Dietician  12.0 40.0 48.0 0.0 0.0 0.0 43.5 43.5 8.7 4.3 
Pharmacist  28.6 38.4 29.7 0.0 1.6 1.6 48.1 33.5 17.1 1.3 
* including a psychologist, psychiatrist, and counsellor. 
Table 5.4.2: Mean travel cost (per incurred case) by healthcare services 
  
Healthcare Services 
PwP reported Total 
OOP 
expenses 
(£) 
Mean OOP 
cost  per 
incurred 
case (£) 
Funding source  
(% distribution) 
N  % NHS SF Other 
GP  382 62.6 3370 8.82 6.9 86.7 6.4 
Practice nurse  153 25.1 910 5.95 6.5 86.6 7.0 
Neurologist/Geriatrician/ 
Elderly Care Consultant  
251 41.1 4755 
 
18.94 5.6 86.6 7.8 
Parkinson’s Nurse  206 33.8 2310 11.21 6.8 87.2 6.1 
Speech and Language Therapist  69 11.3 1045 15.14 8.2 81.6 10.2 
Physiotherapist  100 16.4 2530 25.30 6.1 86.4 7.5 
Occupational Therapist  32 5.2 800 25.00 18.8 68.8 12.5 
Mental Health Professional * 41 6.7 1445 35.24 10.9 83.6 5.5 
Optometrist  79 13.0 3145 39.81 3.8 86.7 9.5 
Dietician  15 2.5 140 9.33 16.0 80.0 4.0 
Pharmacist 100 16.4 1425 14.25 12.9 84.2 2.9 
* including a psychologist, psychiatrist, and counsellor. 
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5.5 Medication and Prescription Cost 
581 PwP provided information about their medication related to Parkinson's. Only 9 (1.5%) 
PwP have not been prescribed medication to manage their Parkinson’s. On an average PwP 
were taking 4 medications; however some of them (4%) were taking 10 or more medications 
for Parkinson's (Table 5.5). A majority of PwP were over aged 65 and thus exempt from 
prescription charges. 84 PwP (14.7%) had paid for prescriptions with mean annual payments 
ranged between £25 and £108.85. Overall mean annual OOP cost of prescriptions was £14.53.  
Table 5.5: Number of prescribed medication, source of funding and OOP expenditure 
Prescribed Medications Sources of Funding Mean 
OOP 
(£) 
No. of 
medications 
No. of 
PwP Percent Prescription type 
No. of 
PwP Percent 
0 9 1.5 Free prescriptions in my area 277 48.4 0 
1 86 14.8 Privately funded 18 3.1 74.44 
2 133 22.9 3 month pre-payment certificate 3 0.5 93.33 
3 103 17.7 12 month pre-payment certificate 61 10.7 108.85 
4 86 14.8 Exempt from charges 211 36.9 0 
5 68 11.7 Other 2 0.3 25 
6 to 9 73 12.6 Total 572 100 14.53 
10+ 23 4 Mean annual no. of prescriptions 13.8   
Total 581 100 Total/Mean no. of medications 2175 / 3.80  
 
Over time PwP experience side effects of Parkinson's medication, which adds costs to their 
daily living. For instance, some PwP on dopamine agonists to manage their Parkinson's may 
develop impulsive and compulsive behaviours, which can range from compulsive gambling 
to binge eating and hypersexuality, as a result of the medication. In our survey out of 572 
PwP on medications 194 (34%) reported such side effects that resulted in heavy out-of-pocket 
expenditure on binge eating, shopping, and gambling; some of them even reported over 
£10,000 expenses on these activities.  To control for impulsive and compulsive behaviours, 
PwP had purchased over the counter medications or supplements. Out of 558 PwP, 146 
(26.2%) bought such medications and on average spent £14.59 per month. The overall mean 
OOP expenditure for all respondents was £3.82 per month which amounting to £45.81 a year. 
5.6 Direct and Indirect Healthcare Cost 
Putting all together the use of healthcare services by 610 PwP over the last 12 months, the 
total direct medical  cost  of consultations, diagnostics, call and ambulance, A&E, inpatient 
services and medication was  £1,285,354 to the NHS and £161,920 to PwP as OOP expenses. 
The total direct annual medical cost estimated was £2388 per PwP (Table 5.6) of which the 
share of NHS was 88.7% in the total direct medical costs. Figure 5.1 shows the breakdown of 
annual costs of Parkinson's to the NHS by type of service. Taking into account travel (£36) 
equipment (£1923) expenses, the total annual healthcare cost per PwP added up to £4347. 
Importantly the share of the non-medical cost component, usually an oversight by health 
policy makers, was 45% in the total healthcare cost. Where appropriate, a breakdown of 
various types of healthcare costs by individual Home Countries has been provided in 
Appendix 6. 
 Page 56 
 
 
Figure 5.1: Distribution of direct medical costs to the NHS by type of service (£, %) 
 
 
Table 5.6:  Total annual healthcare cost to the NHS and PwP 
Direct and 
Indirect 
Cost 
 Type N Total 
Utilisat
ion 
Cost to NHS (£) Cost to PwP  
(OOP in £) 
Mean Cost 
(NHS+ 
OOP) Total Mean Total Mean 
Direct - 
Medical 
Consultations 610 13287 270252 443.04 110350 180.90 623.94 
Diagnosis 610 1617 100716 165.11 11200 18.36 183.47 
Call/Ambulance 610 392 21069 34.54 150 0.25 34.79 
A&E 610 190 37105 60.83 575 0.94 61.77 
Inpatient 610 371 757309 1241.49 5775 9.47 1250.96 
Sub-total 1,186,451 1945.00 128050 209.92 2154.92 
Medication 572 7827 98903* 172.91 8310 14.53 187.44 
Non- 
prescription 
medication  
558 146     25560 45.81 45.81 
Total Medical 1,285,354 2117.91 161920 270.25 2388.16 
Indirect 
(Non-
Medical) 
Travel  610   **   21875 35.86 35.86 
Equipment 594 1013 **   1142275 1923.02 1923.02 
Total Healthcare cost 1,326,070 2229.13 4347.04 
* Number of Annual Free prescription multiplied by £8.20 (3.80 medications per PwP assuming repeat 
prescription every 8 weeks= 3.80*13/2=24.72. About 85.3% received a free prescription, therefore, the cost to 
NHS worked out to be 24.71 x 0.853 x 8.20 x 572. 
** Few PwP received free travel/subsidised equipment under the NHS Continuing Care scheme whose costs to 
the provider were not estimated. 
References 
Curtis L and Burns A (2015).Unit Costs of Health and Social Care 2015. Kent: Personal Social Services 
Research Unit (PSSRU), University of Kent. 
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6.  Economic and Financial Cost 
6.1 Impact on Employment of PwP and Carers 
More than 50% (n=391) of PwP reported that Parkinson’s had a direct effect on their 
employment. One-third (n=171) of carers also reported an impact of Parkinson’s on their 
employment and working conditions. Three-fourths of PwP (71 out of 95) who were working 
had reported workdays lost during the last 12 months due to Parkinson’s and on average they 
lost 62.1 workdays in a year. 61 (64.2%) of PwP were forced to reduce their weekly working 
hours due to Parkinson’s, and on an average, they reduced weekly hours by 12.4. Similar 
types of impact on workdays lost and working conditions were noticed for the caregivers; 
however, the reduction was relatively lower when compared with PwP. Less than one-thirds 
of working carers (49 out of 169) had reported workdays lost as a result of caring for PwP 
and on average they lost 18.9 annual workdays. 54 (32%) caregivers reduced their weekly 
working hours and on an average they cut their weekly hours by 10.7 (Table 6.1.1).  
6.1.1  Current Direct Employment Income Loss  
There were productivity losses both for PwP and those providing care to them. A 
conservative magnitude of these losses in monetary terms could be estimated by using the 
average hourly, daily or weekly earnings of workers. According to the ONS, the average 
weekly earnings in December 2015 was £496 for 37.6 weekly hours (ONS 2016). This 
amounts to a total annual productivity loss (workdays lost plus a reduction in weekly hours) 
of £956,643 for working PwP and £487,656 for caregivers (Table 6.1.1). The total loss of 
annual income from employment to working PwP and carers was £1,444,299. Overall for 729 
families affected by Parkinson’s, this loss worked out to be £1981.21 per household. 
Table 6.1.1: Impact on employment and annual productivity loss 
Impact on employment of Parkinson’s 
PwP Carers 
N % N % 
Yes 391 50.4 171 31.3 
No 338 43.6 345 63.2 
NR 47 6.1 30 5.5 
All 776 100.0 546 100.0 
Currently Working 95 12.4 169 31.2 
Workdays lost 
Reported workdays lost in last 12 months  71 74.7 49 29.0 
Total number of sick days taken 4409 926 
Mean workdays lost per reported person 62.1 18.9 
Total Annual Monetary Loss (@ £496 weekly earnings*) £437,373 £91,859 
Reduction in working hours 
Reported reduction in work hours in last 12 months 61 64.2 54 32.0 
Number of weekly hours  reduced 757 577 
Mean weekly hours reduced per reported person 12.4 10.7 
Total Weekly Monetary Loss (@ £496 for 37.6 weekly hours) £9986 £7612 
Total Annual weekly hours reduction loss  £519,270 £395,797 
Total Annual Productivity Loss £956,643 £487,656 
* ONS (2016): p.17.  
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6.1.2  Current Indirect Employment Earnings Loss  
Here indirect earnings losses due to early retirement or inability to work during the current 
year are estimated. In Chapter 3, Table 3.4 it was reported that 182 PwP took early retirement; 
87 were unable to work (incapacity) due to their Parkinson's whilst 10 PwP were looking for 
work (i.e. unemployed).  These figures for carers for shouldering caring responsibilities for 
their PwP were 56 took early retirement, 8 unable to work and 9 unemployed. The 
unemployed people on average were losing annual earnings of £25792 (£496 x 52).  
Therefore, for 19 unemployed people (10 PwP and 9 carers), the total annual earning loss 
amounted to £490,048 (£25792 x 19). In terms of people who were unable to work 
(incapacity), if we assuming all 95 people (87 PwP and 8 carers) were claiming incapacity 
benefits (which is £105.35 per week for 2015/16 - Department for Work and Pensions [DWP] 
2015: p.7), the net weekly earnings loss estimated to be £390.65 (£496 minus £105.35) per 
person. The annual earnings loss worked out to be £20313.8 per person, and the total loss for 
95 people amounted to £1,929,811. In terms of loss of earnings due to early retirement, 238 
people (182 PwP and 56 carers) took involuntarily retirement early due to Parkinson’s. Of 
these, 85 people (66 PwP and 19 carers) were currently under the age of 65 and thus there 
was an indirect loss of annual earnings of £25792 (£496 x 52) per person, which aggregated 
to £2,192,320 (£496 x 52 x 85). Altogether these annual earnings losses to both PwP and 
carers (unemployed, unable to work and took early retirement as a result of Parkinson’s) 
added up to £4,612,179 (£490,048 + £1,929,811 + £2,192,320), with an overall average of 
£6013.3 for the 767 PwP households (Table 6.1.2). 
Table 6.1.2: Indirect annual employment earnings loss due to Parkinson's 
 
Indirect Employment Earnings Loss Description PwP Carers All 
1. Unemployed (looking for work) 10 9 19 
Annual employment earnings loss (@£496 x 52 per person) 257920 232128 490048 
2. Not working due to illness or incapacity 87 8 95 
Annual employment earnings loss [net weekly earnings loss 
(£496 minus £105.35 as incapacity benefits=£390.65) x 52] 1767300.6 162510.4 1929811.0 
3. Early retired due to ill health/caring responsibilities 182 56 238 
Of which currently under aged 65 66 19 85 
Annual employment earnings loss (@£496 x 52 per person) 1702272 490048 2192320 
Total indirect annual earnings loss due to Parkinson's 3727492.6 884686.4 4612179.0 
Average loss per PwP household (n=767) 4859.8 1153.4 6013.3 
 
6.1.3  Unpaid Care (Earnings Loss) to Caregivers  
The DWP recently provided estimates of 200,000 people4 who are caring for their family 
members for 20 or more weekly hours but have not been registered for carer allowance and 
                                                          
 
4
 According to the 2012/13 Family Resource Survey, 330,000 working-age people were providing informal care 
for 20-35 hours per week. About 40% of the 330,000 were in full-time employment, so would already be paying 
National Insurance contributions, which leaves 200,000 potential beneficiaries of Carer’s Credit (DWP 2016). 
Out of 200,000 (about 70,000 would be male and 130,000 female) around two-thirds would be aged 50 or over. 
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loosing on their pension credit years for national insurance (DWP 2016). Inclusive of missing 
age reporting, 242 (44.3%) carers were aged under 65 of which 141 were working, 6 
unemployed, 7 not working due to ill-health and 19 retired early to undertake caring 
responsibilities of PwP. The remaining 69 carers had devoted fully to looking after their PwP. 
Assuming all of them are caring for 20 hours or more per week and not taking any social 
benefits, then we can estimate their unpaid caring contribution in monetary term. According 
to the ONS, the weekly earnings was £496 for 37.6 weekly hours, then for at least 20 hours of 
care their  weekly earnings loss would be £264 or £13728 in a year. The total unpaid caring 
for 69 carers equated to £947,232 earnings loss per year and overall mean earnings loss (of 
767 PwP household) was on average £1235 per household. A very similar approach 
(opportunity cost of time) was used to estimate unpaid caring for people with Dementia by 
Knapp et al. (2007). 
6.1.4  Total Employment Earnings Loss during Working Life  
To calculate working lifetime earnings loss of all 182 PwP who took early retirement at 
different ages in their working life, one needs to estimate the mean years of early retirement 
before the stipulated age of 65 for men and 60 for women. Although more recently, the 
retirement age has been moving upwards for women, in our survey almost all women 
respondents took early retirement prior to 2015. In the survey, however, we didn't ask in 
which year the respondents took early retirement, although 67 PwP and 54 carers provided 
detailed notes about how Parkinson's had affected their employment and decision to retire 
early (select  quotes regarding their involuntary early retirement decisions are shown in 
Appendix 7). We had worked out through their notes that the average working years lost was 
5.96 years (male 6.41 and female 5.07 years) for PwP which worked out to be 1078 man-
years. Thus, a total lifetime earnings loss as a result of premature retirement for PwP worked 
out to be £27,808,419. Similarly, 56 carers took early retirement. The average working years 
lost was 3.60 years (male 3.38 and female 3.86 years) and thus accounted for the loss of 206 
man-years, equivalent to £ 5,302,835. Thus, a total lifetime earnings loss as a result of 
premature retirement for PwP households added to £ 33,111,254 and overall mean earnings 
loss (of 767 PwP) was £43,170 per household.  These accumulated losses during working life 
are estimated at current earnings level and not have been adjusted for inflation. 
6.2 Financial Cost Related to Changes in Living Arrangements 
6.2.1 Equipment Purchased 
Out of 776 PwP, 594 provided information on equipment purchased during the past 12 
months. Two-thirds of PwP (376 out of 594) purchased a total of 1013 pieces of equipment. 
These were purchased mainly to improve mobility within the house (bedroom, bath/shower 
room, kitchen) and garden, and outside the home so as to improve balance and reduce falls 
due to tremor. The most common items purchased were walking sticks, walkers, medicine 
dispenser/timer, reclining chairs, raised toilet seats, wheelchairs, special cutlery, furniture, 
stair-lift chair, grip handles in shower, bedrooms, entrance and walkways, special hospital 
type beds and mobility scooters or even automatic cars or Wheelchair Accessible Vehicle 
(WAVs). About 82% of equipment were fully self-financed, with the NHS equipment 
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provided mainly through the Continuing Care programme by either supplying equipment for 
free or at a subsidised rate. The support from the local council and a charity was minimal. 
The average OOP expenditure for equipment was £1128, and per incurring PwP was £3038. 
The overall average for 594 PwP was £1923 (Table 6.2.1). 
 
Table 6.2.1: Equipment purchased in the past 12 months by funding source and cost 
How funded 
Equipment 
N % Mean (£) 
NHS 135 13.33 27.41 
Self-financed 826 81.54 1343.70 
Local Council grant 20 1.97 761.25 
Charity support 17 1.68 204.41 
Other 15 1.48 665.00 
Total 1013 100.00 1127.62 
Per incurring PwP (376)     3037.97 
Overall (for 594 PwP)     1923.02 
Number (%) of PwP purchased equipment  376 63.3  
 
6.2.2 Alterations to Accommodation 
Out of 776 PwP, 585 provided information about alterations to accommodation carried out as 
a consequence of having Parkinson’s.  Of these 278 (47.4%) PwP had made changes to their 
accommodation in the past. The type and extent of the alterations depended on the condition 
(severity) of Parkinson’s. For example, some had changed toilets, converted bathrooms to wet-
room or walk-in shower, broadened main-doors, and had a ramp built. If they were no longer 
able to access the bedroom upstairs via a stair-lift, gradually they moved downstairs by 
converting the living room, reception room or garage into a bedroom. Some of the PwP moved 
to a bungalow thus involving a heavy capital expenditure even after retirement from work. 
Thus with the progression of Parkinson’s the accommodation was altered in line with changes 
in needs. About a half of PwP households had made alterations since the diagnosis of 
Parkinson’s.  More than 70% of alterations were self-financed; 13.5% were through NHS 
assistance and 12.6% through local council grants. On an average, OOP expenses for 
accommodation alterations were £2070; and per reporting PwP this was £3894.  The overall 
average for 585 PwP was £1857 since their diagnosis of Parkinson’s. As two-thirds of PwP 
had been diagnosed for more than 5 years, they may not have been able to recall expenses they 
had made on earlier accommodation alterations. Therefore, we have also looked into these 
expenses over the last two years (158 out of 224 PwP had incurred OOP expenses over the last 
two years).  On an average, OOP expenses for accommodation alterations in the last two years 
was £3888 per reporting PwP, with an overall average of £1050 for 585 PwP (Table 6.2.2). 
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Table 6.2.2: Accommodation alterations undertaken by source of funding and cost 
 
How funded 
Alterations in House 
N % Mean (£) 
NHS 71 13.52 104.58 
Self- funded 369 70.29 2737.67 
Local Council grant 66 12.57 558.33 
Charity support 2 0.38 2500.00 
Combination of funding 8 1.52 1643.75 
Other 9 1.71 1541.67 
Total 525 100.00 2069.52 
Per reporting PwP (279)     3894.27 
Overall (for 585 PwP)     1857.26 
Number, % of PwP made alterations 278 47.4  
During last two years 
Per reporting PwP (158) 224  42.67 3888.13 
Overall (for 585 PwP)     1050.13 
 
6.2.3 Driving and Vehicle Modification 
568 PwP and carers provided information about driving licenses and access to a motor 
vehicle. 71% of PwP and 45% of carers or other members of the household had full-driving 
license. A couple of PwP reported that their driving license was revoked by DVLA due to 
their diagnosis of Parkinson’s.  487 PwP out of 568 (85.7%) said that they had access to a 
motor vehicle and 122 (24.4%) reported that was a mobility vehicle. 49 PwPs either modified 
their vehicle or purchased a WAV or an automatic car to improve motor-ability as a result of 
Parkinson’s. Most of PwP (88%) had to meet such expenses through their own pocket. 
During last two years 31 PwP did modification of vehicle with on average of £4278 OOP 
expenses per motor-ability vehicle. One PwP who bought a new automatic car had paid 
£14,500. 
6.3  Out-of-Pocket Expenses on Daily Living and Energy Cost 
Out of 776 PwP, 582 provided information about their spending on takeaways and on 
convenience foods as a consequence of having Parkinson's. 199 (34.2%) PwP were spending 
more on takeaways and convenience food every month on a regular basis (Table 6.3.1). 
Overall mean expenditure per month on takeaways food (for 582 respondents) was £25.44 
and £74.40 per incurring case. 
Table 6.3.1: PwP increasing spend on takeaways/convenience food due to Parkinson's  
 
Takeaway food N Percent Valid Percent 
Yes 199 25.6 34.2 
No 355 45.7 61.0 
Don’t know 28 3.6 4.8 
Total 582 75.0 100.0 
Missing 194 25.0   
 Total 776 100.0   
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Information on the extra use of energy for the home as a result of Parkinson's was provided 
by 466 PwP. The majority of them (55%) reported an increase in expenses related to central 
heating bills and on average reported additional monthly expenses of £56.70 per case, with an 
overall average of £31.15. Some PwP reported additional expenses towards increasing usage 
of an electric blanket (2%), fan heater (4%), air conditioning (3%), and cooling fan (6%). In 
all, 299 PwP (64%) reported some extra energy cost per month (all together £22195), with an 
average of £74.23 increased expenditure as a consequence of having Parkinson's (Table 6.3.2). 
Table 6.3.2: PwP reporting problems with temperature regulation due to Parkinson's  
Energy Cost 
  
PwP Reported Mean Expenses (£) 
No Yes % of 466 
Overall  
(of 466) 
Per incurring 
case 
Central heating  210 256 54.94 31.15 56.70 
Electric blanket  412 54 11.59 2.36 20.37 
Fan heater  410 56 12.02 3.64 30.27 
Air conditioning  455 11 2.36 3.36 141.82 
Cooling fan  387 79 16.95 5.52 32.47 
Other  445 21 4.51 1.63 36.19 
PwP reporting extra energy cost per month    167 299 64.16 47.63 74.23 
 
As described in Section 4.2, several PwP needed help for their daily or routine activities 
within and outside the house. More than one-third of PwP needed help with personal care and 
bathing and about a half for cooking a meal. For cleaning their house, 62% of PwP needed 
help on a daily or weekly basis. As and when required, between 41% and 49% of PwP needed 
help for ironing, decorating and gardening. Similarly, for activities outside the house, 52% of 
PwP needed help for daily or weekly shopping. About a half of them needed help for 
transport and attend to medical appointments as and when these were scheduled. Several PwP 
had reported attending weekly or bi-weekly physiotherapy/exercise classes and 35% of them 
needed help to attend these classes (Table 6.3.3). A family member, particularly a spouse, 
played a critical role in shouldering most of the in-house and outside house activities. PwP 
who were living alone, received help from their children or grandchildren. However, some of 
the tasks like house cleaning, gardening and decorating were done by a privately hired person. 
In those in a more advanced stage of the condition, when the spouse was unable to provide 
adequate support, private agency carers performed some of the personal care and bathing 
tasks. If required, the private carers also shouldered the responsibility of ironing clothes and 
shopping for them. Most of the formal carers were hired through agencies on the weekly or 
monthly basis. A few had reported a payment to a private agency around £2200 per month.  
 
The total OOP expenses incurred for various daily, weekly, or 'as and when required' 
activities from £830 for cooking to £13990 for decorating. Using a weighting procedure to 
add-up weekly costs, a total annual expense incurred to meet such requirement has been 
calculated. The reported weekly expenses for undertaking tasks of house cleaning, personal 
care, bathing, cooking, ironing, shopping and transport which were mostly performed on a 
daily or weekly basis were multiplied by 52; gardening, attending to medical appointments 
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and physiotherapy/ exercise classes usually performed every two-weeks were multiplied by 
26; and decorating which was infrequently performed, was multiplied by 2. 
 
Table 6.3.3: PwP needing help for daily living activities and weekly OOP expenditure  
Type of Help and Cost 
In Home 
Cleaning  
Personal 
care  Bathing  Cooking  Gardening  Ironing  Decorating  
No. of PwP needing help 326 207 178 251 259 217 250 
% of 529  61.63 39.13 33.65 47.45 48.96 41.02 47.26 
Help provided by (% distribution) 
Spouse 36.1 54.0 51.7 69.5 38.2 57.1 29.4 
Child/grandchild 7.8 8.6 11.9 10.3 7.9 8.1 8.3 
Sibling 1.0 1.1 0.7 1.4 1.2 1.0 .9 
Carer 5.4 28.7 30.0 12.7 1.7 12.6 2.2 
Friend 3.4 1.1 1.4 2.8 7.1 3.5 3.1 
Neighbour 0.7       1.7   0.9 
Social Worker   1.1 .7         
Home help 2.0 2.9 2.1 1.9   2.5   
Cleaner 39.9         6.6   
Gardener 0.7       41.1     
Decorator         0.4   52.6 
Taxi               
Other 3.0 2.3 1.4 1.4 .8 8.6 2.6 
All 100.0 100.0 100.0 100.0 100.0 100.0 100.0 
% needed help on 
daily/weekly basis  77.1 77.4 67.6 85.0 34.5 57.0 2.7 
Total OOP expenses (£) 4670 4120 1150 830 3370 1090 13990 
Mean OOP per 
incurring case 14.33 19.90 6.46 3.31 13.01 5.02 55.96 
Mean OOP (£) of 529 8.83 7.79 2.17 1.57 6.37 2.06 26.45 
Total estimated annual 
OOP expenses* (£) 242840 214240 59800 43160 87620 56680 27980 
Type of Help and Cost 
Outside Home 
Shopping  Transport  
 Medical 
appointment  
Exercise/ 
physiotherapy  
Number of PwP needing help 274 246 267 184 
% of 529 provided information 51.80 46.50 50.47 34.78 
Help provided by (% distribution) 
Spouse 55.1 58.0 63.1 36.4 
Child/grandchild 19.6 15.0 12.9 6.4 
Sibling 2.4 1.8 1.2   
Carer 9.4 4.0 6.2 6.4 
Friend 3.3 4.4 5.8 1.7 
Neighbour 0.4     0.6 
Social Worker         
Home help 1.2   0.4   
Cleaner 1.6       
Gardener         
Decorator   0.4     
Taxi 1.2 10.6 5.0 0.6 
Other 5.7 5.8 5.4 48.0 
All 100.0 100.0 100.0 100.0 
% needed help on daily/weekly basis  75.1 28.7 6.7 62.5 
Total OOP expenses (£) 2590 2230 1680 2990 
Mean OOP per incurring case 9.45 9.07 6.29 16.25 
Overall Mean OOP (£) of 529 4.90 4.22 3.18 5.65 
Total estimated annual OOP expenses* (£) 134680 115960 43680 77740 
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The resultant total annual OOP expenses for in-house activities worked out to be £732320, 
for outside of house £372060, and the aggregated cost was £1,104,380. These were reported 
by 529 PwP, therefore, the annual mean OOP expenses estimated as £2087.70 per PwP 
household.   
6.4 Changes in Income and Social Benefits 
Out of 776 PwP, 583 reported on the sources of income and benefits they had received and 
the change in these over the last 12 months. The results are presented in summary and 
detailed sources of income/benefits in Tables 6.4.1 and 6.4.2. Nearly a half of PwP received 
income as state pension and a similar proportion of them received as an occupational pension; 
this is followed by 13% who received income from employment and 9% from other sources. 
In terms of benefits 83% received incomes from various state allowances and credits; 
however, about 8% received Local Council for housing and other benefits. Carers reported a 
similar pattern in sources of income and benefits; however, the magnitude was relatively 
smaller compared to those for PwP.  Further, just under a half of carers received incomes 
from various state allowances and credits.  
 
Over the last year some PwP had reported discontinuance of income from employment (3%), 
state pension and occupational pensions (5%), and state allowances and credits (12%). The 
respective discontinuance rates for carers were 4%, 3%, and 6%. An estimated 
discontinuance of pensions and state benefits for PwP and carers amounts to a loss of 
£10,773.75 and £6060.75 per week respectively, which worked out at £875,394 per year.  The 
overall mean annual loss per PwP household of pensions and benefits due to a diagnosis of 
Parkinson's worked out to be £1502. 
 
Table 6.4.1: Summary of sources of income/benefits for PwP and Carers 
 *Item number details against sources are shown in Table 6.4.2 
Summary of Income/Benefits* 
 
Currently Receiving Received in past 12 months 
but no longer getting 
PwP Carers PwP Carers 
N % of 
583 
N % of 
583 
N % of 
583 
N % of 
583 
Reported income from employment (1) 74 12.69 75 12.86 18 3.09 22 3.77 
Reported income from other sources (29) 55 9.43 30 5.15 0 0.00 1 0.17 
Reported income as State Pension (5) 279 47.86 238 40.82 27 4.63 20 3.43 
Reported income as Occupational Pension (6) 263 45.11 177 30.36 26 4.46 13 2.23 
Reported income from Allowances/Credits (2, 
3, 4, 7, 9 to 25) 
482 82.68 276 47.34 68 11.66 35 6.00 
Reported benefits from Housing/Council/Other 
Benefits (8, 26, 27, 28) 
44 7.55 42 7.20 9 1.54 4 0.69 
All 1197  838  148  95  
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 Table 6.4.2: Detailed sources of income/benefits for PwP and Carers 
 
  
Source  
no. 
Sources of Income/Benefits Currently Receiving Received in past 12 months but 
no longer getting 
PwP Carer PwP Carer 
N % N % N % N % 
1 Regular income from employment 74 6.18 75 8.98 18 12.16 22 23.16 
2 Working Tax Credit 9 0.75 11 1.32 1 0.68 4 4.21 
3 Income Support  4 0.33 2 0.24 1 0.68 0 0.00 
4 Jobseekers Allowance  7 0.58 1 0.12 1 0.68 1 1.05 
5 State Pension  279 23.31 238 28.14 27 18.24 20 21.05 
6 Occupational Pension  263 21.97 177 21.20 26 17.57 13 13.68 
7 Pension Credit 14 1.17 11 1.32 3 2.03 0 0.00 
8 NHS Continuing Care 6 0.50 9 1.08 1 0.68 3 3.16 
9 Attendance Allowance £55.10 a week  22 1.84 17 2.04 2 1.35 3 3.16 
10 Attendance Allowance £82.30 a week  35 2.92 53 6.35 3 2.03 7 7.37 
11 Mobility Allowance 26 2.17 20 2.40 4 2.70 1 1.05 
12 Carers Allowance 23 1.92 19 2.28 5 3.38 2 2.11 
13 
Employment and Support Allowance 
work-related activity group (£102.15/ 
week)  
7 0.58 1 
0.12 7 4.73 5 5.26 
14 
Employment and Support Allowance 
support group ( £109.30/week) 
32 2.67 14 
1.68 8 5.41 2 2.11 
15 
Disability Living Allowance lower rate 
care component (£21.80/week)  
39 3.26 11 
1.32 9 6.08 1 1.05 
16 
Disability Living Allowance middle 
rate care component (£55.10/week)  
40 3.34 22 
2.63 2 1.35 2 2.11 
17 
Disability Living Allowance higher rate 
care component (£82.30/week)  
61 5.10 27 
3.23 6 4.05 1 1.05 
18 
Disability Living Allowance lower rate 
mobility component (£21.80/week)  
10 0.84 9 
1.08 2 1.35 1 1.05 
19 
Disability Living Allowance higher rate 
mobility component (£57.45/week) 
94 7.85 31 
3.71 9 6.08 2 2.11 
20 
Personal Independent Payment lower 
rate daily living component 
(£55.10/week)  
17 1.42 1 
0.12 0 0.00 0 0.00 
21 
Personal Independent Payment higher 
rate daily living component 
(£82.30/week)  
13 1.09 6 
0.72 2 1.35 1 1.05 
22 
Personal Independent Payment lower 
rate mobility living component 
(£21.80/week)  
5 0.42 1 
0.12 0 0.00 1 1.05 
23 
Personal Independent Payment higher 
rate mobility living component 
(£57.45/week)  
9 0.75 5 
0.60 0 0.00 0 0.00 
24 Child Benefit 10 0.84 11 1.32 0 0.00 0 0.00 
25 Child Tax Credit  5 0.42 3 0.36 3 2.03 1 1.05 
26 Housing Benefit  10 0.84 10 1.20 1 0.68 0 0.00 
27 Council Tax Benefit  26 2.17 21 2.51 2 1.35 1 1.05 
28 Other benefit 2 0.17 2 0.24 5 3.38 0 0.00 
29 Other income 55 4.59 30 3.59 0 0.00 1 1.05 
Total sources of income/benefits 1197 100.00 838 100.00 148 100.00 95 100.00 
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6.5 Resultant Societal Cost 
The combined magnitude of both health and social care cost of Parkinson's to society is 
summarised in Table 6.5. The direct healthcare cost was mainly borne by the NHS; when 
these are combined with OOP payments, the average annual cost per PwP was £2388. The 
indirect annual healthcare cost, mainly borne by the PwP, was £1959. Thus, the total annual 
healthcare cost per PwP worked out to be £4347.  There were other non-healthcare expenses 
related to changes in living arrangements and environment that were directly borne by PwP 
households. The annual non-healthcare cost was £3622 per PwP household. The total annual 
healthcare and non-healthcare cost per household added up to £7969. Where appropriate, a 
breakdown of these health and social care costs by individual Home Countries has been 
provided in Appendix 6. 
Table 6.5: Aggregated annual health and social care cost of Parkinson's on society 
 Annual Direct and 
Indirect Cost  Cost/Income Loss Description 
 Total 
Cost (£) 
Mean 
Cost per 
family 
Direct  Healthcare  
1. Health services by the NHS  NHS 1,285,354 2,118 
2.  Healthcare OOP (n=610) PwP 161,920 270 
Sub-total (1 to 2) 1,447,274 2,388 
Indirect Healthcare  
3. Travel (n=610)  
PwP 1,164,150 1,959 4. Equipment (n=594) 
Total Healthcare (1 to 4) 2,611,424 4,347 
Non-healthcare  
5. Alterations in accommodation (n=585) PwP 307,163 525 
6. Living environment - energy cost 
(n=466) PwP 266,340 572 
7. Takeaways (n=582) PwP 177,660 305 
8. Mobility vehicle/car (n=501) PwP 66,313 132 
9. Daily living assistance (n=529) PwP 1,104,380 2,088 
Total Non-healthcare (5 to 9) 1,921,855 3,622 
Income Loss 
(Direct and 
Indirect) 
10. Current Workdays lost and reduction 
in weekly hours  (n=729) 
PwP & 
Carers 
1,444,299 
1,981 
11. Current Indirect employment earnings 
forgone due to early retirement or 
inability to work or unemployed (n=767) 
PwP & 
Carers 4,612,179 6,013 
12. Unpaid caring (earnings loss)  Carers 947,232 1,235 
13. State pension and benefit loss (n=583) 
PwP & 
Carers 875,394 1,502 
Sub-total  (10 to 13) 7,879,104 10,731 
Current productivity loss (10 ) per worker (workers=264) 5,471 
14. Exchequer loss related to reduced productivity (10 and 11) 1,423 
Annual Financial 
Burden of 
Parkinson's  
On Household 16,582 
Adding NHS costs  18,700 
Adding Exchequer loss 20,123 
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To arrive at the total societal cost, we calculated current income loss due to Parkinson's in 
terms of annual sick days off and reduced weekly working hours for both working PwP and 
carers. This was valued at an annual income loss of £5471 per worker and the overall mean 
per household calculated as £1984. Several PwP and carers were forced to take early 
retirement or inability to work or became unemployed due to Parkinson’s; using the 
opportunity cost of time approach we estimated earnings foregone for those who are still in 
their working-age. The overall mean per PwP household for such annual earnings forgone 
worked out to be £6013. Many carers are not enrolled with DWP for caring allowance and 
thus providing unpaid care to their family members. The unpaid caring per household worked 
out to be £1235. Further, many PwP and carers had reported a loss of certain benefits and cut 
in pension since registering with DWP as an elderly disabled person or carer. This amounted 
to an annual loss of £1502 per household. Thus, total annual income loss per household 
amounted to £10,731.  
Further, the direct and indirect earnings loss to the working-age PwP and carers also reflect 
on reduced income tax and national insurance contributions to the Government exchequer. 
According to Knapp et al. (2007), excluding national insurance contribution, the effective rate 
of income tax loss was 17.8% of income forgone. In our survey annual earnings forgone per 
PwP household was £7994 (£1981+£6013); thus after application of the effective income tax 
rate, the resultant exchequer loss worked out to be £1423 per household per year. 
Aggregating all direct and indirect costs, the annual financial burden of Parkinson's on 
society was £20,123 per PwP household. This included the annual financial cost to the NHS 
of £2118 per PwP for their treatment and exchequer loss of £1423 per household. Figure 6.1 
shows the broad breakdown of societal costs per PwP household - the share of income losses 
53% followed by total OOP expenses 29%, and the remaining 11% by the NHS and 7% as 
exchequer loss. 
Figure 6.1: Distribution of societal costs per PwP household by major categories (£, %) 
 
Healthcare cost-
NHS,  £2,118 , 11% 
Healthcare OOP 
expenses,  £2,229 , 
11% 
Income losses,  
£10,731 , 53% 
Additonal 
living/caring 
expenses,  £3,622 , 
18% 
Exchequer loss,  
£1,423 , 7% 
Societal Costs of Parkinson's 
(£20,123 per PwP Household) 
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The annual direct financial burden on Parkinson's household was £16,582 or £1382 per 
month. These cost estimates exclude PwP who were transferred from family care in their own 
home to a nursing home care (the financial burden on families transferring to care home was 
very large, with a couple of families reporting of paying between £2700 and £3200 per month 
for such care). Figure 6.2 shows the breakdown of annual costs of Parkinson's to PwP 
household by type of costs (i.e. income losses and additional expenses).  
Figure 6.2: Distribution of annual cost to PwP households by type of cost (£) 
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7. Financial Impact on Households 
7.1  Impact on Household Income 
Out of 776 PwP, the gross annual household income range category was reported by 527 
(67.9%) household. The majority of PwP (56%) or carers (60%) reported their annual income 
to be under £20,000 (Table 7.1.1). The majority of households (60%) reported the combined 
household income of under £30,000. It was considered that this might reflect on their 
financial capability to manage and provide the best care for Parkinson's. It also suggests the 
financial impact of Parkinson’s to be very large for a majority of households receiving gross 
annual income under £30,000. 
Table 7.1.1: Annual income of PwP and Carers 
Gross Annual Household 
Income 
PwP Carer/Other Total* 
N % N % N % 
Under £10,000 114 21.8 116 29.0 58 11.0 
£10,000 - £19,999 180 34.4 124 31.0 149 28.3 
£20,000 - £29,999 100 19.1 59 14.7 110 20.9 
£30,000 - £39,999 47 9.0 37 9.3 74 14.0 
£40,000 - 49,999 31 5.9 15 3.8 43 8.2 
£50,000 or more 25 4.8 23 5.7 67 12.7 
Don't know 26 5.0 26 6.5 26 4.9 
Total Reported 523 100.0 400 100.0 527 100.0 
* The missing values for the total income category are replaced by the highest income category 
reported for PwP or carer in the household.  
 
About one in four households (25%) reported a reduction in their monthly income as a 
consequence of Parkinson's (Table 7.1.2). This was reported earlier as mainly due to a loss in 
annual working days and forced a reduction in weekly working hours for both PwP and carers, 
and similar concerns are reflected below. The underlying reasons reported for a decreased 
monthly income included a reduction in work hours (31%), given-up work completely (28%), 
moved to less demanding jobs (12%) and the rest (29%) mentioned no specific reasons for 
the reduction in monthly income. 
Table 7.1.2: Impact on monthly income of PwP households by underlying reasons  
 
Household experienced a reduction in income due to 
Parkinson's over the last 12 months N % 
Valid 
Percent 
Yes reduced income by £0-£200 monthly 49 8.4 9.5 
Yes reduced income by £201 - £500 monthly 30 5.1 5.8 
Yes reduced income by £501+ monthly 50 8.6 9.7 
No reduction in monthly income 388 66.6 75.0 
Total Reporting impact  517 88.7 100.0 
Not Reported 66 11.3   
Total Respondents 583 100.0   
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Reason for household monthly income reduction 
I have had to reduce my hours at work 33 5.7 23.4 
I have had to move to a less demanding job 13 2.2 9.2 
My job does not pay sick leave and I have had to take an 
increasing number of days off 2 0.3 1.4 
I have had to give up work and am now claiming benefits 23 3.9 16.3 
My partner/relative had to reduce their hours at work 11 1.9 7.8 
My partner/relative had to move to a less demanding job 4 0.7 2.8 
My partner/relative has had to give up work to care for me 16 2.7 11.3 
Others 39 6.7 27.7 
 All reasons 141 24.2 100.0 
Not Reported/Applicable  442 75.8   
Total Respondents 583 100.0   
 
7.2  Impact on Household Budget 
Overall the financial impact of Parkinson’s on a family was widespread; only 168 (28.8%) of 
the respondents stated that they have not seen the impact at the time they completed the 
survey, although it seems likely this may change as the condition progresses (Table 7.2).  The 
remaining 415 (71.2%) PwP and carers had expressed on average three types of impact 
(1217/415 = 2.9), which having Parkinson’s exerted on their financial situation. The share of 
direct monetary impact in terms of reduced savings and increased borrowings including 
mortgage equity release was the highest (26%); followed by the changed priorities for 
spending (20%), reduced social activities (19%), reduced holidays (18%) and reduced 
spending on festive gifts (11%). 
  
Table 7.2: Financial effect on household budget by type of impact 
 
Overall Financial Impact of Parkinson's on Family N %  
Not affected at the moment 168 28.8 
Had affected 415 71.2 
All 583 100.0 
Impact type 
1. Savings have been reduced 263 21.6 
2. Borrowing has increased to meet basic needs 37 3.1 
3. Re-mortgage to release equity 15 1.2 
4. Reduced holidays 214 17.6 
5. Changed priorities for spending 248 20.4 
6. Reduced social activities e.g. eating out 235 19.3 
7. Level of income on gifts for birthdays/Christmas has reduced 139 11.4 
8. Other 66 5.4 
All 1217 100.0 
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8.  Lifetime Costs of Parkinson's 
8.1 Findings Emerged from In-depth Interviews  
Of the five people interviewed, none lived in a city; all fell into the category of late onset 
(over 40 years at diagnosis), and ranged from being diagnosed from 3 up to 11 years. This 
places CC in the early stages of Parkinson’s, AL, MA and LA in the mid stages, and AC’s 
wife in the late stages of the condition (Table 8.1). 
Table 8.1: Basic coding for interviewees 
 
Identification Person 1 Person 2 Person 3 Person 4 Person 5 
Gender Male: AL Male: MA Male: CC Male: AC Female: LA 
Role Diagnosed 
with 
Parkinson’s 
+ wife joined 
conversation 
Diagnosed 
with 
Parkinson’s 
Diagnosed 
with 
Parkinson’s 
Carer for 
someone 
diagnosed 
with 
Parkinson’s 
Diagnosed 
with 
Parkinson’s 
Age at 
diagnosis 
68 52 65 Spouse aged 
51 at 
diagnosis 
52 
Years with 
Parkinson’s 
Into his 5th 
year  
Into his 9th 
year 
Into his 3rd 
year 
Into spouse’s 
11th year 
Into her 5th 
year 
First 
symptom 
Wife noted 
right-hand 
tremor; AL 
noted slowness 
Both 
slowness and 
tremor 
Both 
slowness and 
tremor 
Stiffness and 
slowness 
Stiffness and 
slowness 
Country England Wales Northern 
Ireland 
Scotland Scotland 
Residential 
area 
Rural Town Town Rural Town 
 
In terms of gaining information, it proved difficult for people who had Parkinson’s for more 
than a couple to years to pin-point when specific changes that necessitated spending (direct or 
indirect) occurred or might occur.  
AL reported what he had noted from reflecting on the past few years:  
‘It is difficult to break down into years one to four. I believe the deterioration due to 
Parkinson’s was a slow and gradual one, I guess the decline is small and the same 
percentage each year. This applies to both the physical side and the emotional/ 
psychological one’. AL by email 
The conceptual social framework (Appendix 2) has been used to chart an overview of the 
costs (financial, social, and psychological) the five interviewees discussed over the course of 
their years with Parkinson’s (Appendix 3). The results have been subdivided into the 
following four subsections: a pre-diagnostic stage: diagnostic experience, elapsing years and 
future years. 
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Pre-diagnostic stage 
Whilst each person with Parkinson’s interviewed could state the year they were diagnosed, 
for some, it took further probing to ascertain how many years prior to this they had been 
experiencing motor symptoms (problems experienced with aspects of movement, usually a 
slowness or stiffness, affecting daily life), and what impact this actually had on their lives. 
As they were all near to retirement, or retired, it was easiest to consider pre-diagnostic 
changes in terms of how it affected their work. For example, AL initially noticed changes in 
his working life during the 5 years prior to diagnosis of finger stiffness affecting his use on 
the computer, and taking longer to recall names and contact numbers for work, something AL 
had prided himself as working well. As he was already retired at this point, he stated the 
changes did not affect his decision to retire. This is different to MA and LA whose decision to 
retire early was based on the Parkinson’s.  
CC initially believed the diagnosis of Parkinson’s had no impact on retirement decision as it 
was made 4 years after retirement. On further questioning however, he noted increased issues 
when covering his 8 – 10 mile round route at work at an outdoor museum that probably led 
him to take an option to retire at 61. 
‘I quite enjoy walking, but I noticed then I was becoming a bit slower, a bit more 
clumsy, tripping over things that really weren’t there, tripping over my own feet.’ 
‘…Other things as well. The loss of concentration came quite easily and a lot of what 
I did and what I still do is talk to groups of people and you get lost for the correct 
word. I know what I want to say, but I can’t find the word.’ 
Whilst over the 60-year retirement option offered employees of his Local Authority, his 
retirement came four years prior to the age of 65 years at which time CC had planned 
retirement: 
‘…but as this [symptoms pre-diagnosis of Parkinson’s] developed I thought, I don’t 
really want to spend the early years in retirement feeling under the weather and 
miserable, so I went at 61. 
MA’s symptoms caused him to look for alternative employment: 
MA: ‘Well initially when I first started noticing symptoms I was self-employed at the 
time. I used to install and service, well I used to do installation of the hands-free kits 
in cars for mobile phones and also install and service two-way radio systems…Well I 
noticed when I was doing installations that I was having problems sort of feeding 
cables through small gaps whereas previously I would’ve done it say in a matter of a 
few seconds. It would take me several minutes to do the same thing. Because I didn’t 
seem to be able to, I didn’t have the dexterity in my hands. Using tools was becoming 
more difficult…I would have to give myself longer on the job which isn’t always a 
good thing because when you’re dealing with, some cases you were dealing with 
CEOs and things of companies and obviously they were under pressure, they need the 
vehicle. You’ve got a limited amount of time to do it so it increased the pressure on me 
as well’. 
‘…Yes I eventually had to give up self-employment and I then when to work for my 
local authority. Initially on relief work as a caretaker and then later on I got a full 
time permanent job as a site supervisor’. 
There is evidence of the financial cost of Parkinson’s affecting earnings, and the ability to 
continue work in section 6.1, but the interviews highlighted the social and psychological 
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consequences that evolved in later years. 
The Sheffield co-researchers felt the pre-diagnostic period to be a time of an increasing sense 
of vulnerability, as many were not believed when they stated varied non-motor and motor 
symptoms and had to request reviews. Despite the push for communication and shared-
clinical decision-making, few people are prepared to openly question medical authority, or 
feel comfortable asking for further investigation (Busari 2013).  
This happened with both AL and CC, who had to return to the GP for a review after initially 
being told they did not have Parkinson’s.  
AL first went to the GP as: ‘….my wife made me’ to investigate a tremor she noticed:  
‘…the first time we saw a locum and she said, no, there’s nothing wrong at all. My 
wife wouldn’t accept it so she dragged me back again. I was sent over to the hospital 
and that’s when the diagnosis was made.’ 
CC story of initial misdiagnosis was different, as his return to the GP was prompted by a 
different medical problem: 
‘I’ve always been fairly active throughout my life and I’d started to notice that I was 
slowing down and my gait wasn’t what it used to be. In fact now with the benefit of 
hindsight I realise I’d developed that Parkinson’s gait, you know where you stoop 
forward and little steps?’ 
‘…but at that stage I obviously didn’t realise what it was, but the tremor in my hand 
was the first noticeable thing and I asked my GP, I went to him at one stage saying I 
was out of sorts, didn’t feel in just top form and I said, I’ve got this tremor in my right 
hand, and he flexed my muscles, flexed my arms and made me put a finger on my nose 
and turn around, all those sort of things, and he said, no I don’t think you’ve anything 
wrong with you, I don’t think it’s, if you’re thinking of Parkinson’s, I don’t think you 
have Parkinson’s disease, and I went away quite content, although I still had the 
tremor and I thought, it’s just old age. And I had to go back to the surgery about, I 
don’t know, three or four months later, with an ear infection, and I saw a different 
doctor and she said to me, it was a young girl, she said to me after she’d looked at my 
ear, I see you’ve got a tremor in your right hand, obviously you’ve not said anything 
about it. Not really, I said, it’s just an old age tremor. So she went through this whole 
process again, finger on the nose, turn your head, stand up, bend over, flex arms and 
legs and she said, I’m not terribly sure about this, you have an essential tremor, I’d 
like you to see a consultant.’ 
‘…So I saw him one morning and he said to me, after he’d done all the usual tests, he 
made me walk around the surgery, he said, I’ll do two tests, a blood test to make sure 
it’s not, I can’t even remember what it was he said, and I’ll send you for an MRI scan, 
but as far as I’m concerned you have Parkinson’s, but it’s early stages yet and it’s 
quite a mild case. 
Some people, whether given a possible diagnosis, had to await the process of referral to a 
specialist consultation and investigation as per guidelines (Scottish Intercollegiate Guidelines 
Network [SIGN], 2010, NICE, 2006), before confirmation of a diagnosis.  
AC’s wife saw several specialist Consultants plus paid to see a chiropractor in the UK for her 
chronic back pain, was finally diagnosed by a consultant abroad: 
AC described the long process that finally led to his wife’s diagnosis: 
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‘Well actually that was, again, before, prior to 2004 [talking about the purchase of a 
stick prior to the year his wife was diagnosed with Parkinson’s], we now know she had 
onset of Parkinson’s. For a number of years prior to that probably as early as 1998, 
1999, we thought it was something to do with her back.  
‘…We went to, yeah it was, because of her back she used to go to a chiropractor, and 
the chiropractor mentioned on a couple of occasions that she should really go and see 
her doctor. 
‘…Yeah she did see a back specialist in [named town] and he said yeah you have a 
bad back but it’s not, you know, you just have to live with it, we’ve nothing we can 
really do with that. And in his notes he’d wrote that he’d suspected mild dyskinesia, 
which is mild involuntary movement. Obviously he could see in her eyes and her face 
there was mild dyskinesia there. And he wrote that in his notes but the doctor didn’t 
pick up on it and just filed the notes and didn’t tell us. It was only when we queried 
the fact that we’d not heard anything back from this back doctor with our own doctor 
that it came to light that this is what he’d put in his notes. So we weren’t very happy at 
all.  
‘…And it was only when we…I used to work in Oman and I took her back, because 
NHS here were…they would’ve taken nearly a year to see a neurologist, I took her 
back to Oman and she was diagnosed immediately with Parkinson’s. So she came 
back to UK, I was still there, she came back to UK and saw a neurologist here who 
concurred with the neurologist in Oman that she did have Parkinson’s, and that was 
late 2004. 
Diagnostic experience 
For the Sheffield group who conceived the social framework for Parkinson’s, the period 
around diagnosis (pre- and immediately post-) was a time they noted as needing the most help 
to enable development of understanding and acceptance of the implications of the condition 
(Evans and Norman, 2009).  
Two issues are noteworthy from the series of interviews:  
The first relates to the fact that individuals are seen to be mobile at the point of diagnosis (the 
standard by which most Parkinson’s assessment is measured) by health and social care 
professionals, so are often provided minimal or no support. AL, CC and LA comment how in 
hindsight, it had been difficult to accept the diagnosis, and that this continues to be an issue 
for some.  
The effect on LA has caused her to be signed off work. She since attempted two returns to 
work, and considered part-time working, but worked irregular hours over a seven-day period, 
so this was untenable. LA stated:  
‘So I tried to work away but a lot of my work is outdoors because it’s working in 
gardens and stuff and that affects and I have digestive problems as a result of the 
Parkinson’s, and some of the medication I’m on, so work was becoming difficult and I 
was becoming very, very self-conscious to the point where I got quite anxious about it 
and ended up being signed off by the doctor with anxiety and depression…and at that 
point in time I realised that I hadn’t, well, I thought I had accepted the fact that I had 
Parkinson’s but I don’t think I had. I don’t think I’d given myself time. I think I just 
did my usual, put your head down and get on with it. 
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‘…I have had to in recent months, not accept but absorb the fact that I’ve got 
Parkinson’s and the impact that’s having on my life as it progressed and the potential 
impact it has on my life, so I decided to approach my boss…I just asked them to 
consider ill health retirement’. 
The second issue relates to the physical symptom discussed and investigated at the point of 
diagnosis i.e. whether it is a tremor or stiffness (Jancovic and Kapadia 2001). Taking an 
accurate history helps in limiting misdiagnosis, as experienced with three of the interviewees 
(AL, AC’s wife and LA) however AL, MA, and CC were unable to state which symptom 
presented first, especially as if their presentation was vague.  
AL’s wife noted his tremor, yet he stated stiffness as his first problem, noticed when typing 
on the computer. MA reported that a tremor made him seek doctor’s advice, but it was 
stiffness limiting dexterity in his manual labour that he noticed first at least two years prior to 
the onset of the tremor. CC states: 
‘I noticed the tremor first, but I think the doctor based it on stiffness…Yes, the first 
symptom was not only the tremor, but I was out of sorts, felt under the weather, that 
sort of thing, I didn’t exactly know what’. 
 
Elapsing years 
This period encompasses the observation that life with Parkinson’s has ups and downs with 
periods of betterment and sometimes some recovery of lost skills following lapses, especially 
if due to other medical conditions. The support required during this period was deemed by the 
Sheffield co-researchers as needing to be relevant to their varied requirements, challenging 
the current system where people with Parkinson’s are expected to fit their needs to available 
services. Also, whilst the co-researchers knew the condition was progressive, they felt that 
they needed to pursue things that kept their spirits up even if they took on (paid for) 
assistance to do so. 
CC noted regarding things he and his wife needed help for: 
‘We’ve suddenly realised that the garden is too big for the pair of us to look after it, 
but we just have to adapt it so that we can manage as best we can before we have to 
actually hire somebody to do it. Some of the things in the garden that I would have 
done years ago like hedge trimming and stuff like that, the heavy work, we get 
somebody to do it for us now’. 
But he still keeps active, and is up for a challenge, now with added incentive: 
‘I still like to maintain my independence in my activities. Last year, funnily enough, 
last year Parkinson’s had a sponsored walk in Northern Ireland in June and it was 
over in the Cave Hill Country Park. Now, it’s quite steep and I think it was about four 
and a half, five miles long. I did that because (a) I wanted to raise some money for the 
organisation, and (b) because I wanted to prove that I could still do it and I did’. 
CC raised £1,200, an achievement of which he was understandably very proud.  
Parkinson’s UK networks were noted as a source of information, and for some of the positive 
support. Whilst all interviewees belonged to the charity, not everyone was ready or able to 
participate in activities offered. 
AL and his wife were fully involved and organised their group events, with unexpected 
consequences when asked if there was a cost involved. AL, about his and his wife’s 
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involvement:  
AL: ‘She’s got running the group. I don’t think there’s any cost in that. Collections 
Funerals, oh yes, yes, yes. We go to a lot of funerals nowadays! ....We’ve had three 
Parkinson’s ones I think’. 
AL’s wife: ‘Yeah, three funerals’. 
AL: ‘Because we’re coordinators we sort of, although we’re pleased to go along, we 
would be expected to go along anyway’. 
LA, on the other hand felt unable to attend meetings: 
LA: ‘I pay my membership and I get the newsletter and I printed off all the 
publications at the time I joined, because I didn’t know anything about Parkinson’s 
when I was diagnosed and I didn’t know anybody that had it. No, I don’t go to support 
groups. I actively avoid support groups…And the reason for that is I have a fear of 
meeting people who are at a much more advanced stage of Parkinson’s, which I could 
potentially be as well. I mean they’re all different, as you’re probably aware, 
everybody with Parkinson’s is different and quite unique, so there’s no saying how it 
will go, but it’s just the fear factor of seeing somebody. I experienced it recently, 
because I’ve taken part in a Dance for Parkinson’s Disease class’. 
MA was unable to participate as fully as he would have liked due to the restrictions placed on 
him by his pathology: 
‘Well I used to go to meetings because they were quite close by but they’ve moved 
further away now so I don’t, I do tend to go when they have certain outings although I 
haven’t been this year because I’ve been in so much pain basically that I haven’t 
really felt like going. But previously I used to take part in the social events quite 
regularly’. 
The pain affects his general social life: 
Interviewer: ‘Right so in terms of your social life have you, you know, do you still see 
the people who you used to see or once you…’ 
MA: ‘To a large extent, yes’. 
Interviewer: ‘So there is still support there’. 
MA: ‘Yes…I’m less inclined to want to do things…because I don’t get the, obviously I 
don’t get the enjoyment’. 
There were differences in the provision of services to maintain a person’s wellness and fitness 
whether through the Parkinson’s UK body or the NHS. For example, AL and CC are on a 
regular programme of monitoring by the health professionals; LA had not thought to access 
any allied health professionals; MA has had to chase the Specialist Nurse for an appointment 
that should be automatically arranged. 
In addition to this, networking through Parkinson’s UK gave people access to participate in 
local research projects, such as the Dance for Parkinson’s classes LA was attending, giving 
them an opportunity to try different things. 
As the Parkinson’s progressed with time, there was occasional disagreement between the 
insight of the person with Parkinson’s and spouse/ carer.   
During the interview, AL and his wife noted differences in their opinions of what was due to 
Parkinson’s, and what was AL’s character. For example, two years a
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local when on holiday in Turin, and wandered off from the party he was with. He states: 
‘…I talk to people. I’m very gregarious and I find people very interesting, I always 
have done and so I love talking to people. Once I get involved in a conversation I’m 
talking to someone. What else goes on around me like a multiple car crash or 
something like that, I probably wouldn’t notice.’ 
His wife felt it had become more of an issue since his diagnosis: 
‘He carries on talking and is not aware, as he says that anything else is happening, 
and that is fairly new’. 
Last year, AL ‘disappeared’ for a time when on holiday in Paris. AL’s wife reported the issue 
as AL looking but not seeing, stating: 
‘It meant that he lost the entire party and went up a different flight of steps…We did 
find him. I’d resigned myself (this would have cost us), because I’d resigned myself to 
staying put and not going with the rest of the party, when he popped his head out of 
the train and was noticed. He was sat in a separate carriage to everybody else in the 
party!’ 
AL reflected how his perceptions about his overall progression differ to those of his wife in 
an email, only noticing the change in his fifth year since diagnosis: 
‘However in year five, there has been a change. The physical side declined at 
approximately the same rate as previously, but there has been acceleration in the rate 
of decline in my hearing and ability to deal with more than one thing at the same time. 
[Named wife]  thinks it is not my hearing but is my inability to process information 
including those relating to sight and hearing. When organising a meeting or event, I 
now sometimes get stressed and confused. This in turn brings on tremors.’ 
His acceptance of the Parkinsonian symptoms was not easy, as reported by his wife: 
AL’s wife: ‘Yes, I can say year one he didn’t accept that he was walking with the 
Parkinson’s gait, the shuffle with the hands. He didn’t believe that he was and he 
didn’t believe that he was talking softly, so it took the year I think for that to be 
accepted.’ 
AL: ‘I think I accepted it very quickly’. 
AL’s wife: ‘You accepted it once you had been persuaded to go to the doctors and 
had been diagnosed, although I actually - he didn’t have a tremor when he went to the 
doctors. I had to imitate it to show them what it was like’. 
 
In CC’s case, he felt he got on with life regardless of the diagnosis, but his wife’s response 
and further questioning made him consider his response to the diagnosis was not as he had 
thought:  
CC: ‘I sort of bottled it all up. I didn’t join the group until nearly a year after my 
diagnosis. Sorry, I’m getting feedback in my ear… (wife saying something, so CC 
asks): Sorry, what did you say?’ 
CC’s wife: ‘Tell her you didn’t accept it for a while’. 
CC: ‘I didn’t accept it for a while apparently…I felt as though I didn’t want them to 
be told about it, if it didn’t, in my time …[unclear]. I didn’t want it just going round 
like wildfire, oh, you know, CC’s [named self] got Parkinson’s disease. So from that 
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point of view, Bhanu, no, I didn’t accept it for quite a while after the first diagnosis. I 
didn’t believe that I had it’. 
Interviewer: ‘But in terms of the fact that you noticed a tremor, did it ever occur to 
you that other people might?’ 
CC: ‘Well, on reflection, yes. Some people that are close to me, whenever I say that to 
them, I’ve got Parkinson’s disease, eventually they go, well, I sort of guessed you have, 
because of the tremor and the way I held myself and the way I walked…Most people 
aren’t stupid, they will notice things and it’s maybe out of politeness they won’t say it 
to you, but on reflection they probably did know that I had something wrong with me’. 
CC: ‘…I probably did isolate myself and stay inside. I certainly didn’t mix too often 
with company at that stage’. 
Future years 
As noted with the social framework, there is often a reduced inclination for people with 
Parkinson’s to think in terms of future needs. Many deal with issues as they arise, although 
from the interviews and survey people were aware that there would be deterioration at some 
point in the future. 
For example, after a medical consultation, CC was referred to a physiotherapist: 
‘…he said, I think actually you could do with a walking aid, a stick. It’s not essential 
to me. I can walk without it, but it’s like a security blanket. If I have it there, I know 
I’m not going to fall over’ (awareness of a potential characteristic of balance loss). 
Interviewer: ‘Right, but have you fallen?’ 
CC: ‘No, it’s the worry of it. It boosts your confidence. Luckily enough I haven’t fallen 
yet’ (anticipatory language).  
What was notable with the interviewees was how some had taken action that pre-empted a 
need before it became obvious e.g. CC brought a car with higher seat at retirement without 
understanding the need for ease when getting into and out of a car: 
CC: ‘When I retired I changed my car. I changed it from a low slung saloon car to 
one of these SUVs, you know, people carriers, so it’s taller. I find it easier to get in 
and out of…I think I just did it automatically without realising it would be an 
advantage. I’m glad I did now’. 
, and MA moved to a bungalow without realising how beneficial it would be, given the pain 
he was currently experiencing limiting his mobility.  
Spouses often consider needs more, anticipating decline, and this was notable in the way 
AL’s wife and AC monitored the progression of their spouses with Parkinson’s. 
AC noted he had been to the GP with his concerns about how his wife would cope if there 
was an emergency (he mentioned a fire), or if something happened to him. Although he 
received advice and a number, the information was poorly communicated, and he continues 
to be unclear what the advice means: 
‘But the doctor… there is a phone number; he did give me a phone number saying 
that these people can help. God knows who they are but he said these people can help 
in situations like that. So maybe it’s respite where they send a carer in but I mean the 
carer can’t be here 24 hours a day.’ 
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It was also interesting to note the difference in opinion as to whether people considered 
themselves a carer or spouse. For example: 
AL’s wife stated:  
‘I’m still AL’s [names husband] wife, but I keep an eye and carry large plasters with 
me!’.  
Whilst AC, when asked if he saw himself as a husband or carer stated:  
‘A carer yes…from day one really…Yeah I don’t think there was a transition period. I 
think it was basically, it’s more, it’s gradually it became more involved. Because, you 
know, as it is, disease is, like for example now, she doesn’t drive now. So the carer bit 
has evolved since the initial diagnosis’. 
8.2 Discussion  
The conceptual social framework for Parkinson’s (Appendix 2) proved of use to explore the 
journey people interviewed had undergone from a point before diagnosis was made, to their 
current situation (Appendix 6). It is hard to pick up any patterns from only five interviews, 
however pertinent issues have been selected from the findings and are discussed briefly 
below. 
In the pre-diagnostic stage, not everyone was clear how the symptoms being experienced 
during that time affected their life (especially for those who were already retired) in terms of 
a loss of income. For some it was only further questioning that drew out where there had been 
a psychological cost e.g. increased pressure from slower physical and mental performance at 
work, or the stress of having to find a new job. Suffering, pain, disability and distress are 
considered social costs of illness (The Sainsbury Centre for Mental Health 2003). Using a 
human capital approach, costs cannot be ascribed to those who do not work (e.g. children and 
retired, older people), but attempts are made by health economists to calculate worth as 
morbidity costs, worked out by hours lost from underperformance of normally provided 
services. These become more ‘costly’ if a person is diagnosed with more than one condition 
e.g. MA and CA’s wife with chronic back pain and Parkinson’s (Cooper and Rice 1976). As 
most of the respondents to the online and paper survey were also older, it might be assumed a 
proportion also have comorbidities. 
At the microeconomic level, although Parkinson’s impacts on people's functioning, in the 
earlier stages, individuals are able to perform their usual day-to-day activities without too 
great a reduction in efficiency. When this ability deteriorates further, people seem to consider 
termination of employment and early retirement more often than a reduction in their hours 
(WHO 2009; Singer 1973; Rice 1967). 
In terms of the diagnostic phase, where the diagnosis was not made swiftly, or there was an 
initial misdiagnosis, there was a time lag impacting on a person’s knowledge of the condition 
they had, adding to the psychological stress. Medical models assume a person to develop 
symptoms of Parkinson’s along a specific prognostic path dependent on whether tremor or 
stiffness is the first symptom in physical presentation (Jancovic and Kapadia 2001), and are 
trying to improve the accuracy of diagnostic processes of Parkinson’s to influence the basis of 
how services are allocated or provided. The degree of probing to ascertain whether stiffness-
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slowness, or whether a tremor is the first symptom, and the inability for some of the 
interviewees to decide which it was, may have affected history taking, and hence any 
subsequent clinical decisions. However, the telephone interviews allowed us to pick up on the 
fact that despite the SIGN (2010) and NICE (2006) Guidelines recommending diagnosis be 
made by a specialist, not all GP’s are recognising the symptoms from which to make a 
referral. This was clear in CC’s case, as he did not present with a clear physical symptom, but 
a vague feeling of being ‘out of sorts’, and also in the case of AC’s wife, who he finally took 
abroad for investigation.  Awaiting for a diagnosis of Parkinson’s is a stressful time for 
people (Stewart DA (2007), and hence a recommendation in available guidelines for swift 
referral and accurate diagnosis.  
There was a clear indication of people coping differently, or experiencing difficulty accepting 
the diagnosis of Parkinson’s (Ehmann et al. 1990). Social support has a significant effect on 
predicting how people cope, enabling the development of a more active style of coping, as 
opposed to commonly demonstrated avoidance strategies where support is minimal (Charlton 
and Barrow 2002; Ehmann et al. 1990). Avoidance tactics however, are how some of the 
interviewees tackled the diagnosis, whether noted by the spouse or the individual, interpreted 
as an unwillingness to accept the diagnosis. For some people with progressive conditions, 
there is an issue of not wanting to see a (possible) future, but if they choose to attend events 
or meetings with others with the same condition, they see the differences between themselves 
and other individuals (Mazanderani, Locock and Powell 2012).  
For many people, support comes through the voluntary sector networks – often the 
Parkinson’s UK groups. These invaluable sources of knowledge-sharing and social benefit 
help people accept and incorporate consequences of their diagnosis into everyday life 
(Charlton and Barrow, 2002). All interviewees were members of a Parkinson’s UK Branch or 
support group, having joined within the first year of diagnosis. Some were more actively 
involved than others, whether on the organisational side or just in terms of attendance.  
The continued activity and support was identified as important as the years diagnosed with 
Parkinson elapsed – the next phase of the social framework for Parkinson’s. Whether 
accessing service through health provision, the voluntary sector, or local authority, people 
with LTC are known to try things that might promote better health, even though they would 
have preferred not to spend time and money on these things had they been healthy; this is 
considered another economic cost of illness (WHO 2009). Unfortunately, not all people can 
participate as fully as they would like due to constraints placed on them by personal 
restrictions (e.g. not wishing to meet others with Parkinson’s), or pathology, including 
conditions in addition to Parkinson’s. 
A more balanced understanding gained during this stage would encourage acceptance, rather 
than resignation or denial, increasing the individual’s perceived control over their Parkinson’s 
physical and emotional symptoms (Evans and Norman 2009). 
The telephone interviews identified examples of where financial costs were saved, but at a 
psychological and/ or social expense, creating richer insight into areas where resources could 
be placed to help improve life for people affected by Parkinson's. It is vital to monitor for 
these in the later (future) years for people with Parkinson’s, as without support, continual 
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encounter of loss can lead to chronic sorrow, a psychological state recognised in people with 
Parkinson’s who experience loss of future plans, restricted social life, and inability to travel 
and participate in hobbies (Lindgren 1996). There is also a link between personality (towards 
pessimism as the condition progresses), loss of internal locus of control and greater disability 
(Gruber-Baldini et al. 2009), so interventions and support are needed to minimise this 
development. 
Two examples include the case of AL and his wife who have traded in two cars for one larger 
one, saving on costs of running both cars, yet increasing the use of taxis, train travel and the 
stress and time of planning the journey (although AL does like to plan such journeys). The 
increasing lack of AL’s attention to where this sociable man needs to be and at what time is 
creating increasing stress for AL’s wife. On two occasions, this has affected holidays, and last 
year, nearly resulted in an increased financial cost as they temporarily ‘lost each other’ on 
their journey home from a holiday abroad. The behaviour is starting to have an impact on 
how independent AL will continue to be (social cost). To manage her rising stress and anxiety 
(psychological cost), it has been suggested AL’s wife tries acupuncture (self-funded, so a 
financial cost). 
MA noted he is going on holiday less (financial saving), as the hotels cannot always 
accommodate his needs (psychological cost), creating fewer opportunities for him to go out 
with friends and associates (social costs). 
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9 Summary, Conclusion and Policy Implication 
9.1  Summary 
The main findings that emerged from the literature review, quantitative survey and in-depth 
case studies examining the economic, social and financial cost of Parkinson's on individuals 
(i.e. PwP), carers and their families are summarised below. 
Literature review  
Detailed searches of UK based quantitative and qualitative studies from published and 
unpublished sources yielded 58 studies for inclusion in the review. These were grouped into 
six themes: Parkinson's incidence differentials; management and care; impact on QoL and 
wellbeing of PwP; impact on QoL and wellbeing of carers and family members; the cost of 
healthcare use; and societal (economic, social and financial) cost of Parkinson's.  
The literature is deficient in terms of reporting incidence and prevalence of Parkinson's by 
countries of UK. However, much UK evidence suggests that Parkinson's management and 
care responsibility has fallen on spouses and extended family members of PwP, directly 
affecting their QoL and wellbeing.  QoL in PwP deteriorated as the condition progressed, 
particularly with further development of non-motors symptoms including sleep disorders and 
depression. The stress and fatigue level among carers also increased as the condition 
progressed, with resultant further deterioration in their own QoL. Certain incidences, such as 
falls in PwP were identified as the most significant factor impacting on both caregiver’s and 
PwP social life and wellbeing, and frequent occurrence of falling lessened the chances for 
carers to go out for their normal activities and decreased their contact with their friends and 
neighbours. Deterioration of QoL of both PwP and caregivers as the condition progressed 
puts a tremendous economic and financial burden on society in terms of social care and 
health care delivery costs.  
The UK evidence suggests a marked increase in the total annual costs of Parkinson’s per 
case; specifically, costs have risen from an estimated £13,800 in 2006, to an estimated 
£29,000 in 2011. These figures show estimated costs have more than doubled in a span of 5 
years. However, the latter estimate is based on PwP in late stage. The share of non-medical 
costs, particularly informal care in the total costs, was the greatest (varied between 80% and 
93%). With regard to hospital admissions for PwP, a majority were unplanned and mostly for 
pneumonia, Parkinson’s itself, urinary tract infections, falls and hip fractures. The share of 
falls and fractures was higher in frequency and length of hospital stay, thus increasing the 
total costs.  
Limited UK evidence is available on the societal costs of Parkinson's in terms of loss of 
employment, reduced work hours, premature retirement of both PwP and carers. The 
evidence suggests that as Parkinson’s progresses, PwP are forced to withdraw from the 
workforce, and most have stopped working after having been diagnosed with Parkinson's for 
more than 5 years. The average time of employment lost related to Parkinson’s was 4.9 years. 
During the course of the condition, PwP were often faced with financial difficulties due to 
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involuntary early retirement and delays in getting welfare benefits. There was no 
comprehensive UK-based quantitative study looking at the impact of Parkinson's on the 
employment and working conditions of carers. 
Quantitative survey coverage  
About 1000 people had expressed interest in participating in the study (including 220 who 
requested a postal questionnaire) during July-Sept 2015. Between October 2015 and February 
2016 people were invited to fill online and postal questionnaires. Due to a limited response 
from BME communities a booster sample survey was initiated in Manchester and Sheffield 
using local community contacts, which recruited 27 PwP families. Information was received 
from 853 respondents. After careful scrutiny of data, information from 776 PwP and 546 
carers was submitted for detailed analysis. 
As the response numbers from some of the four Home Countries are low in comparison to the 
other countries, analyses of costs per country have been difficult to calculate. Where possible, 
this has been done (see statistical tables in Appendix 6), but on the whole, the report provides 
aggregated informational costs.   
Profile of PwP and Carer respondents  
A majority of PwP were men, over aged 65 and studied beyond GCSE (higher education). 
About four-fifths of PwP were married and over 90% were from a White ethnic background. 
In contrast, a majority of caregivers were women (mainly spouses of the PwP) with over-
representation in younger age groups with a mean age of 62.6 years (compared to 67.1 years 
for PwP). Over 80% of PwP were living in England followed by Scotland, Wales and 
Northern Ireland. Three-fourths of PwP were living in their ownership houses and with 
spouses or with their children and extended family. About one in seven (14%) PwP were 
living alone. The mean household size was 2. 
Economic activity  
About three-fourths of PwP and a half of the carers had retired from the workforce; only 
about 12% of PwP and 31% of carers were currently working.  Parkinson's had a direct 
impact on employment and working conditions of both PwP and their carers as about 36% of 
PwP were forced to withdraw from work by taking early retirement, or unable to work due to 
illness/incapacity or looking for a job adaptable to the needs of their Parkinson's. 
Responsibilities of caregivers increased considerably; not only were they looking after the 
PwP but had to work to lessen the financial difficulties that arose because of Parkinson’s in 
the family (see key quotes from PwP and their carers on this issue in Appendix 7). 
Duration of Parkinson’s and other LTC  
In one-third of PwP, the condition was diagnosed less than 5 years ago, for another one-third 
it was between 5 and 10 years ago and for the remainder, more than 15 years ago. The mean 
duration since diagnosis of Parkinson's was 8.37 years, which was significantly higher among 
men compared to women PwP. Only about 38% of PwP were on one or two prescribed 
Parkinson's medications and the rest were on a higher number of prescriptions. A further two-
fifths of PwP had co-morbidities (and were also being treated for other LTC).  
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Quality of life and wellbeing  
Only one-third of PwP reported their health status to be good/very good. However, a majority 
of PwP reported a worsening of their health status over the year.  Similarly, about a half of 
carers had reported that their health status has worsened over the year, thus reflecting the dual  
increased burden of care whilst looking after basic household needs. Between 32% and 60% 
of PwP needed help in one or more of their usual daily activities within or outside the house. 
The need was met mainly through their spouses or family members; their dependency 
increased with age. In contrast, those who were living alone were able to manage better on 
their own; however it should be inferred that over time as the condition progressed they 
would in fact require help from private agency carers, or may even end-up living in a 
nursing/care home. In terms of their HRQoL, a majority of PwP reported between moderate 
and extreme problems for mobility (63%), usual activities (58%), and pain/discomfort (59%) 
thus reflecting on their low QoL. The average QALY score for PwP was 0.576 which is much 
worse than that of a healthy person (QALY=1) or their own carers (0.764). The QALY score 
fell sharply for both PwP and caregivers with a longer duration since diagnosis of Parkinson's, 
but stabilised at lower levels in later years. For caregivers, the mean QALY score was 
significantly lower for women than men carers (0.7465 vs 0.7902) and for carers aged 75 and 
over (0.7163 vs. 0.7722 for aged under 65). Mean wellbeing scores (on life-satisfaction, life 
worthwhile, happiness and not-anxiousness) were lower for both PwP and carers when 
compared to the general population of aged 65 years and over. 
Healthcare use and cost  
About three-fourths of PwP consulted a GP or a Parkinson's nurse for their Parkinson’s, 
followed by a neurologist (67.5%) and a Physiotherapist (43.3%). The average annual 
number of consultations was highest for the GP (3.7) followed by Physiotherapist (2.9), 
Pharmacist (2.8), Parkinson’s nurse (2.2), Chiropodist/Podiatrist (1.6) and Neurologist (1.4). 
On average PwP made 21.8 consultations with various health professionals in a year; this 
reflected a very high usage of healthcare services (i.e., having consultation every 2-3 weeks). 
Between 17.4% and 12.8% of PwP reported an accessing problem with three most sought 
healthcare professionals (i.e. GP, neurologist and Parkinson's nurse).  Most of the healthcare 
services were provided by the NHS free at the point of contact, a significant number of PwP 
had consulted further utilising private services with OOP payments. In more than 50% 
Chiropodist, Podiatrist and Chiropractor consultations, PwP incurred OOP expenses; 29% 
saw an Optometrist privately, and 19.3% consulted a Physiotherapist privately. On average, 
PwP incurred £180.90 OOP expenditure annually on healthcare consultations. PwP also 
underwent diagnostic/clinical tests such as a blood test, MRI scan, EEG, CT scan, DAT scan, 
PET scan and X-ray. On an average 2.65 diagnostic tests were carried out annually, most of 
which were undertaken via NHS provision. 
Emergency and unplanned hospital admissions were quite common among PwP particularly 
in late stage. Two out of thirteen PwP used A&E services and one-fifth were admitted to the 
hospital during the last 12 months with an average 12.6 days of hospital stay. The unit cost 
for unplanned admission is highest, followed by planned and day cases. About 9% of PwP 
were admitted to a hospital as a day case and 6.2% had a planned inpatient admission. 
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However, unplanned admissions (13.2%) were higher than planned ones (4.8% and 8.4% of 
PwP reported unplanned admission for up to 3 days and more than 3 days respectively). After 
applying a unit cost by type of hospital admission, on average £1241.49 per PwP per annum 
was the cost to the NHS. Similarly £95.37 per PwP was towards using emergency services. 
As most of the hospital admissions were handled by the NHS, the OOP expenses were small. 
However, PwP had incurred OOP expenses on travel to use these healthcare services as well 
as on prescription and non-prescription medicines. There were also indirect costs to the 
person who accompanied the PwP to attend various medical appointments. The percentage of 
PwPs who travelled alone varied between as low as 21.2% when consulting a specialist such 
as Neurologist/Geriatrician/Elderly Care Consultant or 28.8% for a Parkinson’s nurse to as 
high as 48.1% in the case of a Pharmacist. A relatively small number of PwP walked to attend 
these appointments, the proportion of which was relatively higher when using community-
based services such as GP services (18%) and Pharmacy (28%). Those who incurred OOP 
expenses on travel, on an average a visit to their GP cost them £8.82 whereas for the Mental 
Health Professional £35.24 and the Optometrist £39.81. On an average PwP were taking 4 
prescribed medications and only 15% of PwP were paying prescription charges (majority of 
PwP were over aged 65 and thus entitled for free medication). About one-third of PwP were 
having side effects of Parkinson's medication as a result most of them were purchasing 
medicines over the counter to subside side effects (on average spending £45.81 a year).  
Further, two-thirds of PwP purchased equipment mainly to improve mobility within the house 
(bedroom, bath/shower room, kitchen and stairs), house entrance and garden, and outside the 
home so as to improve balance and reduce falls due to tremor as well as for better 
management of Parkinson's. The most common items purchased were walking sticks, walkers, 
medicine dispenser/timer, reclining chairs, raised toilet seats, wheelchairs, special cutlery, 
furniture, stair-lift chair, grip handles in the shower, bedrooms, entrance and walkways, 
special hospital type beds and mobility scooters or Wheelchair Accessible Vehicle (WAVs). 
About 82% of equipment purchases were fully self-financed, with the NHS the equipment 
provided mainly through the Continuing Care Programme by either supplying equipment for 
free or at a subsidised rate. The support from the local council and a charity was minimal. 
The average annual OOP expenditure for equipment was £1923. 
Direct and indirect healthcare cost 
Putting all together the use of healthcare services by 610 PwP over the last 12 months, the 
total direct medical  cost  of consultations, diagnostics, call and ambulance, A&E and 
inpatient services  was  £1,186,451 to the NHS and £128,050 as OOP expenses; on average 
this added up to £2155 per PwP.  Including costs towards medication, the total annual 
medical cost was £2388 per PwP. Taking into account OOP expenses towards travel (£36) 
and equipment purchased (£1923), the total annual healthcare cost per PwP raised  to £4347. 
Importantly, the share of the non-medical cost, usually an oversight by health policy makers, 
was 45% in the total healthcare cost.  
 
Economic and financial cost 
The economic and financial conditions of families changed due to Parkinson's and thus 
detailed information was collected on changes in income and expenditure both directly and 
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indirectly affecting their household budget. The most critical among these was the loss or 
reduction in earnings due to changes in employment and working conditions of PwP and 
carers. More than 50% of PwP and one-third of carers reported having a direct impact on 
their employment and working conditions. On average working PwP lost 62.1 workdays in a 
year and reduced weekly hours by 12.4. Similar although the smaller impact was noted for 
the caregivers; on average caregivers lost 18.9 annual workdays and reduced their weekly 
working hours by 10.7. Using £496 as average weekly earnings for the working people 
reported by the ONS, this loss equated to £1,444,299 per annum to working PwP and carers 
and overall average loss worked out to be £1981 per household. We have also estimated 
indirect earnings loss for those PwP and carers who are currently aged under 65 but took 
early retirement or were unable to work or became unemployed due to Parkinson's during the 
current year. The annual earnings losses to both PwP and carers (unable to work and took 
early retirement) worked out to be £4,612,179, with an overall average of £6013 per 
household. Further, many carers aged under 65 are not enrolled with DWP for carer 
allowance and thus providing unpaid care to their family members. The annual unpaid caring 
earnings loss was £947,232 which worked out to be £1235 per household. Thus direct and 
indirect annual employment earnings loss added up to £9229 per household. 
 
We also computed working lifetime earnings loss of all PwP and caregivers who took early 
retirement at different ages in their working life. Assuming the stipulated retirement age of 65 
for men and 60 for women for this group of elderly people, the average working years lost 
was 6 years for PwP and 3.6 years for carers which worked out to be a loss of 1078 man-
years for PwP and 206 man-years for carers. At current monetary values the total lifetime 
earnings loss as a result of premature retirement for PwP households added to £33,111,254 or 
£43,170 per household.   
 
Non-healthcare expenditures  
PwP households made direct expenses towards alterations in accommodation, payments for 
daily living assistance for PwP, additional expenses on utility (energy cost) and takeaway 
foods. About half of PwP households made changes to their accommodation since the 
diagnosis of Parkinson’s, particularly in order to adapt to emerging motor and non-motor 
symptoms.  The type and extent of the alterations depended on the condition (severity) of 
Parkinson’s and this included changing toilets, bathrooms/shower, bedroom, broadening 
main-doors, building a ramp, etc. Some of the PwP moved to a bungalow thus involving a 
heavy capital expenditure even after retirement from work (however, such lumpy costs were 
not included in calculation).  Most alterations done were self-financed with few PwP received 
some meagre subsidies from NHS and local government; the cumulative OOP expenses were 
£1857 since the diagnosis of Parkinson’s.  
 
Two-thirds of PwP household reported additional expenses on utilities; on average their 
additional energy expenses were £74.23 per month. One-third of PwP were spending more on 
takeaways and convenience food every month on a regular basis which on an average 
amounted to £25.44 per month. The major weekly or monthly expenses were towards DLA 
help. More than one-third of PwP needed help with personal care and bathing and about a 
 Page 88 
 
half for cooking a meal. For cleaning their house, 62% of PwP needed help on a daily or 
weekly basis. As and when required, between 41% and 49% of PwP needed help for ironing, 
decorating and gardening.   Similarly, for outside the house tasks, 52% of PwP needed help 
for daily or weekly shopping. About a half of them needed help for transport and attend to 
medical appointments as and when these were scheduled. Several PwP had reported needed 
help to attend weekly or bi-weekly physiotherapy/exercise classes. The DLA dependence to 
formal or private arrangement increased with advances in symptoms and condition, when the 
spouse was unable to provide adequate support. Most of the formal carers were hired through 
agencies on the weekly or monthly basis. The total OOP expenses incurred aggregated to 
£1,104,380 with annual mean expenses estimated at £2088 per PwP household.  
 
Changes in income and social benefits 
Nearly a half of PwP received income as state pension and a similar proportion of them as an 
occupational pension; this was followed by 13% who received income from employment and 
9% from other sources. In terms of benefits received 83% received incomes from various 
state allowances and credits; however, about 8% received Local Council for housing and 
other benefits. Carers reported a similar pattern in sources of income and benefits; however, 
the magnitude was relatively smaller compared to those for PwP.  Further, just under a half of 
carers received incomes from various state allowances and credits. Over the last year some 
PwP had reported discontinuance of income from employment (3%), state pension and 
occupational pensions (5%), and state allowances and credits (12%). The respective 
discontinuance rates for carers were 4%, 3%, and 6%. An estimated discontinuance of 
pensions and state benefits for PwP and carers amounts to an annual loss of £875,394 with 
and overall mean at £1502 per household. 
 
Societal cost 
The combined magnitude of both annual health and social care cost of Parkinson's to society 
is summarised as follows. The direct annual healthcare cost, which was mainly borne by the 
NHS, was £2388 per PwP; the indirect annual healthcare cost, mainly borne by the PwP, was 
£1959; and thus, the total annual healthcare cost per PwP was £4347 of which £2229 (51%) 
was OOP expenses borne by PwP. Further, there were other non-healthcare expenses related 
to changes in living arrangements and environment that were directly borne by PwP 
households. The average annual non-healthcare cost was £3622 per PwP household. The total 
annual healthcare and non-healthcare cost per household added up to £7969. To arrive at the 
total societal cost, current direct and indirect employment earnings loss to both PwP and 
carers as well as an unpaid caring earnings loss to carers were included; this was calculated as 
£9229 per PwP household. Many PwP and carers had reported a loss of certain benefits and 
cut in pension since registering with DWP as an elderly disabled person or carer. This 
amounted to an annual loss of £1502 per household. Thus, total current annual income loss 
per household amounted to £10,731.  
 
Aggregating all direct and indirect costs, the annual financial burden of Parkinson's on 
society was £20,123 per PwP household. This included the annual financial cost to the NHS 
of £2118 (just 10.5% of the total) per PwP for their treatment and loss of exchequer of £1423 
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(7.1%) per household. Thus, the direct annual financial burden on Parkinson's household was 
£16,582 or £1382 per month.  
 
Financial impact on households 
The majority of PwP (56%) or carers (60%) reported their annual income to be under £20,000 
with combined household income of under £30,000 by 60% of households. This income 
distribution suggests that the financial impact of Parkinson’s was huge for a majority of 
households receiving gross annual income under £30,000. About one in four households 
reported a reduction in their monthly income as a consequence of Parkinson's and the 
underlying reasons were a reduction in working hours, given-up work completely and moved 
to less demanding jobs.  
 
Overall the financial impact of Parkinson’s on a family was wide-ranging. On an average 
PwP household felt three types of impact on their financial situation. The share of direct 
monetary impact in terms of reduced savings and increased borrowings including mortgage 
equity release was the highest (26%); followed by the changed priorities for spending (20%), 
reduced social activities (19%), reduced holidays (18%) and reduced spending on festive gifts 
(11%).  Thus PwP household budget had been compressed significantly due to a reduction in 
income and increase in expenditure; the candle is burning at both ends. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Case study interviews 
In contrast to the cross-sectional approach to data collection of survey responses gathered, the 
case studies permitted insight into the impact of costs at a financial, social and psychological 
level of those interviewed. The longitudinal view of their experiences with Parkinson’s pre-
dated the actual point of diagnosis. The issues identified in the case studies utilised a social 
model developed by PwP and captured costs to health and wellbeing over a longer period of 
time i.e. from a time pre-diagnosis to the current day. The interview contribution enabled a 
perspective of combined financial, social and psychological cost impact during the 
progression of the condition, and as needs altered over time. 
9.2 Conclusion  
Published studies presenting the cost of illness information for Parkinson’s, as expected, 
unveil many differences in terms of  methodological decisions and type of costs 
measurements to be included and ways in which those costs are monetised. Direct medical 
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costs are easily assessed and quantified, especially hospitalisations and consultations with 
health professionals as outpatient and visits to A&E, thus accounting for a substantial part of 
the total direct healthcare costs. The difficulty lies in the assessment of indirect costs due to 
Parkinson’s, particularly in studies with higher numbers of subjects enrolled. Indirect costs 
however are significant, and quantification of these is of great worth as the prevalence of 
Parkinson’s, the experiences and symptoms over the course of progression pose a significant 
challenge to those affected by the condition. This includes individuals with Parkinson’s, their 
family, friends and carers, formal health and social services and on society as a whole. 
The survey conducted in this study asked people about their experiences of using the health 
system, and the sorts of items they had to pay for, or the adaptations they had made to homes 
or work environments to better manage their Parkinson’s. Not all the questions were 
answered in full, and the tendency was toward the collection of financially pertinent 
information to costs related to having a diagnosis of, or being affected by Parkinson’s. This 
fulfilled an aim of the study to assess the economic cost of Parkinson’s in the UK.  
The five telephone interviews utilising a social framework constructed by, and for people 
affected by Parkinson’s broadened the informational content gained through the online survey 
research to provide results that are more holistic than other studies, with the implication of 
financial, social and psychological costs.  
When considering the results from the survey and interviews, the demographics of most 
included reflect what one would expect of membership of a large charity such as Parkinson’s 
UK, i.e. older and/ or retired, white, middle-class people, many of who still live in their own 
home (with or without assistance), and have higher levels of education (Deane et al. 2014). 
This was despite the effort made to recruit people from a black or ethnic minority background. 
Most participants were in the middle stages of the condition (over 5 years since diagnosis, but 
are likely to have experienced the onset of symptoms many months or years prior to 
diagnosis).  
In addition to the changing needs of respondents in employment, many taking retirement 
earlier or altering their working conditions to accommodate their Parkinson’s, the costs 
associated with informal care represent a significant share of the total costs for society. It 
should be noted that those costs fall on elderly spouses or working-age children. The burden 
assumed by informal caregivers highlights the importance of using a societal perspective 
when estimating the economic burden of Parkinson’s.  
This study highlighted aspects of the impact of an increasing burden of care over time 
resulting in a more steady deterioration in the health of carers compared with the health of 
people with Parkinson’s, although the majority of carers still reported their health status as 
‘Good’. The areas of decline were more notable in the less tangible and measurable domains 
of ‘Pain/ discomfort’, and ‘Anxiety/ depression’. 
In terms of utilisation of healthcare and identification of services that might benefit people 
with Parkinson’s outside of the NHS, the study highlights the continuation of inconsistent 
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service provision, onward referrals to specific health professionals or access to non-NHS 
provision. These were stressed as requiring improvement following the 2008 Parkinson’s 
Members survey (Parkinson’s Disease Society 2008), and subsequent review by the All Party 
parliamentary Group for Parkinson’s Disease (1999). It is worrying to see that little seems to 
have altered since these two documents were published.  
9.3 Policy Implication 
This study collected online and paper survey information about the costs of Parkinson’s to 
people directly affected by the condition and to society, enriching the data with experiences 
through in-depth interviews with people affected by Parkinson’s. 
The improved understanding of the economic and social consequences of Parkinson's have 
implications for policy makers, professionals and people with Parkinson’s across the health 
and care sectors supporting those affected by the condition. 
Below we suggest some of the issues for stakeholders to consider in light of the findings of 
this research. 
For policy makers 
There continue to be inconsistencies in the provision of services, and funding accessible to 
people with Parkinson’s across the UK. This is despite ongoing work to improve the quality 
and variability of services following identification of problems encountered in a survey of 
Parkinson’s UK members (2008), an All Party Parliamentary Group on Parkinson’s report on 
the state of health and care services, and bi-annual UK-wide audits of Parkinson’s services 
across the NHS. 
The information gathered also identified a high incidence of work-related problems including 
a reduction in hours worked, the need to change jobs, or roles within existing employment, or 
taking early retirement. These issues all impact on households affected by Parkinson’s.  
To enable people living with, or affected by Parkinson’s to stay independent and well for as 
long as possible we encourage policymakers to: 
 Ensure there is consistent provision of health and care services from diagnosis across 
the health, social care and independent sectors  Facilitate communication between statutory and voluntary sectors across the four 
countries to ensure people get access to the right support from diagnosis to end of life 
 Organisations such as the Department of Work and Pensions, and Local Authorities to 
revisit income support and benefits for people required to reduce working hours as a 
consequence of Parkinson’s (whether a person with the diagnosis, or a carer)  Undertake research to understand the socio-psychological and societal impact of 
people living with the condition retiring early. 
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For providers of support (health, social and voluntary sector) 
Utilising cost of illness models has enabled the researchers to gather a basic understanding of 
societal costs in the longer term. However it is important that providers across the sectors 
consider: 
 The provision and promotion of services and support to help people with a new 
diagnosis to come to terms with the diagnosis, and develop relevant coping strategies 
and mechanisms  Encourage people living with the condition to stay positive and plan interventions that 
allow them to manage their own condition 
 To advocate for the needs of caregivers and close families who support people with 
Parkinson’s without seeking financial recompense, but whose psychological and 
social needs are adversely affected as they take on these roles  Supporting their staff to develop a positive attitude and empower people living with 
the condition to manage themselves, and also acknowledge the support available from 
non-health resources such as voluntary organisations. 
For people affected by Parkinson’s 
People affected by Parkinson’s need support from the point of diagnosis to better understand 
the condition, and help plan how they cope in the long term. This is very rarely available 
through the NHS, given the current financial and political position of the Government. It is 
therefore important that: 
 People with Parkinson’s are supported to stay positive and make contact with 
organisations that provide advice, guidance and support like Parkinson’s UK. This 
support could be anything from signposting and advice on benefits from central 
Government, advice on how to claim from Grants that can be utilised to purchase, or 
support the purchase of equipment, or support from organisations such as Parkinson’s 
UK, and the local groups and branches that offer activities and a chance for people to 
meet and to exchange experiences and strategies for coping with Parkinson’s as it 
changes over time. 
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Appendix 1 
Profile and Role of the Members of Research Team 
 
Dr Anil Gumber is Reader in Health Economics and Statistics at the CHSCR with specialisation in 
health economics and health inequalities. He has extensive experience of undertaking economic 
evaluation of health interventions/programmes as focused his research on utilisation and financing of 
health care of people with long-term conditions. Some of his policy level research works on health 
inequalities are: ethnicity and bowel cancer screening uptake (funded by the Department of Health); 
occupational health and work place injuries among ethnic minorities (funded by the Health and Safety 
Executive); ethnic communication in health services (funded by the Department of Health); racial 
inequality in health (funded by the Home Office); and community cohesion (funded by the Home 
Office). He also has considerable experience of undertaking economic analyses of internationally 
relevant clinical trials with focus on South Asian in the areas of diabetes, whiplash injury and cancer 
funded by the NHS, NIH and other UK bodies. His most acclaimed work economic evaluation of the 
UK Asian Diabetes Trial published in Lancet. Dr Gumber was also involved in evaluating information 
leaflets on osteomalacia for South Asians developed by Arthritis Research Campaign charity and 
contributed in the development of health promotional DVDs on Healthy Life for South Asians for 
Warwickshire PCT trust and Heart risk factors for British Heart Foundation which is also available at 
NHS Choices. Anil's detailed CV is available at https://www.shu.ac.uk/about-us/our-people/staff-
profiles/anil-gumber. He has recently developed culturally appropriate cancer information leaflets for 
Muslim community in their own language which is available at 
http://www.shu.ac.uk/research/hsc/cancer-awareness-information-sheets-muslim-communities . 
Ms Bhanu Ramaswamy is a qualified physiotherapist and an Honorary Visiting Fellow at the CHSCR. 
She is currently working part-time as a private practitioner and educator. Her main areas of clinical 
interest include rehabilitation and the treatment of neurological conditions (Stroke and Multiple 
Sclerosis), but is better known for her national and international work with people with Parkinson's. 
Clinically, she works at two clinics in Sheffield, plus uses her qualifications as a Fitness (gym) 
Instructor and in Exercise Referral to run classes for people with Parkinson’s in Sheffield (posture and 
balance, circuit classes and hydrotherapy / aquarobics classes). Last year, she was one of the research 
assistants involved in a project for Parkinson’s UK investigating the issue of ‘Putting people with 
Parkinson’s in control: Exploring the impact of quality social care’. Bhanu retains her input to 
Parkinson's UK and is currently a Chair of the Service User Involvement working group of the 
Parkinson’s Excellence Network. She writes a column about activity for their quarterly magazine, 
lectures at several of the voluntary organisation’s branches around the country, to professionals and 
people affected by Parkinson’s, and has also co-authored chapters in various text books over the years. 
She recently received an OBE for her services to physiotherapy practice specifically for PwP. 
Mrs Rachel Ibbotson (nee Linacre) is a Research Fellow at the CHSCR.  She has primary 
responsibility at CHSCR as the Fieldwork, Analysis and Support Team (FAST). Rachel has over 
fifteen years of experience of research in the community.  Her key projects are: 'Social capital, health 
and economy in South Yorkshire coalfields communities' and 'Social Exclusion Amongst Older 
People in Former Industrial Areas'. She recently completed a project for Age Concern Barnsley which 
involved recruiting older people from Barnsley and equipping them with interviewing/research skills 
to conduct interviews within their peer group.  
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Mr Mubarak Ismail is a researcher at the CHSCR since 2007. Mubarak’s research interests include 
health inequalities, ethnicity, social exclusion and exploration into barriers to health specifically those 
which are experienced by most excluded and 'hard-to-reach' groups, and strategies to recruit and 
engage socially excluded groups in health research. Mubarak has experience of qualitative research 
methods and participatory research approaches. Besides research in health and social care, Mubarak 
has a background in IT & Management and has worked 19 years with the voluntary sector in the UK, 
particularly working with and for people from ethnic minority communities. He has extensive 
experience of community engagement with hard to reach groups and has undertaken the community 
health promotion initiatives/dialogue with ethnic minority communities in Sheffield.  
 
Ms Oranuch Thongchundee is a full-time PhD student at the CHSCR working on 'Cost-Effectiveness 
of Atypical Antipsychotics for the treatment of Dementia in Thailand' under Dr Anil Gumber 
supervision. She has developed a questionnaire for piloting to measure direct and indirect medical 
costs and informal care costs of dementia and thus burden of treatment on patients and their carers. 
 
Ms Deborah Harrop is an Information Scientist and part-time lecturer at the CHSCR. Deborah has 
over eight years of experience in the higher education library and information sector in the health, 
social care and bioscience subject areas. She is an expert at designing, undertaking and writing up 
literature searches as well as bibliometrics.  
 
Dr Peter Allmark is Principal Research Fellow at the CHSCR.  He has published extensively in peer 
reviewed international journals as well as in books and peer reviewed conference papers.  His 
expertise includes research methodology and, in particular, the use of realist approaches to literature 
synthesis and the creation of logic models.  With a team at Sheffield University he helped create a 
logic model of the public health effects of welfare benefits and advice which is highly accessed. 
Mr Abdur Rauf is the manager of a Manchester based health charity (Ethnic Health Forum) and a 
freelance researcher in health and social care with particular interest in public health issues among 
BME communities in the UK.  His areas of expertise are developing, delivering and evaluating 
community-based health promotion projects around minority ethnic communities and mental health, 
cancer support and information gaps in health education programmes among non-English speaking 
communities. He has worked alongside leading academicians in the field of ethnicity and health based 
at Warwick Medical School, Mary Seacole Research Centre - De Montfort University and Sheffield 
Hallam University and was also an Information Scientist for the NHS specialist Library for ethnicity 
and health. His current research interest includes studying health disparities among Muslims in the 
UK. 
Team Role in the Project 
Anil Gumber 
Principal Investigator 
Develop health economics framework and cost of illness questionnaire, 
survey and statistical design, data cleaning and analysis, report writing 
Bhanu Ramaswamy  Piloting questionnaire, in-depth interviews with PwP & carers, report writing 
Rachel Ibbotson  Design online questionnaire, monitor questionnaire returns, data download 
Mubarak Ismail  Co-ordinate online survey, recruitment of PwP from nursing homes and BME 
Oranuch 
Thongchundee 
Contribute in questionnaire on cost of treatment, undertake literature review 
Deborah Harrop Literature search from database, quality check to include papers for review 
Peter Allmark  Chair for Project Advisory Group meetings, comments and editing of report 
Abdur Rauf  Recruitment of PwP from nursing homes and BME from Manchester 
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 Appendix 2 
Conceptual framework for costing Parkinson’s experience: Medical and social models  
Medical Model – 
disease staging 
Hoehn & Yahr (1967) 
0: No signs of 
disease 
1: Unilateral 
disease 
2: Bilateral disease 
without impairment 
of balance 
3: Mild to moderate bilateral disease; 
some postural instability; capacity for 
living independent lives 
4: Severe disability; 
still able to walk or 
stand unassisted 
5: Wheelchair 
bound or 
bedridden unless 
aided 
Linear, progressive older model understood by healthcare professionals as still useful for research (hence the numbers) and clinical/ hospital records 
Medical model –  
Clinical staging 
model – permits 
more flexibility in 
experience of health 
Thomas & 
MacMahon (1998) 
Diagnosis / early  From first 
recognition of 
symptoms/ sign/ 
problem  Diagnosis not 
established or 
accepted 
Maintenance  Established diagnosis of 
Parkinson’s  Reconciled to diagnosis  No drugs or single drugs, four 
or less doses/ day  1 - 2 drugs but stable 
medication for >3/12  Absence of postural 
instability 
Complex  Drugs. > 5 doses or > 2 drugs  Inability to accept diagnosis despite adequate 
information and education  Any parenteral medication (e.g. apomorphine)  Dyskinesia  Neurosurgery considered  Psychiatric manifestations – mild symptoms of 
depression/ anxiety/ hallucinations/ psychosis  Autonomic problems   Unstable co-morbidities  Frequent changes to medication (< 3/12)  Significant dysphagia or aspiration 
Palliative  Inability to tolerate 
adequate dopaminergic 
therapy  Unsuitable for surgery  Advanced co-morbidity 
(life threatening or 
disabling) 
More allowance to fluctuate between phases. Expect acceptance of Parkinson’s in ‘Maintenance’ phase. Used more by allied healthcare professionals  
Social framework – 
conceptual model of 
lived experience of 
people affected by 
Parkinson’s 
(MontyZoomers*, 
2014) 
Non-linear 
(meandering) new 
model understood by 
people affected by 
Parkinson’s. 
Pre-diagnostic phase 
Disconnect between medical 
model and service provision 
when comparing services 
available to need for support 
into next phase. 
Many people not believed, or 
given possible diagnosis with 
long wait for confirmation. May 
look on Internet for information. 
Some would appreciate support 
immediately post-diagnosis to 
counsel through difficult 
experience pre-diagnosis, and 
up to 2 years post-diagnosis. 
Diagnostic and immediate post-
diagnostic experience 
Very different for each person. 
Often better experience with 
geriatricians compared with 
neurologists.  
The more recent experiences are 
better because of support from 
nurses and Parkinson’s UK groups. 
Little support for mental health; 
most caters for physical needs. 
Paradox in messaging: social 
support gives hope; clinical 
message stresses decline 
Elapsing years 
Noting that life with Parkinson’s 
has ups and down with periods of 
betterment and sometimes some 
recovery of lost skills following 
lapses, especially if due to other 
medical conditions.  
Not always the straight path to 
decline stated by the medical 
models. 
Need relevant support as time 
elapses, NOT the current system of 
people with Parkinson’s fitting their 
needs to available services. 
The future: Holding onto hope 
Research promises a cure, plus 
taking part in activity (attitude, 
behaviour) slows decline, and 
coping is better.  
Reduced inclination for most 
people with Parkinson’s to think in 
terms of future needs. Carers often 
consider needs more, pre-empting 
decline. Person with P might 
consider needs more if they had 
annual support and built rapport 
with staff and services. 
*MontyZoomers are a Sheffield-based group of people affected by Parkinson’s looking at support needs for members of the Sheffield Branch of Parkinson’s UK.  
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Appendix 3 
Diagnostic code and residence site with examples of how to interpret the framework 
Sheffield group preferred the use of the 
Social model to probe for indirect and direct 
costs. Coded for symptoms (onset age and 
subtype), where they reside and (personal) 
costs incurred 
Coding 1: Age at onset 
1a) Juvenile onset [JOPD] – onset pre age 21 
1b) Young onset [YOPD] – age 21 to 40 
1c) Late onset cases [LOPD] – onset > 40 years 
1d) Older onset > 75 
Coding 2: Subtype 
2a) Tremor dominant 
2b) Stiff and slow 
 
Coding 3: Resides (service access) 
3a) City 
3b) Town 
3c) Rural 
 
Social model – Froŵ persoŶ ǁith liǀed experieŶce of ParkiŶsoŶ’s aŶd carers/ spouses 
Person 1: AL Pre-diagnostic 
phase 
Diagnostic 
experience 
Elapsing years The future 
AL is in his 
5
th
 year since 
diagnosis. 
Lives with 
wife; has a 
daughter 
who is an 
Occupational 
Therapist so 
informative 
 
Codes: 
1c 
2a from wife; 
AL thinks 2b 
3c 
 
 
Stated he did not 
retire as a 
consequence of 
ParkiŶsoŶ͛s, Ǉet 
Ŷoted ͚stiĐkǇ 
fiŶgers͛ ǁheŶ oŶ 
computer affecting 
work, memory 
(something he 
prided himself in) 
was slightly slower 
affecting work in 
own business of 
small finance 
company. 
Greater 
recollection of falls 
that occurred in 
the five years prior 
to diagnosis due to 
his ͚ĐluŵsǇ͛ Ŷature 
– this is 
contradictory to 
medical pathway 
of falls occurring 
Always a faller 
– from 
childhood 
rickets, so may 
have affected 
how diagnosis 
was made. 
Cannot gauge 
Hoehn & Yahr 
stage. 
Year 1: 
Joined 
ParkiŶsoŶ͛s UK – 
so initial 
membership 
cost. 
Still driving. And 
people he 
collected for 
support group 
helped pay for 
petrol when 
͚taxied͛ to eǀeŶts 
and meetings. 
Wife believes 
still has poor 
acceptance of 
sign e.g. shuffles 
and talks softly. 
AL became 
aware (humour) 
notes spend less 
when out as AL 
drinks less 
alcohol as 
Year 2: 
Has more fixed 
vision – finds it 
difficult to follow a 
ball in table tennis; 
spent money on 
two sets of glasses 
(£400 – £500.00). 
Links need for 
glasses a change 
due to medication 
(hallucinations). 
Employed a 
gardener to stay 
on top of garden 
and stay in the 
house – decision 
based on both 
their needs. 
 
Year 3: 
Increased use of bus 
(1 bus an hour); also 
train journeys as got 
Senior Railcard. 
Changed from having 
two cars to one larger 
car. 
Car parking skill 
affected as judging 
distances 
deteriorated. AL͛s 
wife started helping 
direct into parking 
spaces. 
Noted change in 
dexterity e.g. 
Upgraded to android 
phone, but could not 
cope, so uses a big-
buttoned phone; 
battles with the 
parking machines at 
hospital 
appointments.  
Year 4 into year 5: 
Licence not renewed, 
so takes taxis more; as 
ALW drives, still has 
costs of the car. 
Bought new bed for 
ease of movement – to 
help with the getting 
out of bed, and new 
sofa; higher and more 
upright. 
Bumps into things more 
and is a DIY disaster, so 
spending more on first 
aid! 
Increasingly less aware 
of people and 
surroundings; lost again 
on holiday in Paris, and 
if he had not been 
found would have 
incurred a cost. 
AL becoming aware of 
stresses and strains of 
carers in support group. 
In the process of 
changing 
bathroom to a 
shower room in 
anticipation of 
decline. 
AL and wife do not 
consider her role is 
yet a carer, but 
notes she is 
increasingly 
anxious when he 
heads off on trips 
by himself, so 
increasingly rings 
to check he has 
arrived and is not 
asleep on a train. 
His wife may 
consider 
acupuncture for 
stress, and is more 
acutely aware of 
the strains placed 
on some of the 
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after several years affected more 
quickly. 
Computing slow – 
affected by tremor. 
Lack of attention 
noted by his wife, as 
AL wandered off 
when on holiday in 
Turin and again in 
Paris 
Watches others in 
ParkiŶsoŶ͛s group, aŶd 
also aware of the 
changes secondary to 
ParkiŶsoŶ͛s, aŶd other 
medical condition.  
AL and his wife went to 
House of Commons to 
demonstrate about 
cuts in care costs due 
to their involvement – 
own cost of train and 
meals. 
Đarer͛s iŶ later 
years with 
ParkiŶsoŶ͛s 
 
 
Things with 
no set time  
AL fiŶds it hard to judge his rate of deterioratioŶ; iŶforŵed of ĐhaŶges ďǇ ǁife aŶd SpeĐialist Nurse. ALW states AL ͚looks but does not see͛.  
JoiŶed aŶd iŶǀolǀeŵeŶt iŶ a loĐal ParkiŶsoŶ͛s support Ŷetǁork. The costs include providing occasional refreshments, contribute to attend meetings 
atteŶdaŶĐe at other ŵeŵďers͛ fuŶerals. AL aŶd ALW haǀe takeŶ respoŶsiďilitǇ aŶd orgaŶise ŵeŵďers͛ eǀeŶts, take aŶd returŶ telephone calls, do all the 
related administration. ‘aise ŵoŶeǇ to support the group, aŶd eǆtra toǁards researĐh iŶto ParkiŶsoŶ͛s. AL Ŷotes that the ŵeetiŶgs Đreate pressure iŶ 
terms of time and stress BUT state the benefits of belonging far outweigh any of these incidental costs. AL now not embarrassed to shake a tin at 
people who come calling at the door! 
CoŶtiŶues to eǆerĐise. PlaǇs taďle teŶŶis through ParkiŶsoŶ͛s Ŷetǁork ;a Đouple of pouŶds ĐostͿ; aǁare he is sloǁer aŶd loses more. Started exercise 
classes for the support group. 
Bought a Doset box with timer to keep medications, and ALW occasionally oversees medications are taken on time. 
There is more direct cost as hospital visits create costs – travel and parking. Holiday insurance costs more. 
Indirect costs as increased clothes washing as AL spills more food. When out, AL will ask for things in restaurants like a cup with a large handle. 
From survey, note accesses NHS multi-disciplinary services  
 
Person 2: 
MA 
Pre-diagnostic phase Diagnostic experience Elapsing years The future 
MA is in 9
th
 
year since 
diagnosis. 
Lives alone 
in 
bungalow 
 
Codes: 
1c 
2a and b 
Initially self-employed 
;iŶstalled haŶd͛s free radio 
and car stereo systems) but 
noted decreased dexterity and 
taking longer on a job with 
regards to manipulating 
wiring and cables (costs in 
terms of time and stress as 
jobs might have been for large 
firms who had timescales for 
Year 1: 
Tremor in left hand 
noticed (took six months 
to diagnose), but there 
was stiffness affecting 
nimbleness on feet and 
dexterity as an issue too. 
Becoming stiffer and 
slower in this first year, 
affecting ability to walk 
Year 2: 
MA took early 
retirement 
(loss of 
earnings) 
He hired a 
cleaner 
Year 3 - 4: 
Was provided 
with a stick 
(cost to health 
services) as 
toes started to 
claw affecting 
mobility. 
In old property, 
was provided a 
Year 5 – 6: 
Had operation 
to straighten 
left big toe 
(cost to health 
services March 
2014). 
MA moved to 
sheltered 
housing 
Year 7 
onwards: 
Still goes on 
some outings 
with the 
support group 
(direct cost), 
but restricted 
in the outings 
he joins in 
In the process of 
buying an 
adjustable bed 
(£1,000.00) to 
make it easier to 
get into and out of 
bed in the 
morning. 
Does not foresee a 
need for 
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3b 
 
the work).  
Found employment in local 
authority (2002 – 2009). 
Initially relief work, then full 
time as Site Supervisor. Full 
support from managers as 
diagnosed in 2007, but as 
started to struggle with the 
manual tasks (lifting) due to 
ParkiŶsoŶ͛s ŵore so thaŶ the 
administrative tasks, taking 
longer on jobs, took early 
retirement after Occupational 
Health iŶterǀieǁ aŶd doĐtor͛s 
advice.  
Also has co-morbidity, plus 
operations secondary to tonal 
problems, so difficult to pin-
point issues just to 
ParkiŶsoŶ͛s, as stress affeĐted 
all medical problems. MA stiff 
feels that ParkiŶsoŶ͛s ǁas the 
over-riding reason for earlier 
retirement 
(part of work). 
Had all necessary 
equipment provided by 
work. 
Joined the local 
ParkiŶsoŶ͛s group 
(membership cost and 
cost of activities), but the 
worsening pain in his toe 
limited ability to 
participate in exercise 
classes, so he stopped 
attending 
seat to help get 
into and out of 
the bath 
bungalow; new 
furniture cost 
over £3,000, 
and although 
he would have 
bought new 
anyway, he 
paid heed to 
needs 
secondary to 
ParkiŶsoŶ͛s. 
Purchased a 
shower seat 
Pain worsened 
affecting ability 
to walk. 
with. In part, 
restricted also 
because they 
have moved 
where they 
hold meetings. 
Noted in last 
year becoming 
more forgetful 
e.g. can forget 
to take 
medication, or 
forgets if he 
has taken 
them. Has 
forgotten some 
appointments, 
and becoming 
more 
distractible, 
and unable to 
sustain 
attention. 
alterations to the 
bungalow, as 
already built for 
people with 
disabilities 
Things with 
no set time 
From survey, increased use of convenience food and increasing heating costs. 
Keeps self busy with hobby of amateur radio, and radio-controlled model building, but no longer attends events as less enjoyable as pain affects how 
long he stays. It is a cost saving but psychologically distressing to be restricted. 
Some problems accessing services – e.g. had to ring and request for Nurse Specialist appointment, and is to go to clinic next month – an appointment he 
felt should be generated automatically; also was becoming inconvenient to visit hospital podiatry every 6 – 8 weeks, so arranged to pay for monthly 
podiatry appointment due to clawing creating painful calluses, and a knock-on effect on walking. 
Change in how he holidays as finds many hotels not accommodating; no lift, no shower. So whilst a cost saving as not going on holiday much, has less 
social contact as used to go with friends. One booked in April in the Norfolk Broads with a friend, but apprehensive about how stiff and immobile he will 
be following a long coach journey. 
Sleep is becoming a worsening problem over the years; now gets average 4 hours sleep. Dystonic cramping is an issue.  
 
Person 3: CC Pre-diagnostic phase Diagnostic experience Elapsing years The future 
CC is in 3
rd
 
year since 
SloǁŶess aŶd feeliŶg ͚out of sorts͛; 
ǁeŶt to GP aŶd told Ŷot ParkiŶsoŶ͛s, 
Diagnosis came as a shock, 
based on a vague 
Year 1: 
Only joined a 
Year 2: 
Received a 
Year 3: 
Slight change in 
Garden is getting too 
large to manage, so 
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diagnosis. 
Lives with 
wife. 
Codes: 
1c 
2 a & b – 
slowness at 
least a year, 
but tremor 
most evident 
symptom 
3b 
but went again and saw a different 
GP who referred him through the 
NHS to a private consultation 
(waiting list initiative).  
Initially stated this had no impact on 
retirement decision as diagnosis was 
made 4 years after retirement. On 
probing, CC realised his work at an 
outdoor museum (walking 8 – 10 
miles a day) was suffering. He was 
becoming increasingly slow, clumsy 
and experiencing loss of 
concentration. He did not take the 
option to retire at 60 as was available 
from Local Authority, but expected to 
keep going to 65 years; in the end, 
retired at 61 (has enough income, 
but less than if had gone to 65) 
recollection of a vision of 
someone he knew with 
ParkiŶsoŶ͛s ϭϱ – 20 years 
prior to this. 
He realises now that he 
bottled the diagnosis and 
didŶ͛t ǁaŶt people to 
know. His wife states he 
didŶ͛t aĐĐept it as he didŶ͛t 
tell people aŶd didŶ͛t ŵiǆ 
with people.  
Did not choose to join a 
support group. 
ParkiŶsoŶ͛s 
support group 
(cost for 
membership) 
when passed 
information by 
a friend who 
knew someone 
else with 
ParkiŶsoŶ͛s. 
They run varied 
activities, 
which CC now 
chooses to join 
in with, 
occurring a 
small cost and 
other 
contributions.  
bed rail from 
the therapists 
to help with 
the getting 
into and out 
of bed 
holidays, choosing ones 
where he would be less 
active than prior 
holidays. 
Received a stick from 
Social Services at 
recommendation of a 
physiotherapist, after 
referral from 
Consultant. For posture 
and confidence. No 
falls. 
Took part in sponsored 
ǁalk for ParkiŶsoŶ͛s ;ϰ 
– 5 miles), so still 
walking a good 
distance. Raised 
£1,200.00. 
Physiotherapist also 
organised access to a 
paid (Health for life) 
exercise referral 
scheme 2 x week. 
When the period 
stopped, CC has 
continued to pay to 
attend 2 x week 
sessions. 
thinking of employing 
a gardener. 
Continue with access 
to therapists and 
nurse specialist for 
monitoring purposes. 
 
Things with 
no set time 
Continues to do some of the guided tours at the outdoor museum for the Local Authority, but notices he forgets words. 
Had changed car at retirement, and subconsciously chosen one with a higher seat that was easier to get into and out of. 
Keeps up with physical activity walking daily between 2 – 2.5 km, plus a weekly longer walk with a friend. Tend to keep to flatter routes now. 
 
Person 4: 
AC 
Pre-diagnostic 
phase 
Diagnostic 
experience 
Elapsing years The future 
AC is a 66 
year carer 
whose wife 
(ACW) is in 
Although diagnosis 
made in 2004, AC 
can trace back 
symptoms to at 
AC 
considered 
himself a 
carer since 
Things with no set time lines that have occurred over the years with ACW. 
Costs such a prescriptions and bus pass are free in Scotland, so no expense. 
The Đosts related to joiŶiŶg ParkiŶsoŶ͛s UK iŶĐludes aŶŶual ŵeŵďership reŶeǁal, 
outings, contributions at monthly meetings and events. 
Sees future costs as transport 
– about to stop the only bus 
service, so will be dependent 
on the car. 
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her 11
th
 
year since 
diagnosis. 
Lives in a 
house 
 
Codes: 
1c 
2b 
3c 
 
least 1998. 
Diagnosis made in 
Oman, although 
had seen 
specialists in the 
UK. Back in UK, 
specialist 
concurred with 
diagnosis.  
The issue of 
stiffness and 
slowness has been 
compounded with 
ACW͛s ĐhroŶiĐ 
back problem, 
with trips to NHS 
specialists. Unclear 
of reason for back 
pain (accident in 
youth or 
ParkiŶsoŶ͛s toŶeͿ 
the day of 
diagnosis, but 
is more 
͚iŶǀolǀed͛ 
now. 
They joined 
ParkiŶsoŶ͛s 
UK within a 
year of 
diagnosis 
ACW attends Branch hosted exercise classes including singing when physically able 
(currently clashes with another social event) (£2.00 per session plus money for 
refreshments), and hydrotherapy. 
ACW continues to see a chiropractor paid for privately, as the physiotherapy 
serǀiĐes theǇ ĐaŶ aĐĐess ǀia the NHS do Ŷot haǀe speĐialists iŶ ParkiŶsoŶ͛s͛. HeŶĐe 
ACW has not seen a physiotherapist or Occupational therapist. 
Re the household, ACW still does the cooking, and they both shop. They did engage 
a cleaner 5 years ago to come 2 x week. 
Re equipment/ adaptatioŶs, ACW ďought oǁŶ stiĐk for ŵoďilitǇ iŶ the late ϭ99Ϭ͛s 
due to back pain; in 2011 took delivery of a special chair from the Local Authority, 
and in 2012 self-funded a bed that raised up and down, to make getting into and 
out of bed more easy. 
ACW now experiencing greater fluctuations with on and off periods. has affected 
holidaǇs. CaŶĐellatioŶ of holidaǇ to South AfriĐa ϮϬϭϯ last ŵiŶute as ACW ǁas ͚off͛, 
plus had an exacerbation of back pain; in 2015 they went to Peterborough on 
holiday, taking the train. Incurred more cost as for comfort, have to take First Class 
travel, plus taxis to and from station 
ACW was asked to give up her driving licence in 2015, which fitted ǁell ǁith AC͛s 
retirement 
AC considers costs are not 
insurmountable, but is aware 
the condition may progress. 
Some concerns he is in 
conversation with GP (and 
awaiting Social Service input 
for), regarding how ACW will 
get out of the house in an 
emergency when she has a 
bad back. 
AC may consider starting a 
Carer͛s group, or lookiŶg iŶto 
joiŶiŶg a geŶeriĐ Đarer͛s group 
Issues 
pertinent 
to AC 
AC only retired at ϲϱ Ǉears as eǆpeĐted last Ǉear froŵ a joď as a heliĐopter eŶgiŶeer, ǁith Ŷo tiŵe off ǁork to see to ACW͛s Ŷeeds. 
He has some health issues.  
He finds the role of carer can be difficult, but realises ACW has problems related as much to fluctuating and long standing back problems as well as 
ParkiŶsoŶ͛s. He sees his role as driǀer aŶd Đarer. 
 
Person 5: LA Pre-diagnostic 
phase 
Diagnostic experience Elapsing years The future 
LA is in her 
5
th
 year since 
diagnosis. 
Lives alone 
in house 
 
Codes: 
1c 
2b 
3b 
 At diagnosis, supportive 
employer in a prior role 
where LA expected to 
write meeting notes, 
engaged clerical support 
worker for admin tasks 
as developing 
micrographia, and 
ĐouldŶ͛t uŶderstaŶd oǁŶ 
writing. 
Year 1: 
Issues with 
bowels, so 
purchased 
(self cost) a 
toilet 
pedestal 
from health 
catalogue 
posted 
Year 2: 
Nil  
Year 3:  
Moved to bungalow 
͚ďaĐk hoŵe͛, as 
relationship broke up, 
and to be nearer 
mother who was 
unwell.  
Employed as a Local 
Authority Greenspace 
Officer (supports 
Year 4 – 5: 
Increasing stiffness, pins/ 
needles, loss of dexterity 
and constipation. Made 
work hard, as also had 
fatigue. Was off work with 
anxiety and depression since 
October 2015. Tried to 
return twice, but signed off 
again. Work times are 
About to take early 
retirement (April 
2016) on the grounds 
of ParkiŶsoŶ͛s-related 
ill health. 
Still coming to terms 
with the diagnosis of 
ParkiŶsoŶ͛s, aŶd 
looking forward to 
the fact that in a 
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 JoiŶed ParkiŶsoŶ͛s UK 
but does not attend 
meetings – receives 
Newsletter/ information 
through 
door. 
 
people͛s ǀisioŶ of 
space use and help 
them to develop skills 
to achieve the vision). 
Employed a gardener 
for tiered garden 
irregular, but can be 7 days a 
week, so hard to build a 
routine, including rest and 
meal times. 
Participates in local research 
(tied in with hospital 
consultant visits). 
Attended a dance event in 
Glasgow (petrol and parking 
costs as research paying for 
the class to happen). 
month she will have 
time to look after 
herself. 
Converting bath to 
shower (awaiting 
quotes, and will be 
self-funding).  
Signed up now to 
attend weekly dance 
for a year  
Things with 
no set time 
LA has not accessed any health services apart from medical and nursing care. She is unaware how easy referral would be as never accessed. 
Medications have altered bowel habits, and whilst there is no extra cost in terms of her diet, she has altered what she eats to higher fibre content. 
As she lives alone, does not notice some of the symptoms others pick up on 
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Appendix 4 
Information Sheet for Participants and Leaflet 
 
Research into the Economic and Social Cost of Parkinson's  
 
 
You are being invited to take part in a research project. Before you decide whether to take part it is 
important for you to understand why the research is being done and what it will involve. Please take 
time to read the following information carefully, and discuss it with others if you wish so you can 
decide whether or not you wish to take part. Thank you for reading this. 
 
Research project title 
Assessing the economic and social cost of Parkinson's on people with the condition, their carers and 
families.  
 
What is the purpose of this research? 
 
Parkinson's is a progressive, degenerative condition that primarily affects the nervous system. 
Individuals experience it in different ways throughout its course. The provision of both health 
and social care services to address the management of Parkinson's comes at great economic 
and financial cost to the government and to society. The purpose of this project is to assess 
what that cost might be. 
  
Why is this research needed?  
 
There is a lack of research in estimating total economic cost and burden of Parkinson's in the 
UK, and a study such as this can assess in detail the expenses of the condition for the 
individuals and carers, health and social care providers, and to the wider society.  
 
Am I eligible to take part/ why have I been chosen? 
 
Any person with Parkinson's, their carer and family members are eligible to take part. We 
hope for approximately 1200 people to participate in this study from across the four home 
countries. 
 
How will this research be carried out? 
If you agree to take part, you will be either sent a questionnaire to fill-in or invited to be 
interviewed by a member of the research team. The interview will last about 1 hour and take 
place at a time and venue that is convenient to you. Information will be asked on income, 
living conditions, use of the health and social care system, wellbeing of the households, and 
indirect costs to the individual and their families over the year as well as likely to occur over 
the individual's lifespan as a result of the progression of Parkinson's.  
 
Do I have to take part? 
 
It is up to you to decide whether or not to take part. A decision not to take part will not affect you in 
any way. If you agree to take part you will be offered a signed consent form to keep. 
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Will my taking part in this project be kept confidential? 
 
All information which is collected from and about you during the course of the research will be kept 
strictly confidential. The information you give will not be used in any way that could identify you. 
 
What will happen to the results of the research project? 
 
The results of this study will be a report with case studies to Parkinson’s UK and published in 
academic journals. Nobody will be able to identify you in any reports or publications. If you would 
like a copy of these results please contact the research team. 
 
Who is organising and funding the research? 
 
The Centre for Health and Social Care Research at Sheffield Hallam University are undertaking the 
research, and it is funded by Parkinson’s UK. 
 
Who has ethically reviewed the project? 
 
This research project has been reviewed by the Sheffield Hallam University Research Ethics 
Committee for ethical aspects. 
 
If you have any questions about the about the research, please contact: 
 
Centre for Health and Social Care Research, Sheffield Hallam University 
 
For more information about the research  
 
Email: Parkinsons@shu.ac.uk 
 
Please Contact  
 
Rachel Ibbotson Tel: 0114225 5793 
Anil Gumber     Tel: 0114225 5915 
Mubarak Ismail     Tel: 0114225 2239 
 
Thank you very much for reading this sheet. 
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Parkinson's Leaflet 
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Appendix 5  
Search strategy 
Pilot searches have been undertaken in MEDLINE (EBSCO).  
The searches have been written up for MEDLINE using the EBSCO interface and are 
detailed below. 
Explanation of search terms used: ti = title field; ab = abstract field; af = author affiliation 
field; / = controlled vocabulary term; exp. = controlled vocabulary term exploded; asterisk (*) 
= denotes any character; "" = phrase search; n = proximity operator. 
1. parkinson*.ti,ab 
2. parkinsonian disorders/ 
3. parkinson disease/ 
4. or/1-3 
5. cost*.ti,ab 
6. financial.ti,ab 
7. finance*.ti,ab 
8. fiscal.ti,ab 
9. economic*.ti,ab 
10. socio-economic*.ti,ab 
11. wage*.ti,ab 
12. expenditure*.ti,ab 
13. debt*.ti,ab 
14. income*.ti,ab 
15. saving*.ti,ab 
16. employment*.ti,ab 
17. unemployment.ti,ab 
18. pension*.ti,ab 
19. housing.ti,ab 
20. salary.ti,ab 
21. salaries.ti,ab 
22. paid.ti,ab 
23. outlay.ti,ab 
24. outgoings.ti,ab 
25. expense*.ti,ab 
26. price*.ti,ab. 
27. spending.ti,ab 
28. earn*.ti,ab 
29. budget*.ti,ab 
30. payment.ti,ab 
31. burden.ti,ab 
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32. sacrifice.ti,ab 
33. deprive*.ti,ab 
34. "quality of life".ti,ab 
35. carer* N3 health.ti,ab 
36. carer* N3 impact.ti,ab 
37. carer* N3 "well being".ti,ab 
38. carer* N3 wellbeing.ti,ab 
39. carer* N3 "quality of life".ti,ab 
40. family N3 health.ti,ab 
41. family N3 impact.ti,ab 
42. family* N3 wellbeing.ti,ab 
43. family* N3 "well being".ti,ab 
44. family* N3 "quality of life".ti,ab 
45. families N3 health.ti,ab 
46. families N3 impact.ti,ab 
47. families N3 "well being".ti,ab 
48. families N3 wellbeing.ti,ab 
49. families N3 "quality of life".ti,ab 
50. caregiver* N3 health.ti,ab 
51. caregiver* N3 impact.ti,ab 
52. caregiver* N3 wellbeing.ti,ab 
53. caregiver* N3 "well being".ti,ab 
54. caregiver* N3 "quality of life".ti,ab 
55. cost of illness/ 
56. costs and cost analysis/ 
57. health care costs/ 
58. health expenditures/ 
59. direct service costs/ 
60. hospital costs/ 
61. drug costs/ 
62. cost savings/ 
63. financial support/ 
64. financial management, hospital/ 
65. financial management/ 
66. economics/ 
67. models, economic/ 
68. economics, hospital/ 
69. socioeconomic factors/ 
70. salaries and fringe benefits/ 
71. employment/ 
72. health expenditures/ 
73. income/ 
74. pensions/ 
75. housing/ 
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76. quality of life/ 
77. or/5-76 
78. "united kingdom".af 
79. uk.af 
80. britain.af 
81. scotland.af 
82. england.af 
83. wales.af 
84. "northern ireland".af 
85. exp. great britain/ 
86. england/ 
87. northern ireland/ 
88. exp. scotland/ 
89. wales/ 
90. channel islands/ 
91. guernsey/ 
92. or/78-91 
93. 4 and 77 and 92  
94.  
 
Grey literature searches 
 
NICE Evidence Search = 1015 results 
 
((parkinson*) AND (cost* OR financ* OR economic* OR expenditure* OR debt* OR income* OR 
pension* OR salar* OR spending OR earn* OR budget* OR burden OR sacrifice OR "quality of life" 
OR carer OR famil* OR caregiver)) 
 
This search was shortened as the number of characters allowed was limited. The results were also 
limited to anything published in the last three years. 
 
Google.co.uk = 36,700,000 results 
 
((parkinson*) AND (cost* OR financ* OR economic* OR expenditure* OR debt* OR income* OR 
pension* OR salar* OR spending OR earn* OR budget* OR burden OR sacrifice OR "quality of life" 
OR carer OR famil* OR caregiver)) 
 
This search was shortened as the number of characters allowed was limited. 
 
  
 Page 111 
 
Appendix 6 
Breakdown of Annual Healthcare and Societal Costs by Home Countries 
 
Figure A1: Annual NHS healthcare costs to the NHS and PwP by home country and UK 
 
Table A1: Annual healthcare costs by type across home country  
 
Type of costs Country 
Number 
of 
Responses 
Cost to NHS (£) Cost to PwP (£) Mean Cost 
(NHS+OOP) Total Mean Total Mean 
Consultations 
Not Reported 1 0 0.00 0 0.00 0.00 
England 500 228422 456.84 93275 186.55 643.39 
N Ireland 5 3262 652.40 1100 220.00 872.40 
Scotland 75 30519 406.92 11975 159.67 566.59 
Wales 29 8049 277.55 4000 137.93 415.48 
UK 610 270252 443.04 110350 180.90 623.94 
Diagnosis 
Not Reported 1 0 0.00 0 0.00 0.00 
England 500 90014 180.03 9350 18.70 198.73 
N Ireland 5 1256 251.20 650 130.00 381.20 
Scotland 75 7460 99.47 1125 15.00 114.47 
Wales 29 1986 68.48 75 2.59 71.07 
UK 610 100716 165.11 11200 18.36 183.47 
Call/Ambulance 
Not Reported 1 0 0.00 0 0.00 0.00 
England 500 19194 38.39 150 0.30 38.69 
N Ireland 5 333 66.60 0 0.00 66.60 
Scotland 75 1431 19.08 0 0.00 19.08 
Wales 29 111 3.83 0 0.00 3.83 
UK 610 21069 34.54 150 0.25 34.79 
A&E 
Not Reported 1 0 0.00 0 0.00 0.00 
England 500 31570 63.14 475 0.95 64.09 
N Ireland 5 1640 328.00 0 0.00 328.00 
Scotland 75 3075 41.00 100 1.33 42.33 
Wales 29 820 28.28 0 0.00 28.28 
UK 610 37105 60.83 575 0.94 61.77 
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Inpatient 
Not Reported 1 0 0.00 0 0.00 0.00 
England 500 684443 1368.89 4400 8.80 1377.69 
N Ireland 5 18804 3760.80 0 0.00 3760.80 
Scotland 75 44227 589.69 1375 18.33 608.03 
Wales 29 9835 339.14 0 0.00 339.14 
UK 610 757309 1241.49 5775 9.47 1250.96 
Sub-total 
Not Reported 1 0 0.00 0 0.00 0.00 
England 500 1034449 2107.29 107500 215.30 2322.59 
N Ireland 5 24962 5059.00 1750 350.00 5409.00 
Scotland 75 85281 1156.16 14575 194.33 1350.49 
Wales 29 20690 717.28 4075 140.52 857.79 
UK 610 1165382 1945.00 127900 209.92 2154.92 
Medication 
Not Reported 1 213 213.20 0 0.00 213.20 
England 472 78630 166.59 8210 17.39 183.98 
N Ireland 5 640 127.92 0 0.00 127.92 
Scotland 67 14911 222.56 100 1.49 224.05 
Wales 27 4531 167.80 0 0.00 167.80 
UK 572 98903 172.91 8310 14.53 187.44 
Non-
Prescription 
Medication 
Not Reported 1 
  
60 60.00 60.00 
England 456 21300 46.71 46.71 
N Ireland 5 60 12.00 12.00 
Scotland 68 3120 45.88 45.88 
Wales 28 1020 36.43 36.43 
UK 558 25560 45.81 45.81 
Total Direct 
Medical 
Not Reported 
  
213 213.20 60 60.00 273.20 
England 1113079 2273.87 137010 279.40 2553.28 
N Ireland 25602 5186.92 1810 362.00 5548.92 
Scotland 100192 1378.72 17795 241.71 1620.42 
Wales 25221 885.07 5095 176.95 1062.02 
UK 1264285 2117.91 161770 270.25 2388.16 
Travel  
Not Reported 1 
  
0 0.00 0.00 
England 500 18705 37.41 37.41 
N Ireland 5 10 2.00 2.00 
Scotland 75 2790 37.20 37.20 
Wales 29 370 12.76 12.76 
UK 610 21875 35.86 35.86 
Equipment 
Not Reported 1 
  
1200 1200.00 1200.00 
England 484 958625 1980.63 1980.63 
N Ireland 5 1575 315.00 315.00 
Scotland 74 130725 1766.55 1766.55 
Wales 30 50150 1671.67 1671.67 
UK 594 1142275 1923.02 1923.02 
Total 
Healthcare 
Costs 
Not Reported 
  
1260 1260.00 1473.20 
England 1114340 2297.44 4571.32 
N Ireland 3395 679.00 5865.92 
Scotland 151310 2045.46 3424.18 
Wales 55615 1861.37 2746.44 
UK 1325920 2229.13 4347.04 
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Table A2: Distribution of PwPs and Carers by economic activity across home country 
Main Economic Activity  NR England 
N 
Ireland Scotland Wales UK 
PwPs 
Paid employment - full time 0 30 0 2 2 34 
Paid employment - part time 0 25 0 2 2 29 
Self-employed with employees 0 4 0 1 0 5 
Self-employed (working alone without 
employees) 0 23 0 2 2 27 
Sub-total Workers 0 82 0 7 6 95 
Unemployed (looking for work) 0 8 0 1 1 10 
Not working due to illness or incapacity 3 63 2 12 7 87 
Caring for relatives 0 3 0 0 0 3 
Early retired due to ill health 2 149 1 18 12 182 
Retired/pensioner 9 308 5 48 16 386 
Sub-total Retired/pensioner+ Early retired 11 457 6 66 28 568 
Homemaker 0 0 0 1 0 1 
Others 0 2 0 0 1 3 
Total 14 615 8 87 43 767 
Carers 
Paid employment - full time 0 48 3 8 3 62 
Paid employment - part time 0 46 1 5 2 54 
Self-employed with employees 0 11 0 2 1 14 
Self-employed (working alone without 
employees) 0 31 1 4 3 39 
Sub-total Workers 0 136 5 19 9 169 
Unemployed (looking for work) 0 9 0 0 0 9 
Not working due to illness or incapacity 0 6 0 2 0 8 
Caring for relatives 0 14 0 1 1 16 
Early retired due to ill health 0 45 1 7 3 56 
Retired/pensioner 1 204 1 26 17 249 
Sub-total Retired/pensioner+ Early retired 1 249 2 33 20 305 
Homemaker 0 14 0 1 2 17 
Volunteer 0 0 0 2 0 2 
In education or training 0 1 0 0 0 1 
Others 0 12 0 2 0 14 
Total 1 441 7 60 32 541 
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Figure A2: Annual financial costs to families by type across home country and UK 
 
Figure A3: Societal costs of Parkinson's by home country and UK  
    (Mean Costs per PwP household) 
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Table A3: Aggregated annual health and social care costs by home country 
  Annual Direct and 
Indirect Cost 
 Cost/Income Loss 
Description 
Number of 
Responses Country 
 Total 
Cost (£) 
Mean Cost per 
family (£) 
  
Health services (NHS) 
Not Reported 213 213.20 
England 1,132,273 2273.87 
N Ireland 25,935 5186.92 
Scotland 101,623 1378.72 
Wales 25,332 885.07 
UK 1,285,354 2117.91 
Health services (PWP) 
Not Reported 60 60.00 
England 137,160 279.40 
N Ireland 1,810 362.00 
Scotland 17,795 241.71 
Wales 5,095 176.95 
UK 161,920 270.25 
sub-total of Direct Medical 
Not Reported 273 273.20 
England 1,269,433 2553.28 
N Ireland 27,745 5548.92 
Scotland 119,418 1620.42 
Wales 30,427 1062.02 
UK 1,447,274 2388.16 
Travel and Equipment (PwP) 
Not Reported 1,200 1200.00 
England 977,330 2018.04 
N Ireland 1,585 317.00 
Scotland 133,515 1803.75 
Wales 50,520 1684.43 
UK 1,164,150 1958.88 
Total Healthcare Cost 
Not Reported 1,473 1473.20 
England 2,246,763 4571.32 
N Ireland 29,330 5865.92 
Scotland 252,933 3424.18 
Wales 80,947 2746.44 
UK 2,611,424 4347.04 
Non-Healthcare Costs 
Alterations in accommodation 
(PwP) 
1 Not Reported 1,000 1000.00 
480 England 251,763 524.51 
5 N Ireland 5,000 1000.00 
69 Scotland 28,713 416.12 
30 Wales 20,688 689.58 
585 UK 307,163 525.06 
Living environment - energy 
cost (PwP) 
0 Not Reported 0 0.00 
378 England 212,760 562.86 
4 N Ireland 3,480 870.00 
58 Scotland 35,220 607.24 
26 Wales 14,880 572.31 
466 UK 266,340 571.55 
Takeaways (n=582) 
0 Not Reported 0 0.00 
476 England 141,204 296.65 
5 N Ireland 3,480 696.00 
72 Scotland 21,216 294.67 
29 Wales 11,760 405.52 
582 UK 177,660 305.26 
Mobility vehicle/car (n=501) 
1 Not Reported 0 0.00 
413 England 51,063 123.64 
5 N Ireland 0 0.00 
58 Scotland 15,000 258.62 
24 Wales 250 10.42 
501 UK 66,313 132.36 
Daily living assistance 
(n=529) 
0 Not Reported 0 0.00 
432 England 948,900 2196.53 
5 N Ireland 9,360 1872.00 
66 Scotland 105,280 1595.15 
26 Wales 40,840 1570.77 
529 UK 1,104,380 2087.67 
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Total Non-Healthcare costs 
Not Reported 1,000 1000.00 
England 1,605,689 3704.18 
N Ireland 21,320 4438.00 
Scotland 205,429 3171.80 
Wales 88,418 3248.59 
UK 1,921,855 3621.90 
Income Loss (Direct 
and Indirect) 
Current Workdays lost and 
reduction in weekly hours  
(n=729) 
13 Not Reported 0 0.00 
585 England 1,213,676 2074.66 
8 N Ireland 0 0.00 
82 Scotland 98,643 1202.96 
41 Wales 131,980 3219.03 
729 UK 1,444,299 1981.21 
Current Indirect employment 
earnings forgone due to early 
retirement or inability to work 
(n=767) 
14 Not Reported 86,733 6195.24 
615 England 3,722,932 6053.55 
8 N Ireland 40,628 5078.45 
87 Scotland 490,729 5640.57 
43 Wales 271,157 6305.97 
767 UK 4,612,179 6013.27 
Unpaid caring (earnings loss)  
14 Not Reported 0 0.00 
615 England 823,680 1339.32 
8 N Ireland 0 0.00 
87 Scotland 54,912 631.17 
43 Wales 68,640 1596.28 
767 UK 947,232 1234.98 
State pension and benefit loss 
(n=583) 
1 Not Reported 0 0.00 
478 England 776,989 1625.50 
5 N Ireland 24,118 4823.52 
69 Scotland 47,146 683.27 
30 Wales 27,141 904.71 
583 UK 875,394 1501.53 
Total Income Loss 
Not Reported 86,733 6195.24 
England 6,537,278 11093.03 
N Ireland 64,745 9901.97 
Scotland 691,430 8157.97 
Wales 498,918 12025.99 
UK 7,879,104 10730.99 
Annual Financial 
Burden of Parkinson's  
On Families 
Not Reported 
  
8455.24 
England 17094.65 
N Ireland 15018.97 
Scotland 13375.24 
Wales 17135.96 
UK 16582.03 
Adding NHS costs 
Not Reported 
  
8668.44 
England 19368.52 
N Ireland 20205.89 
Scotland 14753.95 
Wales 18021.03 
UK 18699.94 
Adding Exchequer (Revenue) Loss 
Not Reported 
  
9771.20 
England 20815.34 
N Ireland 21109.85 
Scotland 15972.10 
Wales 19716.48 
UK 20122.96 
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Appendix 7 
Select Quotes on Parkinson's Impact on Employment, Quality of Life and 
Income 
Parkinson's had a varying impact on people's working life. PwP whose job responsibilities 
involved commuting, physical/manual work, vehicle/taxi/train driving, office work (including 
typing), catering, painting/decorating or even talking to customers felt an immediate impact 
on their working conditions. As a result, resignation was considered unavoidable. Few were 
able to retire in a phased manner, with no option of reducing working hours, job 
responsibilities or of demotion.  This was in contrast to those in lighter occupations (e.g. 
teaching or employed in their family business). In most cases, employers were unsympathetic 
and not accommodating to PwP (in terms of reducing their responsibilities or working hours, 
remuneration and redundancy payments), but instead offered redundancy or early retirement 
on medical grounds.  Some PwP who were able to carry on with work remained dependent on 
medication, reporting increasing guilt at not doing a proper job, or increasing stress, which 
for some led to depression. Several PwP felt the impact on their earnings and household 
income immediately, whilst for others, this was delayed. The worsening in their economic 
wellbeing compounded deterioration in their Parkinson's symptoms and QoL as noted in 
quotes from PwP and their carers below. At the end of each quote, we have mentioned in 
parentheses whether the respondent is a PwP/Carer, male/female, his/her current age, last 
job/occupation held, and Parkinson's duration (PD) since the diagnosis, as well as the country 
they are from.  
There were many more responses, and representative of people from each country. Not all 
have been included however, as they either confirm or are similar to the quotes first 
submitted and used.  Earnings loss/reduced pension, some with the additional psychological cost of losing a 
self-built business, and some the psychological cost of accepting work of lower status 
‘I was offered redundancy due to the effect Parkinson's was having on my ability to carry out 
my work role. I was made redundant at the age of 62.My husband also retired the same year (he 
was 63) to provide full time care for me. That year we lost two sources of income although my 
husband has a private pension’ (PwP, F 70, Clerical, PD 14.3 years, England). 
‘I have gone from being a voluntary sector senior manager through being self-employed part-
time to being semi-retired on my occ. pension from £51K down to circa £17K in 5 years’ (PwP, 
M 51, Senior Manager, PD 5.3 years, England). 
‘I had to retire on medical grounds from a well-paid job and because of my condition have 
had to accept a much lower paid job’ (PwP, M 58, Clerical, PD 12.3 years, England). 
‘I lost ten years pension as I had to retire early from my Primary School Headship. I was 
then unable to do any teaching without losing the whole of my pensionable rights.  This was an 
all-or-nothing approach which was disappointing and didn't make use of my good days’ (PwP, F 
63, School Head, PD 13.3 years, England).  
‘In 2009, 3 years after diagnosis, I had to close down a highly regarded nursery school which 
I founded in 1981. This had provided a good income which I lost’ (PwP, F 72, Anglican Priest, 
PD 9.3 years, England).  
‘Own business lost due to not being able to do physical work. 15 years unemployed before 
being offered a role one day a week over two afternoons with Parkinson's UK’ (PwP, F 74, Self-
employed Manager, PD 12.8 years, England). 
 Page 118 
 
‘When diagnosed I was a chemical engineer with a job earning £60K+ . I had to stop this job 
within a year due to safety. I then took an administration job in a College for 8 years earning 
£23K. I am now medically retired’ (PwP, F 42, Engineer, PD10.3 years, England).  
‘When first diagnosed I reduced my hours to 4 days a week, however the work load did not 
decrease. I was also working between two sites. By this time I was 63 with an open contract (no 
end date). I had intended to work for 4 to 6 years more to enable us to save towards our 
retirement as we used much of our existing savings towards a short fall on our mortgage. My 
decision making at meetings and in urgent situations was becoming hesitant and my typing and 
use of my right hand was becoming problematic. I requested early retirement on ill health 
grounds, I was offered part time lower graded post. The difference between this offer and my 
pension was less than £1000, I took the retirement option’ (PwP, F 66, Junior Manager, PD 3.3 
years, England).  Work involved commuting and physical labour and the costs to the work place 
‘I worked for London underground as a Signal Operations Manager on a 24/7 shift rota 
managing staff involved in the maintenance and fault finding of the signalling equipment.   This 
at times involved me going onto the track to manage the staff while trains were still running.   
When I was diagnosed with Parkinson's I informed work and was immediately put on light duties.   
I went into depression and long term sickness and was eventually medically sacked’ (PwP, M 66, 
Middle-level Manager, PD 8.3 years, England). 
‘I was commuting a 1.5 hour journey into London (on a good rail/underground day, bad day 
up to three hours) which was very debilitating. I also have osteoarthritis in both knees, so used 
crutches then and still do.  My Parkinson's affected my handwriting to the extent it was almost 
illegible and my thought processes were slowing down. Not good as part of my job was 
proofreading.  Eventually I asked for voluntary redundancy which the management accepted and 
gave me a most generous redundancy payment, way above the state requirement’ (PwP, M 60, 
Clerical, PD 11.8 years, England). 
‘I was employed by Tesco as a HGV driver with almost 40 years in service.    I was having 
difficulty staying awake and needing to park up for a 15 min break several times in a shift.  I put 
this down to not getting enough sleep.  On one occasion I feel off the trailer, I simply lost my 
balance’ (PwP, M 71, HGV driver, PD NR, country not recorded).   
‘Cannot work at height on ladders, etc.  - May lose my driving licence as ability is getting 
worse.  - Loss of business due to customers' wanting continuity of service knowing that 
realistically I cannot give them long term contracts.  - Difficulty using mobile phone.  - Cannot 
write important forms (the more important the form the worse my shake becomes)’ (PwP, M 55, 
Technical Craftsman, PD 5.8 years, Scotland).  
‘I worked for many years as a football pools collector but had to give up my round shortly 
before I was diagnosed with Parkinson's because it involved 2 to 3 hours walking and I could no 
longer stand doing this with a heavy bag over my shoulder. I still collect from three very local 
clients’ (PwP, F 62, Self-employed Manual, PD 8.2 years, England).  Alteration in ability to manage job responsibilities, with an impact on QoL (some issues 
pre-dating the diagnosis of Parkinson’s) 
‘Mobility slow- I run a diversified farm estate so have to rely on others for feedback about 
many areas which I now struggle to reach.  Less strength…Ordinary routine tasks round the 
estate are now beyond my ability.  Sleep patterns disturbed.  This affects my cognitive ability - not 
easy to focus, much slower at organisational tasks & paperwork in general. Shakiness- much 
slower to type up reports and information of all kinds.  Confidence reduced due to all of above, 
plus incontinence problems. It means that I am less good as a manager and decision maker ’ 
(PwP, F 64, Senior Manager, PD 3.8 years, England). 
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‘I became ill over a period of time, at the time I didn't have an answer too what the illness 
was, It deeply affected my life, I went from very able too unable, physically & mentally, I was a 
danger to myself and those I worked with, working in a kitchen, I had to finish work, then a 
yearlong investigation resulting in the end a Diagnosis of Parkinson's. I applied for ESA and was 
placed within the support group of ESA’ (PwP, M 46, Semi-routine Manual, PD 2.1 years, 
England). 
‘My last employment was at the University of Oxford where I worked with…the business 
orientated functions of the University and businesses worldwide to help initiate new research 
projects…and encourage other interactions of mutual benefit. The work required good 
interdisciplinary skills and the ability to engage effectively with the interests and aspirations of 
academic staff and business leaders alike.   I found it progressively more difficult to "keep up" 
with academic staff and, on reflection; I think that some of the physical symptoms of Parkinson's 
were starting to intrude into my work by 2008.  In 2010 I was diagnosed with Parkinson's and at 
the end of that year I retired on medical grounds with a reduced pension from the Universities 
Superannuation Scheme. I now spend my time either at home or helping Parkinson's charities as 
much as my condition allows’ (PwP, M 62, Senior Manager, PD 5.3 years, England). 
‘My husband was diagnosed with Parkinson's at 50 and had to retire at 57 due to ill health 
and the restrictions and restraints of the disease. I had to be the sole bread winner and was also 
looking after teenage family and elderly parents. The on-going effect of looking after him and 
being a full-time carer is very tiring and as I am getting older feeling weary with many broken 
nights sleep, doing everything in the house, garden, working and caring. You need to include this 
in your questionnaire. I am not depressed but finding it physically and emotionally challenging 
and very tiring’ (Carer, F 69, Modern Professional, PD 29.8 years, England). 
‘Having sold 65% of my general accountancy practice just before being formally diagnosed 
in February 2011 as having  Parkinson's ( which was approx. one year earlier than planned due 
to the symptoms), I have slowed down consistently since in managing the client based retained 
whereby it is approaching full time work again. I am accordingly disposing of my remaining 
client base so as to fully retire a year  or so earlier than anticipated’ (PwP, M 69, Accountant, 
PD 4.7 years, England).  
‘He was being treated for anxiety and depression before his diagnosis of Parkinson's was 
made. He was asked to resign as he could not do the job he had been employed for and they 
offered him an alternative but changed the job which was even more unsuitable when he tried to 
go back to work’ (Carer, F 66, Senior Manager, PD 7.8 years, England).  Reduction in working hours/responsibilities/demotion/job change, some which have been 
psychologically beneficial, impacting positively on health, and others detrimental to 
psychological wellbeing  
‘Was full time but struggled with health issues but changed to 3 days per week now down to 
two days due to head teacher wanting to change my working days to every other day. I work with 
autistic and multi disability 5 year olds on my feet and working on my knees most of the day 
which I need a block of days off together to recover, rest & therapies. She [Head Teacher]  had 
no understanding how part day working would not work for me’ (PwP, F 57, Teacher, PD NR, 
Wales).  
‘I resigned from my fulltime teaching as stress was aggravating my condition. Began, and 
still do, supply teaching which I find less stressful’ (PwP, M 52, Teacher, PD 1.4 years, 
England).  
‘I am self-employed in family business so have taken on another member of clerical staff to 
cover on a daily basis, meaning I can stay at home as and when I feel necessary’ (PwP, F 60, 
Self-employed Manager, PD 1.3 years, England). 
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‘When I informed my employer they 'froze' my remuneration package at my original senior 
level and demoted me 5 jobs levels to 'remove any stress'. I worked for a further 5 years before 
being forced to give up work. I was not forced by my employer who made strenuous efforts to 
retain me’ (PwP, M 67, Modern Professional, PD 15.2 years, England). 
‘The Special school that I worked in for 15 Years decided that I was unable, in their opinion, 
to carry out the majority of my job description as a Senior Teaching Assistant and they could not 
find me any other position in the school I had to take early retirement due to ill health or have my 
employment terminated.  I was at one time classed as a health and safety risk as I might freeze 
and fall on one of the children.  I was stopped from going on school trips and banned from the 
weekly trip to the swimming pool as I could fall over.  They kept focusing on this and the fact that 
Parkinson's is a progressive illness.  This only applied when they decided as I had to go with the 
school when they did a performance out of school.  I was watched and coerced into not doing bits 
of my job description by members of staff and senior management.  I also had to be assessed by 
Atos and other outside agencies.  I was of ill, recovering from a lumpectomy and facing 
radiotherapy, when I was told that I was to be terminated by the county councils human 
resources’ (PwP, F 61, Senior Teaching Assistant, PD 8.8 years, England). 
‘Well supported for first 2 years of diagnosis. I planned to take early retirement when offered 
by NHS scheme, and was also offered part time employment by my service manager. 
Unfortunately my service manager  wrote a referral to Occupational Health which I had not seen 
or signed which included symptom's which was very offensive and distressing for me and my 
family which I did not have and in the words of the occupational health lead nurse had been 
copied from a book or internet. This resulted in Grievance against my manager.  Due to changes 
in service and informed I do longer had a 'safety net'! I felt vulnerable and retired’ (PwP, F 57, 
Nurse, PD 3.3 years, England).  Forced early retirement/unable to do work/redundancy/ psychological cost from lack of 
understanding 
‘I was diagnosed with PD in summer 2005 and forced to take ill health retirement aged 57 
years. My job entailed counselling and training with much travel involved. The job was very 
satisfying, well paid but also quite stressful.  I had successfully undertaken the job for 10 years 
when I was diagnosed and foolishly confided in my boss.  I was subjected to considerable 
pressure to retire, which as the chief earner in our home, added to the stress I was already 
suffering whilst coming to terms with the diagnosis.  Once defeated and retired (unwillingly) I 
was then pressured by the Jobcentre to look for alternative poorly paid unskilled work.  However 
it was soon apparent, even to them, that this was more than I could cope with at the time as I was 
extremely tearful and emotional about the job I had loved and lost and the PD diagnosis.  In 
retrospect I can see that I really needed to retire from my job as I was under too much stress to 
function well and the stress worsened my symptoms’ (PwP, F 68, Modern Professional, PD 11.3 
years, Wales). 
‘Currently my Parkinson's prevents me from working.  Previously it had astronomical effects 
upon my working life, resulting in losing jobs and having to have endless medical tests and 
reports, 'disciplinarians' for not successfully meeting my targets, and hours spent with senior 
union representatives to defend me’ (PwP, M 63, Cleaner, PD 11.2 years, England). 
‘For some years my ability to complete my duties efficiently suffered even prior to my 
diagnosis. Eventually, I had some time off due to this when my manager offered me the chance to 
retire early. I initially, I declined the offer in the hope that medication changes may enable me to 
return to work but I eventually had to retire early’  (PwP, F 69, Clerical, PD 11.3 years, 
England).  
‘Was made redundant, then couldn't find a job when I informed prospective employers of my 
condition.  Most were sympathetic but wouldn't take the risk of me needing special facilities. The 
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Parkinson's nurse advised me to sit on my hand (The one that shakes most of a ll) at interviews so 
they didn't know I had Parkinson's and NO SHE WASNT JOKING!’ (PwP, M 61, Junior 
Manager, PD 15.3 years, England). 
‘My employers did not understand my condition and put pressure on me which resulted in me 
having a bit of a nervous breakdown and, as I was off work for a long time, they dismissed me’ 
(PwP, F 67, Modern Professional, PD 7.3 years, England).   
‘I was given ill health retirement from my job as I was a kitchen assistant in a busy school, it 
was very hard, hot, and none stop for 4 hours a day. I was very stiff when I got home and 
exhausted, I would sit in my arm chair, sleep and when come to get up could not straighten my 
back, it was almost locked and I had to walk round slowly till I loosened up. It was getting hard 
also with my left hand shaking as my Parkinson's is in my left side, also I am left handed, to serve 
the children hot gravy, custard, any hot liquid, I could have easily hurt them and or even myself’ 
(PwP, F 58, School Dinner Lady, PD 14.3 years, England). 
‘All of my work is done by hand so it has had a massive effect on my work. Having being 
diagnosed I stopped painting for almost ten years and pretty much gave up on self-employment, 
taking part time work where I could. Only starting painting (though differently now) and doing 
design work professionally again about two years ago’ (PwP, M 48, Self-employed Architect, 
PD 11.8 years, England). 
‘Was a senior Secretary to Managing Director, but eventually could not take shorthand or 
minutes at Board meetings.  Typing was also effected, speed reduced to 100 wpm to 15 wpm.  I 
stepped down to a less pressured role.    The company provided a voice activated programme to 
assist but this did not prove to be practical.    Eventually I was unable to do my job due to pain in 
neck, shoulders and hands, inability to do shorthand anymore and difficulty writing.  Sitting for 
long periods was problematic and eventually my memory and organisational skills were affected. 
After being in the job for 16+  years I took early retirement.  Losing a good salary and now have 
a reduced pension…’ (PwP, F 58, Senior Manager, PD 2.3 years, England).   Negative consequences of Parkinson’s creating social/family problems impacting on QoL 
‘I managed to work part-time for 10 years before it all got too much for me. I no longer felt 
motivated to get the work done and didn't feel on top of the job at all. I was struggling with 
sleepiness, soft voice, problems with continence, depression, loss of self-esteem, and lack of 
mental sharpness while at home I was dealing with the breakdown of my marriage and debt. I 
was dismissed on the grounds of incompetence due to ill health (with my agreement) and received 
an enhanced occupational pension’ (PwP, F 63, Modern Professional, PD 16.9 years, England). 
‘PD mainly affects my voice: I moved back to UK from Moscow (my home of almost 20 
years), leaving behind a wife & daughter who couldn't support me. I chose to leave: It broke my 
heart’ (PwP, M 53, Self-employed Tutor, PD 2.8 years, England). 
‘I personally feel that my PD was a contributing factor in our company's liquidation; because 
I made so many mistakes as Finance Director, whilst trying to get my medications working for 
me English tutor’ (PwP, M 69, Junior Manager, PD 11.1 years, England). 
‘I was medically retired from my job as medical secretary to a local GP practice.  I was 
conscious that I was beginning to lose concentration and was worried about making mistakes 
which could affect other people's lives.  I was becoming forgetful and not meeting deadlines, 
routine computer work was taking longer.  The crunch came when I crashed the practice 
computer system.  I knew then that I could not carry on and sought medical retirement’ (PwP, F 
60, Clerical, PD 7.4 years, England). 
‘Had to give up work soon after we married to preserve his health and quality of life in order 
to live as normally as possible and stay off PD drugs for as long as possible as diagnosed so 
young’ (Carer, F 56, Teaching Assistant, PD 29.3 years, England).  
